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Abstract
The main purpose of this thesis is to develop a population-based cel-
lular model of remodeled electrophysiological properties in a single
cell of a human ventricle under heart failure conditions. The devel-
oped model is used to study ventricular arrhythmia (VA) applications
under heart failure (HF) conditions, such as inducing early afterdepo-
larizations (EADs) in single cells and initiating spiral waves in tissue.
Early afterdepolarizations as well as reentrant waves are an important
cause of ventricular arrhythmias in heart failure. However, the un-
derlying transmural distribution of alterations in currents is unknown.
Therefore, it is important to study the impact of remodeled transmu-
ral currents on inducibility of early afterdepolarization in heart failure
across population-level variability. We seek to develop a population-
based transmural heart failure electrophysiological model and assess
the relative contribution of each ionic current in early afterdepolar-
ization development during HF. We developed an electrophysiological
model that incorporates HF-induced remodeling of related currents,
pumps and exchangers as documented in the literature, by modifying
a recently published model of human ventricular cell electrophysiol-
ogy, namely the O’Hara, Virág, Varró, and Rudy (OVVR) model. To
do so, we broke down our work into the following categories: First,
we analyzed healthy human models where we implemented six cellu-
lar models under normal conditions in tissue to validate the behavior
of these models. Second, we developed and analyzed a human heart
failure model, where we developed a general HF model in an isolated
myocyte and characterized the difference between normal and HF
electrophysiological properties in a single myocyte (0D). The analysis
included action potential (AP) properties, sodium concentration and
calcium dynamics. We used steady-state and S1-S2 protocols to as-
sess the dynamics of the developed HF model. In addition, we built
a more human-specific HF model and introduced population-based
remodeling variability on the developed human-specific HF model for
three cell types as observed experimentally. Then, the developed HF
models were extended to include the analysis of a one-dimensional ca-
ble (1D) where we measured the conduction velocity (CV) under HF
conditions and compared it with the normal case. Since arrhythmia
can be caused by abnormal formation and/or propagation of the ex-
citation wave, it is important to investigate the behavior of our devel-
oped models under this scenario. Therefore, we induced arrhythmia
in a two-dimensional (2D) tissue by initiating spiral waves using a
cross-field stimulation protocol. Then, we measured the vulnerability
window, stability of reentrant waves, spiral tip trajectory, duration of
induced arrhythmias, dominant action potential duration (APD) and
rotation period in the myocytes that constituted the tissue during
reentry. Third, we assessed the inducibility of EAD for the general
HF model as well as the human-specific HF model across population-
level remodeling variability for all types of human ventricular cells.
Our thesis should help to elucidate the roles of alterations in electro-
physiology on ventricular arrhythmia properties during HF.
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More than 15 million Americans suffer from coronary heart disease (CHD) in the
United States. One-third of them suffer from heart failure (HF) and ∼280,000
die yearly [71]. HF is characterized by decreased contractility and an inability of
the ventricles to pump enough blood to the body.
At the cellular level, HF is accompanied by remodeling of the ion channels
that govern the electrical activity of the heart. During HF, the electrophysiology
and the associated arrhythmogenesis mechanisms are altered and this alteration
depends on the etiology that led to HF [38]. Therefore, HF cannot be represented
by a single set of electrophysiological changes. However, there are a number of
consistent findings thought to be important for arrhythmogenesis. These include
ion channel remodeling, altered calcium homeostasis, and increased accumulated
sodium concentration [38; 70]. Many experimental studies observed altered ionic
currents and exchangers in failing human ventricular myocytes [38; 40; 70; 141;
144; 174]. Moreover, non-invasive measurements have confirmed differences in
membrane potential and calcium dynamics between failing and non-failing human
hearts [139; 144], with potentially pro-arrhythmic implications [40; 174].
Therefore, understanding the impact of HF remodeling at the cellular level
on the dynamics of cardiac electrical activity and ventricular arrhythmia proper-
ties necessitates investigating how a remodeled transmural human heart failure
cellular model and its variability for each ventricular cell type affects the cellular
electrophysiological properties and contributes to inducing early afterdepolariza-
tions. This will help elucidate how the alteration of ionic channels on a single cell
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could impact the related action potential properties and induce the incidence of
ventricular arrhythmias. In the meantime, many researchers have studied the ab-
normalities at sub-cellular and cellular levels for many years on a single myocyte.
However, these studies did not investigate how the heterogeneous remodeling un-
der HF modulates the electrophysiological properties that may lead to arrhyth-
mias considering all remodeled currents. In addition, previous studies did not
introduce uncertainties in their HF models explicitly. These uncertainties may
represent the averages from different HF causes or the variability between isolated
myocyte samples from the investigated subject. Therefore, we constructed an HF
population-based model by incorporating the upregulation and downregulation
of transmembrane current conductances as observed in experiments.
1.1 Thesis Contribution
This dissertation develops a new heart failure model considering uncertainties of
remodeling ionic channels. In addition, it assesses the roles of electrophysiological
remodeling in ventricular arrhythmia (VA) development, e.g. early afterdepolar-
izations (EADs) during heart failure (HF). The main components of the thesis
contribution can be summarized as follows:
1. Assessment of the behavior of human ventricular cell models in tissue level
to ease selecting an appropriate model for a target application.
2. Development of an electrophysiological heart failure (HF) model, based on
recent human ventricular experiments, by proposing real and precise alter-
ations of ionic currents, permeabilities, and exchangers that may lead to
one form of cardiac arrhythmia such as alternans (ALTs), or early afterde-
polarizations (EADs) in an isolated myocyte.
3. Introduction of uncertainties to the developed HF model through generating
a population of remodeling ionic currents based on experimental observa-
tions for different cell types.
4. Investigation of the properties such as the conduction velocity (CV) in a
1D cable of HF-remodeled cells.
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5. Investigation of the properties such as the initiation and dynamics of reentry
in a 2D tissue of HF-remodeled cells.
6. Prediction of the formation of early afterdepolarization (EAD) formation
across population-level variability in ion channel expression for all human
ventricular cells under normal and HF conditions.
1.2 Thesis Overview
This dissertation is organized into seven chapters and these chapters can be de-
scribed as follows:
Chapter 1: Introduces the thesis contribution and reviews the structure of the
whole thesis.
Chapter 2: Presents a background on the cardiac anatomy discipline, followed
by an explanation of the types of ventricular remodeling. Then, an overview
of the previous observations of anatomy remodeling for patients with HF
is discussed. After that, it reviews background on the cardiac electrophys-
iology discipline with preceding findings on the main ionic currents and
exchanger dynamics under HF conditions in lab experiments and simula-
tion studies. Finally, a literature review for previous heart failure models
is discussed.
Chapter 3: Presents the methods that have been used throughout the thesis.
The measurement of restitution curves and accommodation is explained.
Then, the spiral wave dynamics and tip trajectory methods are stated.
After that, the cardiac electrical modeling in single cells and tissue is pre-
sented. The numerical methods, including the spatio-temporal discretiza-
tion and boundary conditions handling are explained. In addition, the
implementation tactics for efficient computation gain, which include con-
structing lookup tables, parallelization, and operator splitting are described.
Chapter 4: Presents a quantitative analysis of the behavior of human ventricu-
lar cardiac electrophysiology models in tissue under normal conditions. It
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begins with describing the model formulation of the chosen ventricular cell
models. Then, a comparison of the action potential shape, main transmem-
brane currents, and calcium transient dynamics in single cells is presented.
After that, transmural variations in action potentials are mentioned. Lastly,
a tissue level analysis is conducted.
Chapter 5: Presents the developed HF electrophysiological cell model with a
detailed explanation of each altered ionic current and pump and how each
affects the shape of an action potential (AP). Then, we present a quanti-
tative analysis of the HF model properties in a single myocyte (0D) along
with a comparison of the original undiseased model. The analysis of 0D
properties includes the AP morphology, the rate dependence of an AP and
the major currents and exchangers. Steady-state (S-S), S1-S2, and abrupt
change restitution curves of an APD are used to assess the behavior of
the developed HF model in single cells. Also, the dynamics of alternans
in an isolated myocyte are investigated. The HF model properties in a
single myocyte are compared with the experimental observations from the
documented literature of human species when applicable. In addition, a
comparison with previous HF model findings is conducted. After that, we
present a quantitative analysis of the HF model in a 1D cable. The anal-
ysis of 1D cable properties includes the rate dependence of an AP and the
major currents. Steady-state (S-S), S1-S2, and abrupt change restitution
curves of an APD and CV were used to assess the behavior of the devel-
oped model in tissue. In addition, the dynamics of alternans in 1D tissue is
characterized. Then, the HF model properties in a 1D cable are compared
with experimental observations from the documented literature of human
species when applicable. Finally, a quantitative analysis of the HF model
in a 2D tissue is presented. The analysis of the 2D sheet includes the tip
trajectory patterns of the spiral wave, dominant APD and rotation period.
Chapter 6: Presents an application of the developed HF model in single cells.
An assessment of the induction of early afterdepolarization (EAD) forma-
tion for the general HF model and human-specific model across population-
level variability in ion channel expression for transmural human ventricular
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cells is conducted. The simulations involve varying ten ionic current param-
eters one at a time with fixing all other nine parameters. The assessment of
inducing EADs is based on three different quantitative measurements: the
onset of EAD cycle length (CL), the range of CLs for which EADs can be
induced, and the number of additional peaks (upstrokes) during the induc-
tion of EADs. Lastly, a comparison with the original model is conducted,
in terms of inducing EADs.
Chapter 7: Presents the conclusion, limitations, and future research directions.
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Chapter 2
Background and Related Work
The heart is an important organ of the cardiovascular system and its anatomical
structure is very complicated [68]. It is a synchronized muscular pump that
is responsible for circulating the blood; it supplies approximately 8,000 liters of
blood [155] and beats 100,000 times each day [155]. The heart contracts with each
beat to circulate the blood through every part of the body, and the contraction
of the heart is stimulated by the electrical activity which is known as an action
potential (AP), or transmembrane potential (TMP).
2.1 Cardiac Anatomy
The heart is situated close to the anterior chest wall, directly behind the sternum,
which resembles a pyramid in shape. The inferior pointed tip of the heart muscle is
known as the apex and the other end of the heart, which is located posterior to the
sternum, is known as the base. A common human heart measures approximately
12.5 cm between the base and apex [155]. The heart is a hollow muscular organ
that consists of four chambers. They are connected vertically in pairs as the
right atrium (RA) and right ventricle (RV), along with the left atrium (LA)
and left ventricle (LV), as indicated in Fig. 2.1. Each pair is separated by an
atrioventricular valve to prevent the back-flow of blood into the atrium, where the
tricuspid valve separates the RA and RV and the mitral valve separates the LA
and LV. A normal human heart is encompassed by a double-walled sac known as
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Figure 2.1: Human heart anatomy. Reproduced from [97]
the pericardium. This wall can be categorized into three layers: the epicardium
layer, which is the visceral pericardium that constitutes the exterior surface of
the heart, the midmyocardium layer, which is the muscular wall that constitutes
both the atria and ventricles, and the endocardium layer, which covers the heart
valves and forms the inner surface of the heart [155].
The primary function of the heart muscle is to pump the oxygenated blood
to the whole body and the deoxygenated blood to the lungs. The oxygenated
blood starts from the lungs and then travels through the pulmonary veins to the
LA, after which it discharges into the LV through the mitral valve. When the
LV contracts, it discharges the oxygenated blood to the whole body through the
aorta. Deoxygenated blood returns to the heart from the whole body to the RA
through the inferior and superior vena cava and it discharges into the RV through
the tricuspid valve. When the RV contracts, it discharges the deoxygenated blood
to the lungs through the pulmonary artery. The LV muscular wall is thicker than
the RV muscular wall, as depicted in Fig. 2.1, because the systemic circulation,
which is the general circulation of the blood through the body, has four times
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higher pressure than the pressure in the pulmonary circulation, which represents
the blood flow from the heart muscle to the lungs and vice versa [53].
Each cardiac beat could be separated into two phases: systolic phase and
diastolic phase. Atria store the blood in the diastolic phase to ensure that the
ventricles are emptying the blood, while the ventricles contract in the systolic
phase. Then, the atria contract to fill the ventricles with the blood.
2.2 Heart failure progression and ventricular re-
modeling:
Heart failure is a clinical syndrome resulting from structural (anatomical) and/or
functional (electrophysiological) disorders. Under HF conditions, the muscle of
the heart wall begins gradually to weaken and enlarge. This prevents the heart
muscle from pumping enough blood to the body.
Ventricular, or cardiac, remodeling can be defined as an alteration in the
structure of the heart muscle, function of the heart muscle, or both together as a
result of hemodynamic load and/or cardiac injury. The remodeling development
could include molecular, cellular, structural, or functional alterations. During this
development process many elements are involved such as fibroblasts. However,
the main element involved in this development process is a cardiac myocyte.
Patients who had severe cardiac remodeling manifested these changes over a long
period of time [66; 206]. However, mechanisms other than remodeling also can
affect the evolution of heart disease. In addition, the heart disease progression
may develop without remodeling.
Heart failure is commonly verified by changes in cardiac dimensions and pres-
sure, and it is projected as a degradation in cardiac performance. The anatomy
remodeling could cause an increase in the ratio of chamber diameter-to-wall
thickness that is associated with elevated wall stress and ventricular dysfunction
[48; 110]. Some reports [67; 217], indicate that the chamber dilated in patients
with HF is due to excessive myocyte lengthening. Data from animal models with
HF support the concept that myocyte elongation without concomitant transverse
growth may be a hallmark of ventricular dilation and HF [127; 275]. Myocyte
8
length-to-width ratio increases in humans with HF from ischemic and dilated
cardiomyopathy [67; 217].
2.3 Cardiac Electrophysiology
2.3.1 Action Potential Generation
The heart muscle regularly and continuously contracts without resting. Each car-
diac contraction undergoes a series of electrical and mechanical events that leads
to a cardiac cycle, which is the duration that the heart needs to complete all
mechanical and electrical events for one period. Each cardiac cell is surrounded
by an insulating thin membrane that consists of two layers of lipid molecules and
whose thickness is about 7.5-10 nm, [148]. This membrane regulates the flow
of ions between inner and outer space of the cell and isolates the inside of each
cell from the surrounding environment. The membrane behaves as a capacitor
because it stores energy in the electric field created between the inside and the
outside of the cell membrane and then discharges it. However, most of the ions
can travel across the cell membrane through voltage sensitive channels that are
species-specific. The most important ions that pass through the membrane are
sodium (Na+), calcium (Ca2+), and potassium (K+). The difference in intracel-
lular and extracellular potentials is called the transmembrane potential (TMP) or
simply action potential (AP). The electrical potential across the cell membrane
changes transiently as a consequence of the flow of different ions through the cell
membrane. When a cardiac cell is at rest, the intracellular sodium concentra-
tion (Na+) is ∼ 10mM compared to ∼ 145mM extracellularly. This means that
the concentration gradient of Na+ ions favors inward diffusion [62]. Likewise, the
Ca2+ concentration also diffuses inwardly because the extracellular concentration,
between 1− 2mM at rest, is much higher than the intracellular concentration,
which is in the range of ∼ 50− 300nM . Conversely, the extracellular concen-
tration of K+, ∼ 4mM , is less than the intracellular concentration, ∼ 135mM ,
which causes the K+ ions to diffuse outside the cell.
In addition, it depends on the Nernst potential (which is the voltage for which
there is no net diffusion across the membrane for a given ion species in the absence
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of other ions) of each channel that carries specific ions across the cell membrane.
When a cell membrane is at rest, the main ion species that contributes to the
membrane permeability is K+, through the inward rectifying potassium current
(IK1), which will close at the Nernst potential for K
+ (EK) at about −96mV .
Therefore, the TMP of a cardiac cell, which is approximately between −90mV
and −70mV , is near the equilibrium potential of the K+ ions [200]. At the K+
equilibrium potential the outward K+ ion flux from diffusion due to the con-
centration gradient exactly matches the inward K+ ion flux, due to electrical
gradient. As a result of applying an external stimulus current directly to the
cell, and/or implicitly through the diffusive current from the adjacent cells via
gap junctions, the TMP potential will rapidly increase and trigger cellular acti-
vation when the TMP reaches ∼ −50mV . This activates the voltage-dependent
fast sodium channels, which permit the influx of sodium ions and depolarize the
cell membrane, as depicted in Fig. 2.2. The permeability of Na+ channels per-
mit Na+ ions to flow inside the cell until the transmembrane potential reaches
the Nernst potential of Na+, which is ∼ 20mV . This depolarization phase is
maintained only for a few milliseconds because it is derived from the fast sodium
current (INa), which inactivates quickly. These Na
+ ion channels remain inacti-
vated until the TMP repolarizes below ∼ −50mV , when the cardiac myocyte is
in the absolute refractory period, which means that the cell cannot be activated
during this period. During the depolarization phase, the permeability of K+ ion
channels is reduced. However, partial repolarization occurs due to the outflow of
the K+ ions, primarily through the transient outward current (Ito).
In the meantime, the late calcium current (ICaL) is activated because the
voltage increases enough during the depolarization. Therefore, the Ca2+ channels
voltage-dependence will be activated. Calcium-induced calcium release (CICR)
will activate the intracellular release of calcium channels from the sarcoplasmic
reticulum (SR) that causes the cell to contract. As a consequence of the relative
equilibrium between the flux of calcium ions toward inside of the cell membrane
and the flux of potassium ions toward outside of the cell membrane, the TMP
maintained without change during the plateau phase. Through both the delayed
rectifier potassium (IK) and the inward potassium (IK1) currents, additional K
+
channels will open and the TMP will begin to repolarize. This will cause the TMP
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Figure 2.2: Ventricular action potential with a schematic of the ionic currents
flowing during the phases of an action potential. The potassium current IK1 is
the principal current during phase 4, and it determines the resting membrane
potential of the myocyte. The sodium current generates the upstroke of the ac-
tion potential (phase 0); activation of Ito with inactivation of INa inscribing early
repolarization (phase 1). The plateau (phase 2) is generated by a balance of repo-
larizing potassium currents and depolarizing calcium current. Inactivation of the
calcium current with persistent activation of potassium currents (predominantly
IKr and IKs) causes phase 3 repolarization. Reproduced from [236]
to return close to the Nernst potential of K+. During the repolarization phase,
the sodium channels recover from inactivation, which allows the cardiac cell to
activate again if stimulated. During this time, the cell is said to be in the relative
refractory period [277]. The sodium-calcium exchanger INaCa current is important
for Ca2+ handling, but it does not affect the plateau phase with its contribution
during the late phase of an AP. Similarly, the sodium-potassium exchanger INaK
current plays a minor role in the plateau phase. Both exchangers mainly function
to create and maintain the Na+, K+, and Ca2+ gradients balanced across the
cell membrane.
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2.3.2 Action Potential Propagation
One study [277], indicated that under normal circumstances, the human heart
beats ∼70 times a minute with the timing of the heart beat cycle governed by
the electrical signals. These electrical signals are driven by a small group of
self-excitatory cardiac cells, known as pacemaker cells, that usually reside in
the right atrium (RA). This cluster of cells is known as sino-atrial (SA) node.
These specialized cells depolarize spontaneously during diastole, as a result of
interaction between an inward leak of sodium ions via the If current, activation
of T-type Ca2+ channels, and/or the net inward current from the INaCa current
[136]. These pacemaker cells are spontaneously excited when a certain Na+
activation threshold is reached and the L-type calcium channels are opened.
Propagation of this transmembrane potential spreads from cell to cell via gap
junctions, which directly couple and allow ion diffusion between cells, throughout
the RA and LA to the insulating barrier between the atria and ventricles, atrio-
ventricular (AV) node. The AV node slows conduction velocity from 0.5-1 m/s
to 0.05-0.1 m/s to ensure that there is a gap of time allowing the ventricles to
be filled with the blood before contracting sequentially after the atria. Normally,
the AV node is less driven by the SA node rhythm, which prevents automaticity
of the AV node [4; 148]. Following the activation of the AV node, the ventricles
activate swiftly through a specialized conduction system. This system includes
the bundle of HIS, which is a group of specialized heart cells and part of the
cardiac conduction system, the right and left bundle branches, and the Purkinje
network, which has a rapid conduction speed about 3-5 times faster than the
speed of propagation through the ventricular muscle. The bundle of HIS and
the right and left bundle branches reside in the interventricular septum, whereas
the Purkinje system resides on the endocardial surfaces, in humans and some
animals, such as canines. The process of ventricular activation begins at the
inter-ventricular septum and then propagates swiftly to the endocardial surfaces
of the RV and LV, spreading to the epicardium, and from the apex to the base:
see Fig. 2.3.
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Figure 2.3: Representative action potential during normal rhythm from the SA
node, atria, AV node and ventricles. The vertical line on each action potential
recording indicates a common time reference. Reproduced from [172].
2.3.3 Ventricular Arrhythmia and Heart Failure
When the pathways that convey the electrical activity become structurally dam-
aged, the normal pattern of this electrical activity gets disturbed, a phenomenon
known as arrhythmia. Generally, we can classify cardiac arrhythmias into two
classes, tachycardia, where the heart rate increases, and bradycardia, where the
heart rate decreases. The mechanisms underlying these types of arrhythmias
generally are different. It could be organized such as stable monomorphic ven-
tricular tachycardia (VT), or disorganized electrical activity such as sinus tachy-
cardia. Cardiac arrhythmias can be confined to the atria or to the ventricles.
Atrial arrhythmias include atrial tachycardia (AT), atrial fibrillation (AF), and
supraventricular arrhythmias (SVT). Ventricular arrhythmias (VA) include ven-
tricular fibrillation (VF), ventricular tachycardia (VT), and premature ventricu-
lar contraction (PVC). VF is more severe than AF because AF causes rapid and
irregular ventricular rate as well as an increased risk of stroke, whereas VF com-
promises the heart’s ability to pump blood, which may lead to sudden cardiac
death (SCD) [95]. Mortality in the USA alone from the SCD ranges between
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300,000 and 400,000 deaths annually [202; 276]. Most of these deaths, ∼84%,
are caused by VT [42] because the currently available treatment is insufficient to
prevent SCD, as ventricular arrhythmias degenerate quickly in a way that do not
leave time to diagnose VF before it is life-threatening [89; 95; 276]. Usually, VT
easily degenerates into VF [17; 226] and quickly leads to SCD.
Figure 2.4 shows the general classification of cardiac arrhythmia mechanisms.
The dysfunction of cardiac electrical activity may arise either as impulse genera-
tion abnormalities, impulse propagation abnormalities, or both together [89; 90;
226; 277]. On the one hand, the abnormality occurs from the generation of the
action potential and can be categorized into two main classes: spontaneous ac-
tivity and triggered activity. In spontaneous activity, the rhythms can be normal
or abnormal in which case other cells, besides the SA node, initiate APs (ectopic
focus). In triggered activity, there are two kinds of rhythms: early afterdepolar-
izations (EADs), which happen with extra depolarization during either plateau
phase, or repolarization phase of APs and delay afterdepolarizations (DADs),
which occur with abnormal stimulation during late repolarization phase, or early
resting phase of an AP.
On the other hand, the abnormality that occurs in the propagation patterns
of the AP can be classified as conduction block and reentry. Block within the
conduction system can occur at the SA node, AV node, or bundle of HIS, as well
as in normal atrial or ventricular myocardium. The propagation of a wavefront
as a spiral or scroll wave, where the electrical activation continually reenters
previously excited tissue, is known as reentrant electrical activation, or simply
reentry. The wave may circulate around an obstacle that is associated with
anatomical structure, such as blood vessels, infarct scars, or branches of the
Purkinje network where this kind of reentry is known as anatomical reentry.
Alternatively, the reentry may not be associated with anatomical structure and
is said to be functional reentry where the wavefront propagates around the central
area of unexcited tissue [240]. In this case, refractory tissue functions the same
as the anatomical structure obstacle by blocking the propagation of the electrical
wavefront. Functional reentry is more common in ventricles [240] because they
have fewer tissue ridges and large vessels than the atria. Reentry is considered
to be an essential cause of many cardiac arrhythmias [5; 58; 75] and it may lead
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to sustained tachycardia and fibrillation.
There are complicated interwoven factors that predispose patients with ven-
tricular arrhythmias to congestive heart failure and vice versa. Also, HF could
be caused by other diseases such as myocardial infarction, and cardiomyopathy.
2.3.4 Computational Modeling
Traditional experiments and mathematical models can be complementary. Ide-
ally, researchers use experimental observations to propose an appropriate frame-
work for mathematical models and benefit from the results of these models to
improve future experiments. In this way, it is possible to verify simulation results
and to make predictions for situations that are difficult to implement in the lab.
Therefore, for the last two decades, there has been a paradigm shift from
experiments to computer simulations that model the electrophysiological condi-
tions of the heart [35; 83; 122]. The reasons to use computational methods can
be classified into three categories. First, often it is difficult to control the ex-
perimental environment, and it is difficult to record experimental observations
without altering the physiological processes that are under investigation, because
it is not always possible to isolate one component from many variables present in
a heart tissue. Second, advances in computer power, speed, and capacity allow
researchers to simulate electrical propagation of the heart within an anatomically
realistic geometry in three dimensions. Third, advanced knowledge in under-
standing physiological properties of the heart at microscopic levels has allowed
the advancement of more sophisticated mathematical computational models.
Cardiac electrophysiology modeling has many advantages over experiments.
First, with computational models, any variable can be easily viewed at any time
step in the solution domain. Second, we can create different scenarios that repre-
sent different pathophysiological cardiac conditions, through adjusting the input
model parameters, and examining the effect of this adjustment on the results of
the model. We can benefit from these results to forecast the behavior of new
cardiac diseases and suggest suitable therapies.
Fundamentally, many models of cardiac physiology [35] are dependent on the































































































































































































































































































































models depending on the scale of how it represents the diffusion term (simu-
lates the propagation of the electrical wave that triggers the cardiac contraction)
namely, Eikonal Models (EM), Phenomenological Models (PM) and Ionic Models
(IM). EM models [37; 119; 218] calculate only the time of depolarization of the
electrical wave at specific spatial positions of cardiac tissue. They can be very
fast to compute [32], almost in real time [186] using a fast marching method
[54]. This type of model has one or two parameters that can control the whole
model. However, it cannot be used to simulate complex arrhythmias because of
the complexity of the wavefront curvature as well as its refractoriness. PM models
[3; 18; 60; 166] are based on partial differential equations (PDEs) in simulating
the diffusion of the electrical wave at the tissue level. The PM models are more
complex than EM, because the PM model can be controlled using two or three
parameters, but it needs more computational resources. IM models [176; 177; 232]
are based on ordinary differential equations (ODEs) to simulate the propagation
of the electrical waves at the cellular level including ionic interactions within the
cell. These models are very complex because it has more than fifty parameters
and it is very slow to compute due to the high computational cost demands.
However, they are the most realistic models because they have the ability to sim-
ulate ionic currents and concentration dynamics simultaneously inside the cell.
Also, we can use IM models to construct larger tissues and investigate the tissue
properties, rather than investigating the single cell properties.
2.3.5 Reentry waves in a 2-dimensional sheet
One of the fastest communication systems available within the human body is
the signaling information that propagates through the myocardium in the form
of electrical waves. Under normal circumstances, these electrical waves stimulate
the cardiac muscle to contract in a controlled and organized rhythm. Any depo-
larization or repolarization disturbance that occurs to these electrical excitation
waves may give rise to cardiac arrhythmias. One of the most dangerous cardiac ar-
rhythmia classes is known as reentrant ventricular arrhythmias, or simply reentry.
Reentry has two forms: ventricular tachycardia and ventricular fibrillation. For
ventricular tachycardia, the heart rate is increased substantially and for the ven-
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tricular fibrillation, the heart rate becomes disorganized. In reentrant ventricular
arrhythmias, the wavefront periodically reenters previously excited tissue where
in many cases it degenerates to ventricular tachycardia, or ventricular fibrillation,
which may lead to sudden cardiac death (SCD).
2.3.5.1 Reentry wave types
There is consensus among scientists that many life threatening arrhythmias be-
gin with reentry [117; 146; 196]. For ventricular reentry to happen, two tissue
conditions are required for an excitation wavefront: the excitable and unexcitable
(obstacle) tissue. Based on continuing research, people classify the formation of
reentrant excitation waves based on how this obstacle is formed. The reentry
waves can be classified as follows:
• Anatomical reentry
The idea of reentrant activation is always associated with the wavefront
propagating around an obstacle, which in this case could be infarct scars,
blood vessels, or branches of the Purkinje network. When reentry is fa-
cilitated by anatomic structure, there will be a clear reentry path in the
underlying structure of the tissue.
• Functional reentry
When there is no clear path in the underlying tissue structure during reen-
try, it is classified as functional reentry and it is always associated with the
ionic kinetics in a single myocyte.
2.4 Literature review of electrophysiological re-
modeling in human HF
One of the prominent hallmarks of heart failure is the prolongation of action
potential duration (APD) of a failed ventricular myocyte. This APD prolongation
could be caused by many underlying remodeled ionic current mechanisms such as
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the decrease of an outward current [114; 115], the increase of an inward current
[243], or the inactivation alteration of the calcium current [93; 182; 256].
Although characterizing the cellular electrical activity under heart failure con-
ditions is essential to the electrophysiological community, few studies address this
problem at the biophysical level of probing the effect of the electrical propagation
on the whole myocardium. Our aim is to remodel ionic currents and exchang-
ers on a single myocyte depending on experimental observations and investigate
the effects of this remodeling on the whole myocardium. The related previous
experimental observations can be classified based on the alteration (up/down-
regulation) of each current and pump, which is under HF conditions compared
to the control heart conditions.
2.4.1 Alterations in sodium (Na+) currents
Generally, (Na+) currents can be classified into two categories: fast and slow (or
late). Neither the fast sodium (INa) nor the late sodium (INaL) currents, are well
studied in heart failure myocytes. However, recently some research and experi-
ments have been done to elucidate the effects of these depolarization currents on
heart failure.
• Fast sodium (Na+) current
It is widely accepted that the INa current is responsible for rapid activa-
tion (depolarization phase) of an action potential (AP) [214; 243] and it is
the main contributing factor in determining the conduction speed at the
whole myocardium level, because it provides energy to a cardiac cell that
stimulates electrical propagation. Therefore, any reduction in the INa cur-
rent will contribute to slowing the conduction velocity (CV) in HF [149],
which favors reentry [172]. In addition, the inactivation of the INa current
is important in repolarizing an AP [210; 242]. Accordingly, slow rates of
inactivation in the INa current, which is one of the observations that accom-
panied cardiac arrhythmias in HF, will produce a large inward INa current
during the plateau phase causing failure to repolarize the AP [24; 241], in-
creasing the propensity for EADs [241], and tendency for life-threatening
VAs [169].
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The majority of the studies suggest that the peak of INa current is reduced
under HF conditions [65; 221; 246]. However, these studies tested different
species and have different percentages of this reduction ranging between
↓39.3±6.5% - ↓91.1±9.3%. On the contrary, one study reported that the
peak of the INa current is unchanged [211]. The findings of all these stud-
ies are summarized in Appendix B Table A.1 in chronological order with
consensus studies first, followed by dissenter studies.
• Late sodium (Na+) current
A late sodium current is an ultraslow inactivation and reactivation current,
which participates in both the plateau and repolarization phases of an AP
[120; 150; 249], which means that an alteration of this current will prolong
or reduce an action potential duration (APD). Also, it has been reported
that this current contributes to generating arrhythmias [246]. The INaL
current is significant in maintaining the plateau phase of an AP as reported
by [150] in human ventricular myocytes. This means that this current can
modulate the APD with a range of pacing rates, especially in HF [150]. In
addition, this current also contributed to the repolarization phase of an AP
in human and rabbit ventricular trabeculae [249], which may prolong APD
and participate in generating an arrhythmia in failing human and canine
hearts [246].
Most of the studies reported an increase in the INaL current in human and
animal heart failure [151; 152; 244; 246] with a wide range of enhancement
↑30±0% - ↑238.5±1.3%, when compared to normal hearts. However one sole
study [150] observed the same maximum density of INaL current on both the
normal and failing human ventricular cells. The more detailed observations
of these studies are summarized in Appendix B Table A.2 in chronological
order with consensus studies first, followed by dissenter studies.
2.4.2 Alterations in L-type Calcium (ICaL) Current
The primary functions of this current are maintenance of the plateau period of
an action potential, electromechanical coupling, automaticity, and conduction in
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the SA and AV node [214]. It is also involved in the occurrence of EADs [243].
There is a massive amount of research that has been done towards the alter-
ations of the ICaL current in human ventricular myocytes under HF conditions.
Most of the experimental observations on HF support that the ICaL current is
unchanged [9; 12; 14; 26; 47; 114; 133; 158; 198; 213; 215; 235]. However, a few
studies found that the ICaL current is either down-regulated [231], or increased
[188]. Table A.3 in Appendix B summarizes in chronological order the main
findings of these studies in terms of species, protein, and mRNA levels.
2.4.3 Alterations in Potassium (K+) Currents
Contrary to the sodium (Na+) currents, potassium (K+) currents are well es-
tablished and studied in HF myocytes. These studies have linked (K+) currents
with heart failure.
• Transient Outward Potassium (Ito) Current
This current affects the notch segment in the early phase of repolarization
of an AP, especially in the epicardial cell types. Prominent Ito current
has been measured from epicardial ventricular cells isolated from different
species [184]. The main contribution of the Ito current is during the early re-
polarization phase of an action potential. Therefore, up- or down-regulation
of this current will modulate the plateau and repolarization phases of an
AP [255], as well as the other properties that are related to these phases of
an AP.
A considerable number of studies from heterogeneous transmural human
cell types showed consistent findings where most of them agreed that the
Ito current is decreased on cardiac HF myocytes [13; 91; 114; 133; 164;
165; 235; 261; 274]. However, these studies differ in terms of amount of
downregulation, which is ranging between ↓26.4±1.3% - ↓73.2±5.8%. In
addition, some of these studies investigate the down-regulation difference
in the transmural heterogeneity of the Ito current density in normal and
failing hearts [165; 261]. In contrast, a few studies [165; 261; 262] report
an unchanged Ito current density. These studies share many characteristics
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where all of these studies investigated myocytes that have been extracted
from patients with end-stage HF. However, there are variabilities in cell
types investigated that could explain the observation difference because
within the same studies [165; 261] they observed a reduction in the Ito cur-
rent in both the sub-epicardial and sub-endocardial cell types, respectively.
The observation discrepancy between these two studies could be related to
the tissue sampling. In [261] study, it did not restrict their sampling tissue
from a specific ventricular site. Instead, it segments a thick wall to obtain
sub-epicardial and sub-endocardial myocytes. This allows large variability
of the extracted myocytes that may influence the observations. In [165]
study, it excised the tissue from the left ventricular anterior wall and both
the sub-epicardial and sub-endocardial cells were obtained by removing the
thin layer of both the sub-epicardial and sub-endocardial surface with a
scalpel. Other studies have reported that the reduction in the Ito current
is accompanied by changes in the ICaL current, Na
+/Ca2+ exchanger, and
other currents [209; 251; 281] and it is very difficult to predict the exact
changes in these currents that affect the APD and how it may degenerate
to a heart failure. One study [1] observes that as a consequence of down
regulating the Ito current in HF myocytes, a prominent decrease in the
spike-and-dome morphology is exhibited. The findings of all these stud-
ies are summarized in Appendix B Table A.4 in chronological order with
consensus studies first followed by dissenter studies.
• Inward Potassium (IK1) Current
In the ventricular myocyte, the IK1 current stabilizes the AP in resting state,
and at the same time it participates in the terminal repolarization phase of
an action potential [8; 114; 190; 203; 235; 236]. In addition, it contributes
to forming delayed afterdepolarizations, simulating action potentials, and
arrhythmogenesis in heart failure [190].
There are many studies on ventricular myocytes that show a decrease of IK1
current in HF hearts [2; 13; 114; 125; 132; 133; 231; 235], ranging between
↓40.0±0% - ↓64.0±2.2%. As a result of reducing IK1, the likelihood of an
arrhythmia in heart failure is increased as reported by [190]. However, there
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is one investigator, Wang et al. [257] who demonstrates that the IK1 current
does not change under HF conditions. The findings of all these studies are
summarized in Appendix B Table A.5 in chronological order with consensus
studies first, followed by dissenter studies.
• Rapid Delayed Rectifier Potassium (IKr) Current
The (IKr) current contributes during the last portion of the repolarization
phase of an AP. The IK current is mainly responsible for generating the
repolarization phase of an action potential, controlling the duration of an
action potential, as well as the refractoriness at the tissue level [255].
There are many studies on heterogeneous transmural ventricular myocytes
that investigate the IKr current in failing myocytes [13; 50; 114; 115; 133;
248; 258], but with controversial results. For example, one study, [133]
reports that there is no change in the IKr current in isolated epicardial my-
ocytes. However, in a more recent study [50] it observes a reduction in the
protein levels of IKr current by ↓45.9±9.5% in single epicardial myocytes.
The same observation occurs for endocardial myocytes where one study
[258] found that the IKr current levels do not change, while [50] observes a
reduction of IKr protein levels by ↓27.3±1.7%. Only one study [13], could
not observe IK current in normal hearts. The variability in these findings
regarding IKr current may be due to the differences in the stage of HF,
or the difference in isolation region as happens between [50; 258] where
the first study isolates the endocardial myocytes from RV while the second
study extracted it from LV. Also, most of the dissenters’ studies investi-
gate the mRNA or protein expressions that underlie the IKr current, not
the density of the IKr current itself, which means that this reduction may
be compensated by other expressions and preserves the density of the IKr
current. All of the findings from these studies are summarized in Appendix
B Table A.6 in chronological order with consensus studies first followed by
dissenter studies.
• Slow Delayed Rectifier Potassium (IKs) Current
This current affects an AP during the late period of the repolarization phase
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and more greatly when blocking IKr current. At fast rates, the IKs current
is the important factor that contributes to the repolarization phase of an
AP [111], leading the reverse use-dependence of IKr blockers. However,
other studies suggest that IKs possesses a limited contribution during the
repolarization phase of an AP. In one study [130], reports that blocking IKs
results in small or no effect on the duration of an AP in ventricles under
normal conditions in spite of the pacing frequency. In another study [247], it
shows that the IKs contributes to repolarization of an AP only when the AP
is abnormally prolonged. Another study [255], claims that the IKs serves
mainly to inhibit extreme prolongation of APD. Also, blocking IKs may
remove this protection process and consequently contributes to initiating
such arrhythmias.
Several studies investigated the IKs current under HF conditions from ven-
tricular cells that were isolated from humans as well as from canines [2; 13;
132; 133; 258]. Most of these studies agreed that the IKs current is decreased
in the range ↓49.5±1.6% - ↓61.7±1.4%; except for two studies where this
current is either not observed [13], or the mRNA is increased [258]. Dis-
crepancies between these studies could be associated with the severity level
of HF, or with the underlying heart disease. For [258] study, it did not
observe the same levels of the IKs current density. Instead, it analyzed
the underlying transcripts of the IKs current, which does not necessarily
directly reflect the density itself. All of the findings from these studies are
summarized in Appendix B Table A.7 in chronological order with consensus
studies first, followed by dissenter studies.
2.4.4 Alterations in Sodium/Calcium (Na+/Ca2+) Exchanger
INaCa helps to regulate intracellular Ca
+2 and it is affected by [Ca2+]i and [Na
+]i
concentrations as well as the transmembrane potential, where all of which are
modified during HF. This means that an alteration in the INaCa function will
contribute to abnormally regulate intracellular Ca2+ and Na+ dynamics, and
consequently the AP morphology. The sodium-calcium current is a surface mem-
brane protein, which transfers sole calcium ions in exchange for three sodium
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ions. The (Na+/Ca2+) exchanger contributes in shaping the AP profile. This
exchanger current has two modes; during the forward mode, in which the Na+
ions are transported into the cell, it initiates an inward current causing prolon-
gation of the APD. During the reverse mode, in which Na+ ions are transported
outside of the cell, it contributes to the early plateau phase and causes shortening
of an APD. However, some experimental data reports that the combination of
both the forward mode and the late ICaL inactivation may contribute to increase
the APD [266]. In the existence of large [Na+]i levels and small [Ca
2+]i levels,
as observed in HF, there is an abundant Na+/Ca2+-dependent calcium inward
flux during the AP [191], which eventually necessitates removing these excessive
calcium ions during the diastolic phase. This makes the Na+/Ca2+ exchanger
an essential efflux pathway, which could facilitate a maintained inward current
during the diastolic interval. The sodium-calcium exchanger prolongs an APD,
causes fluctuation of the RMP, and initiates abnormal impulses [224].
The INaCa can be arrhythmogenic, due to sustained inward current simulta-
neous with the removal of calcium, which can initiate DADs. As a consequence of
increasing the Na+/Ca2+ exchanger and decreasing IK1 current, the likelihood of
an arrhythmia in heart failure is increased, as suggested by [190]. The functional
rule of this current under HF conditions is more important to calcium dynam-
ics than in normal conditions because of changed sarcoplasmic reticulum (SR)
function [45].
Direct studies of Na+/Ca2+ exchanger activity under HF conditions are lim-
ited [45; 229; 235], and many studies demonstrate an increase in the Na+/Ca2+
exchanger activity as well as the mRNA and protein levels ranging between
↑80.0±0%-↑200.0±0% [61; 81; 199; 228; 229]. Generally, Na+/Ca2+ exchanger
mRNA and protein levels are increased under pressure overload ventricular hy-
pertrophy. However, explicit recordings of Na+/Ca2+ exchanger activity INaCa
revealed significant reduction that could represent related disease remodeling in
the specified Na+/Ca2+ exchanger protein to the SR [212]. However, the alter-
ations of this current under HF conditions are controversial. The same protein
levels of Na+/Ca2+ in human HF have been disclosed [45; 81; 215; 216; 235]. All
of the findings from these studies are summarized in Appendix B Table A.8 in
chronological order with consensus studies first, followed by dissenter studies.
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2.4.5 Alterations in Sodium/Potassium (Na+/K+) Exchanger
The sodium-potassium exchanger transports potassium ions inside the cell and
sodium ions outside the cell according to stoichiometry of 2:3. Accordingly, it
generates an outward repolarizing current. It establishes and stabilizes most of
the ionic gradients that cause transport through the cell membrane [8]. Also, it
maintains cell homeostasis and the excitation-contraction mechanism [227].
The majority of experimental observations claim that the expression as well as
the function of INaCa current are reduced in failing hearts within a range between
↓36.0±0% - ↓56.0±0%, [22; 106; 113; 121; 145; 216; 219; 253], compared with
control hearts. All of the detailed findings from these studies are summarized in
Appendix B Table A.9 in chronological order with consensus studies first, followed
by dissenter studies.
2.4.6 Alterations in the Intracellular Calcium [Ca2+]i Han-
dling
One prominent mechanism that occurs inside the cell is that the dynamics of
[Ca2+]i is found to be altered in failing cells when compared to normal cells. There
is no agreement upon the direction of alteration of [Ca2+]i because many currents
and exchanger activities are involved in this alteration such as: INaCa, ICaL,
Sarcoplasmic Reticulum Ca2+ pump (SERCA), and ryanodine receptor (RyR).
In this thesis, we will focus on the SR Ca2+ because most of the experimental
observations report that an alteration of the intracellular [Ca2+]i concentration
on failing human and animal myocytes is profoundly based on the contents of SR
Ca2+.
There are two opinions about what causes the content of SR Ca2+ to reduce,
which is either the reduction of Ca2+ uptake via SERCA [7; 41; 46; 79; 80; 81;
86; 107; 121; 135; 139; 144; 157; 187; 192; 268], or regulation of the efflux of Ca2+
via RyR, [153; 154; 156]. These studies agreed on a reduction of the SERCA
activity of failing myocytes within a range between ↓15.4±10.0% - ↓65.0±7%,
[7; 46; 79; 81; 121; 139; 144; 157; 192; 268]. All of the detailed findings from these
studies are summarized in Appendix B Table A.10 in chronological order with
consensus studies first, followed by dissenter studies.
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2.5 Previous HF Simulation Models
In addition to the experimental observations that prove alterations to many cur-
rents and concentrations, there are several simulation studies [72; 94; 143; 160;
161; 170; 193; 195; 222; 237; 254; 266; 267; 272; 273; 278] that aimed to simulate
the remodeled AP properties during heart failure. The adapted alterations of the
transmembrane currents from these simulation studies are summarized in Table
2.1. We will explain the remodeled currents of these HF models and the impact
of each altered current on the HF model. In this section we focus ourselves to
investigate how these models remodel their currents and exchangers. In chapter
5, subsection 5.4.6, we will compare our results with their simulation results.
For the fast sodium current INa, most previous HF simulation studies on
a single myocyte [72; 160; 161; 193; 195; 222; 237; 254; 266; 267; 272] did not
consider remodeling INa in their HF models, except a few studies that consider
a reduction of INa [143; 273; 278] by ↓57%, 34%, and 40%, respectively. In
addition, one study [170] considered scaling INa by 25% - 200% from the control
value. Reducing INa will affect the amplitude as well as the upstroke velocity of
an action potential.
Regarding the late sodium current INaL, previous simulation studies [143; 160;
193; 195; 222; 254; 266; 267; 278] did not consider remodeling INaL in their HF
models. However, more recent HF simulation studies [237; 272; 273] [72; 161; 170]
believed that remodeling the INaL plays a dominant role in changing AP char-
acteristics during the plateau and repolarization phases, and as a consequence
this current could alter the duration of an AP. INaL is remodeled in these simu-
lation studies through increasing the peak current density 12-fold in [273], 2-fold
in [237], 6.7-fold in [272], 0.25-2-fold in [170], 2-fold in [72], and 10-fold in [161].
The former simulations of HF cell models did not consider altering the L-type
calcium current ICaL [72; 143; 161; 170; 193; 195; 222; 237; 266; 267; 272; 278],
except three studies [160; 254; 273] that remodeled ICaL by ↑200%, ↑↓30%, and
↑150%, respectively.
Previous HF simulation studies show agreement regarding the transient out-
ward current Ito. Most of these studies reduced Ito in human by ↓33% [222], ↓36%
[160; 161; 273; 278], ↓40% [72], ↓60% [237], and ↓64% [143]. For animal species,
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Ito is reduced by ↓36% [195] in rabbit, ↓66% and ↓84% in canine [266; 272], and
↓66% in guinea pig [267] myocytes. Two HF models did not change Ito [170; 193].
One study [254] perturbed Ito in both directions by ↑↓30%.
Most of the existing simulation studies follow the findings that show downreg-
ulation of the inward rectifier potassium current IK1 by implementing a reduction
of IK1 density between ↓25% and 68% in their HF models [193; 237; 266; 267;
272; 273] [72; 143; 160; 161; 195; 222; 278]. Two HF studies [170; 254] used the
same IK1 as in normal conditions.
Surprisingly, none of the previous simulation studies [72; 143; 160; 161; 170;
193; 195; 222; 237; 266; 267; 272; 273; 278] considered remodeling the rapid de-
layed rectifier potassium current IKr in their HF cellular models to investigate
the effects of this current on AP characteristics. Only one study [254] considered
investigating the effect of IKr by ↑↓30%.
Similarly, most of the previous HF simulation models [72; 160; 161; 170; 193;
195; 237; 266; 267] did not investigate remodeling the slow delayed rectifier potas-
sium current IKs. However, there are a few studies [143; 222; 254; 272; 273; 278]
that integrated a reduction of IKs within the range ↓30% - 50%. One study [273]
did not specify the percentage reduction in IKs density used in the paper.
In addition, many HF studies [72; 143; 160; 161; 195; 222; 237; 266; 267; 272;
278] remodeled the sarcoplasmic reticulum calcium SERCA activity ranging from
↓24% to 85%, along with one study [273] which did not specify the percentage
of reduction. One study [170] scaled SERCA by 25% - 200% from the original
value. In addition, one study [254] considered perturbing SERCA activity by
↑↓30%. One sole study [193] did not consider remodeling SERCA.
On the contrary, most of the preceding HF simulation models realized the
importance of incorporating remodeling of the sodium calcium exchanger INaCa.
Therefore, an upregulation was incorporated with a broad range of ↑36% to 200%
in these HF models [72; 143; 160; 193; 195; 222; 237; 266; 267; 272; 273; 278].
One study [254] perturbed INaCa by ↑↓30%. Also, two studies [161; 170] did not
consider remodeling this current in their HF models.
For the sodium-potassium pump Na+/K+, some of the HF cellular models
incorporated remodeling INaK through reducing its conductance (GNaK) by ↓10%









































































































































































































































































































































































































































































































































































































































































































































































































































































































previous studies, ↓10% - 42%. In addition, one study [72] remodeled INaK by
↓90%, while the rest of the HF models [160; 170; 195; 222; 254; 266; 267; 272; 278]
did not remodel this pump.
Regarding background currents, most of the previous HF models did not
change the sodium background current INab, except one study [161], which in-
creased INab 16-fold. However, some of these HF studies [193; 273] altered the
calcium background current ICab by ↑25%, while [237] [72] altered this current by
↑153%. One study [143] did not specify the percentage of remodeling ICab.
For Ileak, many of the previous HF models [94; 143; 170; 193; 195; 254; 266;
267; 272; 273; 278] did not consider remodeling this current. However, a few
studies [72; 160; 161; 222; 237] increased this current with disparate percentages
of ↑500%, 300%, 30%, 300%, and 350%, respectively. In addition, two studies
[143; 222] considered remodeling the ryanodine receptor (RyR), but with opposite
direction of remodeling. One study [222] incorporated an increase of RyR activity
by ↑300%, while [143] considered a reduction of RyR activity by ↓50%.
Concerning remodeling heterogeneous cell types, most of the previous HF
models [143; 160; 161; 170; 193; 195; 222; 237; 254; 266; 267; 273; 278] remodeled
a single cell type, except for two studies [72; 272], which considered remodeling
three transmural types of cells. One of these studies [272] did not remodel the
statistical difference between cell types during HF as observed experimentally,
instead, it used the same remodeling parameters setting across all types of cells.
In addition, the other [72] considered remodeling only two types of ionic currents,
INaCa and ISERCA.
Most importantly, most of the previous HF models [72; 143; 160; 161; 193;
195; 222; 266; 267; 272; 273; 278] incorporated a fixed set of remodeled current,
exchanger, and pump parameter values without introducing any kind of uncer-
tainty to the remodeling parameters. However, a few studies [170; 237] considered
different ways of including uncertainty. One study [170] scaled the sarcoplasmic
reticulum calcium uptake current Iup by 25% to 200% as well as the time con-
stants of fast and slow sodium channel inactivation τh,j by the same scale. In
addition, [237] performed a sensitivity analysis of ionic currents by ±15% to as-
sess the sensitivity of electrophysiological biomarkers to changes in ionic current
properties. Another study [254] generates a population for both normal and HF
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Figure 2.5: Afterdepolarizations. Abnormal oscillations that occur either during
(EAD) or following repolarization (DAD) of the action potential. Figure adapted
from [82].
cellular models through perturbing the GCaL, Gto, GK1, GKr, GKs, GNaCa, and
Jup ionic parameters by ±30%.
2.6 Afterdepolarization proarrhythmias
Generally, afterdepolarization arrhythmias [234] are irregular oscillations of the
action potential, which occur either before or after full repolarization of the AP
as depicted in Fig. 2.5. When the irregular oscillations occur prior to the AP
repolarization phase, it is referred to as early afterdepolarization (EAD); whereas
when the irregular oscillations occur following the AP repolarization phase, it is
referred to as a delayed afterdepolarization (DAD). In tissue level, when these
irregular oscillations propagate between cells as an excitation wave, it is referred
to as triggered activity.
2.6.1 Early afterdepolarizations (EADs)
There are many possible mechanisms for setting the stage to induce EADs through
prolonging an APD [25]. This prolongation could be a result of increasing the
total inward currents over the total outward currents, or reactivating the L-type
Ca2+ current. While all these mechanisms for inducing an EAD are possible,
they depend on magnitude rather than time. Therefore, these mechanisms can
not explain precisely the induction of an EAD with multiple oscillations (see Fig.
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Figure 2.6: EAD with multiple oscillations. Epicardial cell type of the HF-OVVR
model with decreasing IKr to 78%.
2.6).
2.6.2 Delayed afterdepolarizations (DADs)
Although DAD is outside the scope of this chapter, it is important to mention it
because its mechanism is involved in a subset of EADs, especially during the EAD
phase 3, which occurs after the repolarization phase of an AP via the sodium-
calcium exchanger (NCX) [25]. The process of reverse excitation-contraction
coupling occurs through the calcium transient, which induces a voltage response
as shown in Fig. 2.7. DADs occur when the intracellular Ca2+ is sufficiently
high to produce a significant enough NCX-mediated inward current to produce a
bump in the membrane potential following repolarization [25]. In the case that
this oscillation depolarizes with enough magnitude and rate to activate sodium
channels, then either all-or-none AP is initiated. This abnormal AP could propa-
gate through the whole myocardium and constitute what is known as an ectopic
beat.
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Figure 2.7: Delayed afterdepolarization (DAD). DADs that rise with sufficient





The purpose of this chapter is to present the methods that have been used in
this thesis. We begin with the procedure of measuring the restitution curves
using steady-state and S1-S2 protocols and accommodation of action potential
duration. Then, we explain the measurements used to assess the spiral wave
dynamics, which include initiating spiral wave, tracking the tip trajectory, calcu-
lating dominant action potential duration and period, and assessing spiral wave
motion. After that we explain the implemented numerical methods used to model
cardiac cells and tissue. Then, we discuss some implementation tactics used to
increase the computational efficiency. These strategies include creating lookup
tables, parallelization, and operator splitting. Finally, we present the experimen-
tal data used in this thesis, which include data sources, measurement conditions,
measuring variability, and calculating electrophysiological biomarkers.
3.1 Measurement of restitution curves and ac-
commodation
In order to study how the cycle length (CL) perturbation affects the ventricular
APD, two common protocols were implemented: steady-state restitution (S-S),
and S1-S2 restitution, along with probing the accommodation of APD to a single
change in CL for single cells (0D) and in one-dimensional (1D) cables. For every
protocol, we generated APs using a current strength twice diastolic threshold at
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a CL of 1000 ms; in the 1D case, the stimulus was applied only to one end of the
cable. APDs were assessed by measuring the repolarization voltage thresholds
corresponding to 90% (APD90) and 50% (APD50) after pacing for 1 min at the
corresponding CL. APD measurements in 1D were taken from the middle of the
cable to minimize the effects of current stimulation and the boundaries [30].
For the steady-state protocol, the targeted myocyte was stimulated for 1 min
beginning from a CL of 1000 ms, after which the CL was decreased in steps
until 2:1 block was observed. For every CL, the last APD and the prior diastolic
interval (DI) pair were recorded. However, when the targeted myocyte exhibited
alternans during pacing process, the last two DI and APD were registered.
For the S1-S2 protocol, the intended myocyte was stimulated for 1 min with a
constant CL, which is known as S1, after which a second stimulation (S2) was used
after a variable DI. The last pair of DI and APD was recorded. The amplitude of
short-term memory (STM) was computed as the variation between APD values
for the maximum DI at the highest S1 CL, which is in our simulations 1000 ms,
and the lowest S1 CL before block or alternans was noticed [29].
In addition, we adapted a protocol for measuring the accommodation of APD
to an abrupt change in CL, since this protocol was recommended as a clinical
marker for arrhythmia risk [194]. We follow the same procedure from the preced-
ing studies [63; 128] to construct the accommodation curve by recording APD90
at a CL of 1 s after pacing for 8 min, after which the CL was abruptly decreased
to 600 ms for a similar pacing period (8 min). Then, the CL was restored to 1 s
for another 8 min pacing period (for more details see [51; 52]).
Note that it was not always possible for the models to reach a stable steady
state, even when assigning a charge carrier to the stimulus current and axial
current in tissue [96]. For example, the difference between consecutive APDs
after pacing single cells using the Grandi-Pasqualini-Bers (GPB) and O’Hara,
Virág, Varró, and Rudy (OVVR) models at a constant CL for 5 minutes was on
the order of 10−4 to 10−3 ms, as indicated in Table 3.1. Although the difference
between successive APDs was decreasing, it did not appear to saturate.
We used the same steady-state and S1-S2 protocols to measure conduction
velocity (CV) restitution curves in 1D cables. The CV was measured between
two adjacent cells in the middle of the cable to minimize boundary effects. The
35
Model CL (ms) 1000 (ms) 750 (ms) 500 (ms) 400 (ms)
GPB
APD1 − APDn -10.02 4.37 3.18 2.91
APDn−1 − APDn −2.20× 10−3 0.45× 10−3 0.18× 10−3 0.08× 10−3
OVVR
APD1 − APDn -10.32 1.63 1.16 0.96
APDn−1 − APDn −2.80× 10−3 0.56× 10−3 0.37× 10−3 0.10× 10−3
Table 3.1: Variation in single-cell APD for epicardial formulations of the GPB
and OVVR models. APD1 is the first APD measured and APDn is the last APD
measured for a given CL after pacing at a fixed cycle length (CL) for 5 minutes.
Differences are given in ms. Initial conditions in all cases are as specified in the
original model publications.
resulting CV values were plotted as a function of the preceding DIs recorded in
each restitution protocol. S1-S2 CV restitution curves obtained using different
S1 CL values were used to assess the presence of memory in CV [18].
3.2 Measurement of spiral wave
Spiral wave dynamics Many mechanisms for functional substrate to facilitate
reentry have been proposed, but the current state of the art focuses on
modeling spiral waves. Spiral waves are continuously rotating spirals around
a distinct point. The center of spiral waves is known as the spiral core, or
phase singularity [21; 43; 55]. In spite of the excitability of this region,
it stays unexcited while the spiral waves rotate. This is due to the large
curvature of the wavefronts at the spiral tip, which reduces the amount of
current available to depolarize this region [10]. The reentrant wavefront
that rotates around a phase singularity is known as a rotor [55].
• Spiral wave initiation
Spiral waves were initiated in two-dimensional (2D) isotropic and ho-
mogeneous tissue sheets using a cross-field stimulation protocol [64].
• Tracking the spiral wave tip trajectory
The spiral tip trajectory was tracked using the zero normal-velocity
method [56] by detecting spiral tips as the intersections of the isopo-
tential line V = 260 mV and the line dV/dt = 0 for all models except
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for the OVVR midmyocardial cell type, for which we used the isopo-
tential line V = 265 mV.
• Dominant APD and period
One mechanism to obtain the valuable information for understand-
ing arrhythmias is to investigate the distribution of action potentials
over both the single cell and the entire tissue. Here, we extract the
spatiotemporal distribution of the transmembrane potentials over the
whole tissue used.
Histograms of APD, diastolic interval (DI), and cycle length (CL) val-
ues measured to the nearest 1 ms were developed from all points in
the 2D sheet during the simulation and were used to calculate the
dominant APD and dominant spiral wave period for each model.
• Spiral wave motion
Spiral waves may remain stationary in a small region, or they may
jump and drift, giving rise to multiple dynamic reentrant pathways.
We measured the movement of the tip trajectory.
3.3 Cardiac electrical modeling
In this part, we aim to explain how the numerical methods are implemented for
modeling cellular models used in this thesis including our developed HF model
in tissue. The numerical simulation of an evolving time and spatial extension
system, like the reaction-diffusion system we have, which describes the propa-
gation of electrical signals within the myocardium, requires both temporal and
spatial discretization. In addition, it requires a computational algorithm that can
handle and track model dynamics that evolve over time, especially with this non-
linear cellular model we use. The spatiotemporal coupling approach could lead
to very different simulation results in terms of precision and the computational
complexity (such as the time needed to run the simulation). However, based on
the spatiotemporal discretization chosen, some schemes may be unsuccessful in
reaching the solution because of a loss of the numerical stability as the simulation
runs (such as capturing the upstroke velocity and calcium dynamics). In the case
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of cardiac propagation involving two coupled subprocesses, one reactive and one
diffusive, both are potential candidates for a loss of numerical stability. Their
coupling could also potentially induce a loss of stability, even if each one of them
taken individually leads to stable solutions.
3.3.1 Time discretization
Determining an optimal time step for a cardiac cellular model in tissue is a
complex decision, which is based on many factors, including the chosen numerical
approach and the used cellular model. In addition, it depends on the anatomy’s
geometrical characteristics. The decision should not be to ensure the stability of
the chosen numerical approach. However, it should consider that the outcome of
the model fulfills the accuracy requirements. The purpose is to guarantee that fast
mechanisms like the upstroke of an AP and the calcium dynamics are accurately
resolved temporally. One approach to fulfill these requirements is to choose the
time step depending on the dynamics of the reaction-diffusion characteristics. The
speed of depolarized action potential could be used to measure the maximum
temporal resolution limit. Simultaneously, there is no agreement on the exact
value that should be used. Previous simulations on real geometries used temporal
resolution within a range of 0.01 ms - 0.02 ms to consider the diffusion term of the
cardiac cellular model, along with lower temporal resolution for the membrane
dynamics of the cell.
There are three techniques that have been adapted to determine the time
dependence of AP propagation: explicit, implicit, and semi-implicit techniques.
The choice of any of these techniques will influence the aforementioned char-
acteristics including the numerical stability of the model, the accuracy of the
results, and the efficiency of the model implemented. One approach to overcome
the numerical instability for the diffusion part of the model is to compute it ex-
plicitly for each time step. The ordinary differential equation (ODE) system of
equations for membrane potential and ionic dynamics in all cellular models was
calculated utilizing the forward Euler method. This was used because it has low
computational cost to integrate temporally and because of the ease of implemen-
tation. However, it needs to have a small enough time step to ensure that the
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cardiac tissue model is stable. In the case of implementing either semi-implicit,
or implicit approaches, high temporal resolution can be implemented without
worrying about the numerical instability. However, when a temporal resolution
becomes very large, it can cause faults in conduction velocity, as mentioned in
the preceding studies (Cherry et al., 2003; Courtemanche, 1996).
3.3.2 Spatial discretization
Finding an optimal space resolution for cardiac cellular models in tissue is nontriv-
ial because it depends on many factors, including the chosen numerical approach
and the cellular model used. In addition, it depends on the anatomy’s geomet-
rical characteristics. This optimal space resolution should not be decided upon
merely to ensure the stability of the chosen numerical approach. However, the
outcome of the model does need to fulfill the accuracy requirements. The pur-
pose is to guarantee that fast mechanisms like the sharpness of spatial gradients
(propagating wavefront), are accurately resolved spatially. One approach to fulfill
these requirements is to choose the space step size depending on the dynamics
of the reaction-diffusion characteristics. The size of the wavefront could be used
to measure the maximum spatial size limit. However, there is no agreement on
the exact value that should be used. Previous simulations on real geometries
used spatial resolution within a range of 0.1 mm - 0.2 mm. In higher dimensions
such as 2D and 3D, space resolution can be an integral part for exploring the dy-
namics of the tissue model. Choosing inappropriate spatial resolution can cause
curved wavefronts to develop corners, even with using finite difference methods
on a uniform lattice. A previous study (Cherry 2010) shows that the corners
could develop 45-degree angles. The spatial resolution required to prevent these
diversions differ between models and depends on the steepness of the upstroke
for the specific model. This type of distortion has greater effect on model kinet-
ics that are under HF conditions due to more complicated model scenarios such
as complex spiral wave trajectories, which may cause model instability. When
anisotropy is considered, extra spatial resolution constraints should be consid-
ered. Also, choosing coarse spatial resolution may affect the fast sodium current
as shown by Spaach and Kootsey, and Wu and Zipes with all related properties
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such as increasing upstroke velocity and decreasing CV.
In addition to the aforementioned electrophysiological properties in tissue such
as the CV, shape of the wavefront, trajectory of the spiral wave, and reentrant
rotation period, inappropriate space size could affect simulation results in many
different ways. Choosing large spatial discretization could induce spiral wave
breakup whilst small spatial discretization produces stable spiral waves (Fenton et
al., 2002; Panfilov and Keener, 1995). In addition, the opposite may happen. For
example, using large spatial discretization will cause stable tip trajectories. How-
ever, small spatial discretization produces spiral wave breakup (Bueno-Orovio et
al., 2008; Panfilov, 2002). Therefore, one of the prominent electrophysiological
properties in a 1D strand that should be considered is the conduction velocity. It
was reported to be highly sensitive to the spatial discretization.
3.3.3 Single cells
Modeling cardiac electrophysiology can be classified into two processes: the reac-
tion process that represents the simulation of an action potential in an isolated
myocyte, and the diffusion process that represents the propagation of the cur-
rent between cells. Generally, when modeling cardiac electrophysiology in tissue,
there are two dominant approaches used, namely monodomain and bidomain.
The monodomain approach represents the intracellular space of the tissue and it
is sufficient to use in many applications, such as simulation of wave propagation.
However, the bidomain approach represents both, intra- and extra-cellular spaces
in the tissue. It is also beneficial if we need to consider extracellular conductivities
or investigate the effects of stimuli bath, for example. The bidomain approach
gives greater realism, but it comes at the cost of computational time.
In this work, the following differential equation was used to describe the time-
dependent electrophysiological behavior of a single normal myocyte [181]:
dVm/dt = −(Iion + Istim)/Cm (3.1)
where Vm is the transmembrane voltage; t is time; Iion is the total of all trans-
membrane ionic currents, pumps, and exchangers; Istim is an external stimulus
current; and Cm is the cell membrane capacitance.
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Time derivatives were integrated uniformly using the explicit Euler method
to solve the ordinary differential equations (ODEs) of the AP and concentration
dynamics of the cellular model. The integration of the ionic gating variables was
implemented using the Rush and Larson method [207]. The time resolution used
for all models were 0.02 ms, except the calcium equations of the OVVR model
were integrated with a smaller time step of 0.001 ms. All single-variable functions
were pre-computed and saved in lookup tables [87] to reduce the computational
time. Action potentials were stimulated using a transmembrane stimulus current
32.0 µA/µF for 2.0 ms.
All simulations were written in Fortran 95, visualized using MATLAB, and
run on a MAC Pro 2×2.8 GHz Quad-Core Intel Xeon CPU with 32 GB 800 MHz
DDR2 FB-DIMM RAM. It took 1.3 minutes to simulate 60 seconds of physical
time and performing the whole simulation for each cell type under one set of
conditions took 2.2 hours.
3.3.4 One-dimensional cables
In all cases, we solved the following monodomain representation of cardiac tissue:
∂tVm = D∂
2
xVm − Iion/Cm (3.2)
Where Vm is the membrane potential, D is the diffusion constant, Iion is the sum of
the ionic currents given by the model formulation used in each case, and Cm is the
membrane capacitance (set to 1 mF/cm2 in all cases). All models were integrated
using the explicit Euler method with uniform spatial and temporal resolutions.
The Rush and Larsen method [207] was used to integrate the Hodgkin-Huxley-
type equations of the gating variables in all models. Some variables were inte-
grated semi-implicitly to extend the range of time steps for which the method was
stable. In 1D strand, the time step used for all models was 0.02 ms and the spatial
resolution used in all tissue simulations was 0.015 cm. For the OVVR model, we
also used operator splitting to integrate the calcium concentration equations with
a smaller time step of 0.001 ms, which was necessary to accurately capture the fast
dynamics of these equations. To increase efficiency, pre-computed lookup tables
were used to calculate single-variable computationally intensive functions, such as
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exponentials [88]. The diffusion coefficient used in all cases was 0.001171 cm2/ms,
as calculated for human ventricular tissue [18]. No-flux boundary conditions were
used in all tissue simulations and initial conditions were as specified in the pub-
lications of the original models [18; 74; 99; 181; 193; 232; 233]. The length of the
cables in 1D for all models was 1.5 cm. We used the same temporal and spatial
resolution for previously published models except the time resolution of the Iyer-
Mazhari-Winslow (IMW) model, where we used 0.01 ms. Our codes are consis-
tent with the implementations for the models available at www.cellml.org (GPB
model) and http://rudylab.wustl.edu/research/cell/code/AllCodes.html
(OVVR model) with the exception that for the GPB model we set the coefficient
in the equation for IK1 to 0.35, as in the original paper, rather than to 10.35, as
in the CellML code. All other parameters are as specified in the original papers.
The cable equation is applied to a 1-D isotropic strand of cardiac tissue with
the assumption that there is no-flux boundary conditions. With adequate spatial
discretization of 3.4, using a constant space step ∆x=0.015 cm, the evolution of
the transmembrane potential at any myocyte i can be explicitly updated from a
specific time at t to the subsequent time that can be expressed as t+ ∆t by:





(V t,i−1m − 2V t,im + V t,i+1m ) +
∆t
Cm
(I t,iion − I
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stim) (3.3)
Which is the generalized Laplacian current with a finite difference centered
scheme for the evaluation of the second spatial derivative, computed at node i
using (V
t,i−1

















Where Vm is the membrane potential, D is the diffusion constant, Iion is the sum
of the ionic currents given by the model formulation used in each case, and Cm
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is the membrane capacitance (set to 1 mF/cm2 in all cases). In the 2D sheet,
we utilized the Laplacian method which approximates each point by calculating
the averages of the four neighboring points. All cells of different models were
integrated using the explicit Euler method with uniform spatial and temporal
resolutions, which facilitated parallelization in 2D. The time step used for all cell
models was 0.02 ms and the spatial resolution used in all 2D simulation domains
was 0.015 cm. No-flux boundary conditions were used in all tissue simulations.
For all 2D tissue, we used a square domain of size 14.4 cm × 14.4 cm, which
represents a grid with 960 cell × 960 cells, except for the epicardial cell type
of the OVVR model, where the 2D sheet size was 18.0 cm × 18.0 cm, which
represents a grid with 1,200 cells × 1,200 cells. In addition, we used isotropic
diffusion for both directions with a diffusion coefficient used in all 2D domains of
0.001171 cm2/ms, as calculated for human ventricular tissue [18].
3.4 Computationally Efficient Implementation
Since simulating electrophysiological properties such as the electrical wave prop-
agation within the ventricles will be computationally very intensive, we incorpo-
rated some strategies in our implementation of cardiac electrophysiological cell
models besides the chosen numerical approaches itself. For example, to accurately
simulate the OVVR biophysical membrane model for each time step, a large num-
ber of ordinary differential equations need to be solved. Furthermore, there is a
diffusion term that must be evaluated for each time step. Without making some
useful strategies, the simulation for one cardiac cycle in 3D may take days. This is
based on the computational resources devoted to perform the simulation. There-
fore, efficient implementation in solving the monodomain equation is necessary
using some specific tactics. These tactics are aimed at reducing the computa-
tional time when running the simulations of the cardiac electrophysiological cell
models, especially when it is implemented in higher dimensions such as simulat-




Most cardiac electrophysiology cell models have highly computational functions
such as logarithms, divisions, and exponentials that need to be solved. For single
variable functions, such as membrane voltage and sodium concentration, pre-
calculated lookup tables were generated because this increases computational
efficiency. These precomputed values can subsequently be beneficial when solving
cellular models.
3.4.2 Parallelization
There are many solvers for parallel implementations. These solvers were evolved
and applied to simulate cardiac tissue electrophysiological models such as open
multi-processing (OpenMP). These solvers were evolved and applied to sim-
ulate cardiac tissue electrophysiological models such as open multi-processing
(OpenMP) and Message Passing Interface (MPI) http://www.mpi-forum.org/.
In MPI, a message with required information is passing between an application
programming interface which permits codes that run on multi-processors to in-
teract with each other. There are many advantages of using an MPI technique
such as ease of implementation and achieving high scalability. In addition, codes
that are based on the MPI approach can be executed on either distributed, or
shared memory architectures.
In our case, we developed a specific code to accommodate an MPI approach,
where we divided the heart geometry into x subdomains/subregions. Each proces-
sor can solve a separate subdomain of the tissue/myocardium in conjunction with
other processors that lie within the boundaries of the subdomain. This means
that there are messages passing between the nodes that lie on the boundaries on
adjacent subdomains. For example, the membrane potentials at these nodes must
be explicitly passed between processors. Adapting this approach should decrease
the computational time by a factor of x, theoretically.
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3.4.3 Operator Splitting
The aim of using an operator splitting technique on a system that has either or-
dinary differential equations (ODEs), or partial differential equations (PDEs), is
to split the model, cardiac cellular models in our case, into a set of sub-equations
either to ensure model stability, improve the computational efficiency, ease analyz-
ing the model numerically, and/or reduce the dependency between the variables.
In our case, we used an operator splitting technique in the OVVR model to in-
tegrate the calcium concentration equations with a smaller time step, which is
necessary to accurately capture the fast dynamics of these equations. Without
incorporating this technique, the calcium dynamics will be unstable.
3.5 Developed HF-OVVR model description (ex-
perimental data):
Certain ionic exchanger and pump currents were investigated with their corre-
sponding experimental human HF data published and remodeled based on these
observations. We used the same equations of the normal OVVR model [181]
and reformulated the maximum current conductances for major currents of the
undiseased OVVR model [181], while other values remained unchanged, such as
the background currents. We took the first steps toward developing a meaning-
ful representation of population variability through calculating the mean and the
standard deviation for each ionic current across experimental observations found
in the literature. Tables 5.1 and 5.2 summarize the heterogeneous remodeled
ionic currents used in our HF-OVVR model along with the data sources. The
details of HF remodeling for each current are discussed below.
• Data sources: In this thesis, we developed two heart failure models where for
both models the underlying model is human. However, the HF remodeling
is either general without considering any differences between species type,
or is more human-specific where it is mainly based on humans, except when
there is scarcity of data on humans. For some currents during heart failure,
we benefit from the existence of data from other animal species found in the
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literature. Therefore, we incorporated canine [2; 115; 132] and rabbit [203;
238; 280] data. So, for the general heart failure model, we considered all the
HF-remodeled experimental data available in the literature. However, for
the more human-specific model, most of the sources of experimental data
used to construct and simulate human HF myocytes are based mainly on
human species.
• Measurement conditions: For all simulations used in this thesis, we stim-
ulated each ventricular cell type until it reached steady-state with cycle
length 1000 ms. However, for assessing EADs, we used three different pac-
ing protocols beginning at CL=2000 ms, CL=4000 ms, and CL=10000 ms.
Then, we calculated the biomarkers.
• Data variability: Data for the HF-OVVR model are presented as the mean
± standard deviation (µ± SD). We calculated the SD in this manuscript








i is the variance of the
instance (myocyte) i and n is the number of experiments involved in the
calculations of the specified remodeling current.
• Biomarkers calculation: We varied each modified parameter from (µ+2SD)
to (µ− 2SD) in increments of 1 SD and calculated the biomarkers for each
varied parameter value. For each biomarker, the minimum and maximum
biomarker values obtained over all parameter variations and over all currents
are given as the range in Table 5.8.
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Chapter 4
A Quantitative Comparison of




The purpose of this chapter is to analyze quantitatively the human ventricular
cell models [18; 74; 99; 181; 193; 232; 233] with an emphasis on rate-dependent
properties associated with tachyarrhythmias and compare the dynamics of these
models with each other. In this chapter, we start by introducing the available
ventricular cell models and explaining why analyzing these models in tissue is
important. Then, we describe the formulation of these electrophysiological mod-
els. After that, we introduce the restitution protocols, which are used to assess
the behavior of these models in a 1-dimensional cable, followed by an explana-
tion of the extracted properties, which are useful in characterizing these models
in 2-dimensional tissue. Then, we present the action potentials, transmembrane
currents, and calcium dynamics results with declaration of transmural variations
in action potentials for each model. This is followed by an exhibition of the rate
dependence of action potential duration (APD) and conduction velocity (CV)
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and short-term memory (STM). In addition, an alternans in a 1D cable is il-
lustrated by showing the dynamics of each model after initiating spiral waves.
Then, there is a discussion of the observed results and we close this chapter with
an explanation of the candidate model, which will be developed to a heart failure
(HF) model.
4.1 Introduction
Over the last several decades, mathematical models of the electrophysiology of
cardiac cells have become an important resource for studying the mechanisms
underlying cardiac arrhythmias. These models generally use systems of coupled
ordinary differential equations to describe the movement of sodium, calcium, and
potassium ions across the cell membrane through different ion channels and the
changes in membrane potential during an action potential. Many models also
represent sub-cellular processes, such as cycling in intracellular calcium that is
responsible for contraction at the cellular level. Tissue-level phenomena can be
studied by including cell-to-cell coupling, normally through a diffusion term, to
allow for propagation of electrical waves. The models can be used to study the
normal electrical state of the heart, in which electrical waves remain coherent to
stimulate a coordinated contraction, and arrhythmic states, in which electrical
wave disturbances, such as reentry and fractionation, compromise the heart’s
ability to pump blood.
The advantages models provide include reproducibility, the ability to vary pa-
rameters systematically, and ready access to all simulation results at high spatial
and temporal resolution, serve as a useful complement to traditional biological
experiments and can be used to develop and to perform preliminary tests of
hypotheses. As modeling cardiac electrophysiology has become a more impor-
tant investigative tool, models have grown in number, specificity, and complexity
[57; 59]. For example, models have been developed to describe different regions
of the heart, including atria, ventricles, sinoatrial node, atrioventricular node,
and Purkinje network, and in many cases are designed to reproduce the behavior
of cells of particular species, sometimes under various disease conditions. Mod-
els may be developed to incorporate new experimental data on ion channels or
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other intracellular processes, to address limitations of previous models, or to rep-
resent a specific system or mechanism not previously modeled. The availability
of a large number of mathematical models of cardiac cells leads to challenges
in selecting an appropriate model. Even when a particular species and region
of the heart are identified, it is often the case that several models are available
[20; 27; 29; 31; 180; 233; 263]. The choice of model becomes especially challenging
for simulations in tissue, where electronic coupling can cause the emergent prop-
erties in higher spatial dimensions to differ from the characteristics of isolated
cells [28; 33]. For example, important properties of alternans in tissue, such as
alternans magnitude, range of cycle lengths (CL) exhibiting alternans, and even
whether alternans occurs at all, can differ significantly from what is observed
in single cells [29]. In addition, some tissue behavior, such as reentrant wave
dynamics, currently cannot be predicted from the properties of isolated cells.
Models of human cells and tissue are of particular importance because of
their potential for clinical relevance. A number of mathematical descriptions of
human ventricular cells have been published over the past decade and a half
[11; 18; 99; 193; 232; 233]. More recently, two new models were developed:
the Grandi-Pasqualini-Bers (GPB) model [74] and the O’Hara-Virág-Varró-Rudy
(OVVR) model [181]. These models incorporated more detailed physiological
data concerning intracellular calcium dynamics and transmembrane currents. Al-
though the authors established model behavior in isolated cells and for some
conditions in tissue, important dynamical properties, including the behavior of
reentrant waves, have not been shown previously.
4.2 Model descriptions
4.2.1 Electrophysiological model formulations
In this study, we focus on two recently published models of human ventricular
cells derived from different experimental data: the Grandi-Pasqualini-Bers (GPB)
model [74] and the O’Hara-Virág-Varró-Rudy (OVVR) model [181]. The mod-
els have different formulations: the GPB model uses 38 state variables and 14
transmembrane currents, whereas the OVVR model has 41 state variables and 12
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transmembrane currents. Eleven currents are common to both models: the fast
Na+ (INa), L-type Ca
2+ (ICaL), transient outward K
+ (Ito), rapidly and slowly
activating delayed rectifier K+ (IKr and IKs, respectively), inward rectifier K
+
(IK1), Na
+/Ca2+ exchanger (INaCa), Na
+/K+ pump (INaK), sarcolemmal Ca
2+
pump (IpCa), background Na
+ (IbNa), and background Ca
2+ (IbCa) currents. In
addition to these, the GPB model includes Ca2+-activated Cl− (ICaCl or Ito2),
plateau K+ (IKp), and background Cl
− (IbCl) currents, as well as fast and slow
components of Ito, and the OVVR model includes a background K
+ current (IbK).
Another difference in transmembrane currents is the inclusion of both Na+ and
K+ transport through L-type Ca2+ channels in the OVVR model, whereas the
GPB model accounts for Na+ but not K+ transport.
Along with differences in transmembrane currents, the two models incorpo-
rate different local subspaces, each of which includes ion concentrations and state
variables. The GPB model tracks separate Na+ and Ca2+ concentrations in the
junctional cleft (submembrane space near the T-tubules), subsarcolemma (SL)
(the submembrane space not near the T-tubules), and cytosol along with the
concentration of Ca2+ in the sarcoplasmic reticulum (SR) and a single intracellu-
lar K+ concentration. The OVVR model includes separate cytosol and junctional
cleft concentrations of Na+, K+, and Ca2+, along with junctional and network
SR Ca2+ concentrations.
The different concentrations allow ion channels to sense different ion concen-
trations depending on their location and thus are related to the spatial distri-
bution of ion channels within the cell. For most ion channels, the GPB model
placed 89% of the channels in the SL and the remaining 11% in the junctional
cleft, which represents a uniform distribution based on locating 11% of the mem-
brane in the junctional cleft. Although the distribution of channels is uniform,
different concentrations of Ca2+ and Na+ ions in the junctional cleft and SL re-
gions lead to differences in the currents through the channels in those locations.
Only ICaL is distributed differently, with 10% of channels in the SL and 90% in
the junctional cleft (in close proximity to the T-tubules and RyR Ca2+ release
channels). Those currents that involve neither Ca2+ nor Na+ concentrations (Ito,
IKr, IK1, IKp, and IbCl) are distributed uniformly and do not require any special
consideration. For the OVVR model, uniform channel distribution is assumed
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except for ICaL, which is located entirely in the junctional cleft, and INaCa, which
is distributed as 20% in the junctional cleft and 80% elsewhere in the membrane,
where cytosolic ion concentrations are sensed.
Several other features of the models are noteworthy. The GPB model includes
extensive buffering of Ca2+ and Na+ to regulate ion homeostasis. The OVVR
model includes phosphorylation by Ca2+/calmodulin-dependent protein kinase II,
which affects intracellular Ca2+ cycling. In addition, both models include modifi-
cations for representing transmural differences in electrophysiological properties.
The GPB model includes epicardial and endocardial formulations, which are ob-
tained by varying the maximum conductance of Ito alone. In contrast, the OVVR
model reproduces epicardial, midmyocardial, and endocardial cells by modifying
a large number of parameter values, including maximal conductances of most
transmembrane currents and some parameters governing calcium fluxes, along
with the inactivation time constants for Ito.
For comparison, we also present results using the Priebe-Beuckelmann (PB)
[193], Iyer-Mazhari-Winslow (IMW) [99], Ten-Tusscher-Panfilov (TP) [233], and
Bueno-Orovio-Cherry-Fenton (BCF) [18] human ventricular models. The PB,
IMW, and TP models have 22, 67, and 19 state variables, respectively, and 10,
13, and 12 transmembrane currents, respectively. The BCF model uses a differ-
ent formulation focused on reproducing mesoscale electrophysiological properties
(such as action potential shape and rate-dependent behavior). It includes four
state variables and tracks the sum of fast inward, slow inward, and slow outward
transmembrane currents. The GPB, OVVR, PB, and TP models rely primar-
ily on Hodgkin-Huxley representations of transmembrane currents, in contrast
to the IMW model, which uses Markov formulations (leading to a significantly
larger number of state variables). In addition, the IMW model utilizes data ob-
tained from both recombinant human channels and isolated human ventricular
epicardial myocytes, whereas the other models are based on isolated human ven-
tricular myocyte data. To represent transmural heterogeneity, the TP and BCF
models include formulations for epicardial, endocardial, and midmyocardial cells
(through changing the maximum conductances of Ito and IKs for the TP model),
whereas the PB and IMW models include only epicardial formulations.
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Figure 4.1: Rate dependence of action potentials, primary transmembrane cur-
rents, and intracellular calcium concentration. Action potentials, currents, and
calcium transient in a single cell for the GPB (columns 1 and 3) and OVVR
(columns 2 and 4) models for cycle lengths of 1000 ms (solid black), 750 ms
(dashed green), 500 ms (dashed red), and 300 ms (dashed blue). Insets show
peak current values for the same cycle lengths following the same color scheme.
The GPB model generally shows more rate dependence; however, the OVVR
model shows greater rate dependence for IK1 and [Ca
2+]i. Both models show
significant rate dependence for IKs, although the effect of rate is opposite for the
two models, and for the ICaL.
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4.3 Results
4.3.1 Action potentials, transmembrane currents, and cal-
cium transients
We compared the action potentials, main transmembrane currents (ICaL, INaCa,
IK1, IKr, IKs, and Ito), and calcium transients in single cells of the GPB and
OVVR models for a range of different CLs for the epicardial formulations. As
shown in Fig. 4.1 A-B, the action potentials of the two models have similar
shapes, although action potentials obtained using the OVVR model have higher
plateaus and shorter durations and exhibit less rate dependence than those of the
GPB model.
The main transmembrane currents of the two models generally show differ-
ences in magnitude and in the degree of rate dependence. Neither model displays
much rate dependence of ICaL (see Fig. 4.1 C-D), but the peak current at long
cycle lengths is nearly twice as large for the GPB model (24.3 pA/pF) as for
the OVVR model (22.4 pA/pF). INaCa exhibits stronger rate dependence for the
GPB model and limited but biphasic rate dependence for the OVVR model, as
shown in Fig. 4.1 E-F. The peak inward current is twice as large for the GPB
model as for the OVVR model at longer CLs (1000 ms) and is similar for the
two models at short CLs (300 ms) with a value of 20.53 pA/pF, but the GPB
model has a more pronounced outward component early in the action potential
than the OVVR model.
IK1 is similar in the two models; however, the peak current is about 50% larger
for the GPB model than for the OVVR model, as shown in Fig. 4.1 G-H. In
addition, IK1 in the GPB model displays almost no rate dependence, whereas for
the OVVR model the peak value of the current decreases slightly with decreasing
CL. As shown in Fig. 4.1 I-J, IKr exhibits very slight rate dependence in both
models, but in opposite directions, and its peak value for the OVVR model is six
times larger than for the GPB model, indicating that it plays a more significant
role during repolarization for the OVVR model. IKs also is larger for the OVVR
model than for the GPB model by more than a factor of ten (see Fig. 4.1 K-L).
Both models show rate dependence of IKs, but in opposite ways: as CL decreases,
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Figure 4.2: Transmural cell types. (A) Epicardial and endocardial action poten-
tials for the GPB model. (B) Epicardial, endocardial, and midmyocardial action
potentials for the OVVR model. All measurements were obtained after pacing a
single cell for 30 s with a CL of 1 s.
the peak value of IKs decreases for the GPB model but increases for the OVVR
model. For Ito, the OVVR model shows limited rate dependence, in contrast to
the GPB model where the peak value decreases considerably with decreasing CL,
as shown in Fig. 4.1 M-N. The peak current is two times larger for the GPB
model than for the OVVR model at slow pacing rates, but both models have the
same peak value at fast rates.
Fig. 4.1 O-P shows the calcium transients (intracellular calcium concentration
[Ca2+]i) for both models. The peak value is about twice as large for the OVVR
model as for the GPB model during slow rates and more than four times as large
during fast rates. In both models, the [Ca2+]i peak value increases as the CL
increases from 1000 ms to 300 ms, so that the [Ca2+]i peak-frequency relationship
is always positive. In addition, the calcium transient rises and falls more slowly
for the GPB model than for the OVVR model.
4.3.2 Transmural variations in action potentials
Both the GPB and OVVR models include endocardial cell formulations, and the
OVVR also includes a midmyocardial cell formulation, as shown in Fig. 4.2. Ac-
tion potentials obtained using the endocardial formulations do not have a promi-
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nent notch because of decreased Ito density and are longer than epicardial action
potentials. For the midmyocardial cell type, the OVVR model exhibits a promi-
nent dome with the height of the plateau higher than the peak of the upstroke
for both single cell and tissue. The APD of the midmyocardial cell for the OVVR
model at a CL of 1000 ms is 348.6 ms, which is longer than that of the epicardial
cell by 119.7 ms and that of the endocardial cell by 90.2 ms. The OVVR model
APDs for both epicardial and endocardial cells are shorter than those of the cor-
responding cell types in the GPB model, and the difference in GPB epicardial
and endocardial APDs is also smaller (11.8 ms), as shown in Fig. 4.2. Additional
details are given in Table 4.1.
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Figure 4.3: Action potentials for the epicardial formulations of six human ventric-
ular models. Action potentials in single cells (left column) and in 1D tissue (right
column). Data are taken from the middle of the cable (cell 50) with a 100 cells
cable after pacing for 30 s at a CL of 1 s. Because of electrotonic coupling effects,
all of the model APs lose amplitude in tissue compared to single cells, with the
PB model decreasing the most (23.7%) followed by the GPB model (17.6%), the
TP model (12.9%), the OVVR model (12.4%), the IMW model (10.5%), and the
BCF model (4.0%). 56
4.3.3 Comparisons with other models
For comparison, we also analyzed the properties of action potentials of the PB,
IMW, TP, and BCF models and compared them with those of the GPB and
OVVR models in single cells and in 1D cables. Figure 4.3 (left column) shows
action potentials obtained after pacing for 30 s at a CL of 1000 ms, and Table
4.1 includes action potential characteristics obtained from the epicardial cell type
of all four models at the same CL. In single cells, all of the models have similar
spike-and-dome action potential morphologies for epicardial cells; however, the
prominence of the action potential notch and the plateau potential as well as the
resting membrane potential (RMP) vary among the models. The PB model has
the largest upstroke peak and AP amplitude, whereas the GPB model has the
smallest peak and AP amplitude. The RMP is lowest for the IMW model (-90.7
mV) and highest for the GPB model (-81.4 mV). In terms of action potential
morphology, the PB model has a clear two-phase repolarization, in contrast to
the other models where the transition is smoother, and the plateau phase for the
TP model is longer than for the other models, for which repolarization begins
sooner. APDs vary significantly among the models, ranging between 228.9 ms
for the OVVR model and 393.2 ms for the PB model for epicardial cells.
In tissue, the action potential upstrokes are decreased by electrotonic effects
(see Fig. 4.3, right column). For the OVVR model, the membrane potential
continues to increase after the upstroke, so that the plateau height is greater
than the upstroke depolarization, and there is no clear distinction between the
upstroke and the plateau. For the GPB, PB, IMW, and TP models, a distinct
upstroke spike still is observed, but with a peak lower than the plateau value.
Only the BCF model has a maximum upstroke potential higher than the plateau
in tissue. The maximum upstroke velocities vary considerably among the models,
ranging from 81.6 V/s for the OVVR model to 302.9 V/s for the GPB model.
Despite the morphological changes near the action potential upstrokes, APD does
not change much between 0D and 1D; the APD in tissue increases by 0.8 and 1.4
ms for the OVVR and BCF models, respectively, and decreases by 1.1, 1.3, 7.1
and 0.9 ms for the GPB, PB, IMW, and TP models, respectively. The maximum
upstroke velocity, however, decreases significantly from single cells to tissue: for
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the GPB model, the decrease is 23% (from 394 to 303 V/s), but for the OVVR
model, the decrease is 62% (from 217 to 82 V/s for epicardial cells). The PB, TP,
and BCF models also show decreases of 32%, 28%, and 12%, whereas the IMW
model shows no decrease in this quantity.
Figure 4.4: Rate dependence in a 1D cable for the GPB and OVVR models. (A,D)
Action potentials at cycle lengths of 1000, 600, 500, 400, and 300 ms. Compared
to isolated cell APs, the upstroke amplitude is decreased because of electrotonic
effects. (B,E) Steady-state and S1-S2 APD restitution curves. Steady-state resti-
tution curves (solid lines) were obtained after pacing for 30 s and S1-S2 restitution
curves (dashed lines) were obtained after 30 s of pacing for five different S1 cycle
lengths. Both models show memory in APD. (C,F) Steady-state and S1-S2 CV
restitution curves. The GPB model shows no apparent memory in CV, whereas
the OVVR shows limited CV memory.
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4.3.4 Rate dependence of APD and CV and short-term
memory
Action potentials for both the GPB and OVVR models exhibit significant rate
adaptation, as shown in Fig. 4.1 A-B for single cells and Fig. 4.4 A and D for 1D
cables. The steady-state restitution curves reflect this adaptation to rate, with
the APD in 1D varying by 70.6 ms and 37.5 ms for the GPB and OVVR models,
respectively, over CLs below 1000 ms, as shown in Fig. 4.4 B and E (solid lines).
The slopes of the steady-state restitution curves in tissue for both models are <1
over all DIs, with a maximum slope of 0.3 for the GPB model and 0.2 for the
OVVR model. Similar behavior is seen for single cells (not shown).
Short-term memory, which reflects the influence of pacing history, is an impor-
tant property demonstrated by both the GPB and OVVR models. The effects
of short-term memory can be observed through differences in S1-S2 APD and
CV restitution curves as the S1 CL is varied. Figure 4.4 B and E (dashed lines)
show S1-S2 APD restitution curves for a range of S1 CLs superimposed with
the steady-state restitution curve for the GPB and OVVR models. Both mod-
els show memory; we quantify the memory using the memory amplitude, which
we define as the difference between the maximum and minimum APDs over the
range of S1 CLs at the longest DI of 1000 ms [29]. The memory amplitude for the
epicardial cell type is considerably larger for the GPB model (54.2 ms) than for
the OVVR model (22.8 ms) in a 1D cable. In terms of restitution curve shapes
and slopes, S1-S2 curves for the GPB model are nearly flat, but generally become
biphasic at shorter DIs (< 200 ms). In contrast, S1-S2 restitution curves decrease
monotonically for the OVVR model, a phenomenon not observed for the GPB
model.
Figure 4.5 A shows steady-state APD restitution curves from all six models.
All the curves decrease monotonically. However, the IMW model shows a marked
decrease for long DIs and abrupt slope changes arising from lack of convergence
to a steady state, which renders the model strongly sensitive to pacing protocol.
For CLs below 1000 ms, APDs vary the most for the TP model (with a 119.8 ms
or 39.5% decrease) and the least for the OVVR model (with a 37.5 ms or 16.4%
decrease). The GPB APD range is in between, at 70.6 ms, as shown in Fig. 5A.
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As shown in Fig. 4.4 C and F (solid lines), wave propagation is considerably
faster in the GPB model than in the OVVR model over all DIs; in fact, the
minimum steady-state CV obtained for the GPB model in a 1D cable is larger
than the maximum CV for the OVVR model. Over the range of DIs, the CV
decreases by 27.9 cm/s (39.1% of the maximum CV) for the GPB model and by
9.1 cm/s (24.1% of the maximum CV) for the OVVR model. Although all S1-
S2 CV restitution curves decrease monotonically for both the GPB and OVVR
models (see Fig. 4C and F, dashed lines), the GPB model exhibits almost no
memory in CV; at long DIs, the CV changes by less than 1.0 cm/s as the S1
CL decreases from 1000 to 320 ms. The OVVR model shows a modest degree of
memory in CV of 3.1 cm/s as the S1 CL decreases from 1000 to 165 ms.
Figure 4.5: Steady-state APD and CV restitution curves for all six models in 1D
epicardial cables. (A) APD restitution curves. (B) CV restitution curves. Curves
were obtained after pacing for 30 s and show significant differences among the
models.
Across all six models, the BCF model has the largest maximum CV and the
OVVR model has the smallest, as shown in Fig. 4.5 B. The CVs of the GPB
and BCF models fall within a realistic range [109; 167; 230] with a maximum of
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71.4-74.6 cm/s, and the CVs of the PB, IMW, and TP models are only slightly
slower, ranging from 62.2 to 65.3 cm/s. However, the CV of the OVVR model
is nonphysiologically slow with a maximum of 37.8 cm/s. As discussed below,
this can be remedied by substituting the TP model formulation for INa. The PB
model displays the least variation in CV as the DI is varied, with a steady-state
CV range of 7.6 cm/s, followed by the IMW and OVVR models, with ranges of
9.0 cm/s and 9.1 cm/s, respectively. The TP and GPB models show the widest
steady-state CV ranges of 32.6 cm/s and 27.9 cm/s, respectively. The steady-
state CV range for the BCF model is in between, with a value of 15.3 cm/s.
Figure 4.6: Alternans in the OVVR model. Action potential traces (left) and
bifurcation diagrams (right) for (A) epicardial single cell, (B) epicardial cable,
(C) endocardial single cell, and (D) endocardial cable. Cycle lengths in the action
potential traces are (A) 165, (B) 320, (C) 200, and (D) 310 ms.
4.3.5 Alternans
Alternans was never observed for the GPB model, however, it occurs for a small
number of CLs in 0D and 1D for the OVVR model in both the epicardial and
61
endocardial cell types (but not in midmyocardial cells). Fig. 4.6 A shows that in a
single epicardial cell, alternans occurs only for a CL of 165 ms, with a magnitude
(difference in the APDs of two consecutive beats) of 0.9 ms. In tissue, the OVVR
epicardial model shows alternans for a single CL of 320 ms with a magnitude of
25.2 ms, as shown in Fig. 4.6 B. Alternans for a single endocardial cell occurs for
CLs between 200 and 280 ms, with a maximum magnitude of 12.0 ms, as shown
in Fig. 4.6 C, but in tissue, alternans occurs only for a single CL of 310 ms with a
magnitude of 70.8 ms (see Fig. 4.6 D). Although alternans occurs in both single
cells and 1D cables, the CLs exhibiting alternans were lower in 0D than in 1D
for both cell types.
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Figure 4.7: Reentrant spiral wave dynamics in 2D for the GPB and OVVR mod-
els. (A) The epicardial cell type of the GPB model features wave fronts that often
stall and reform, and the dominant period is 308 ms. (B) The endocardial cell
type of the GPB model shows similar stalling and recombining without breakup
and a dominant period of 321 ms. (C-E) Spiral wave dynamics for (C) epicardial,
(D) endocardial, and (E) midmyocardial cell types in the OVVR model. The
epicardial model exhibits a quasi-breakup where a new spiral wave tip is created
before the pervious one has dissipated. It has two dominant periods of 337 ms
and 481 ms. The endocardial model shows similar dynamics to the epicardial for-
mulation with a dominant period of 405 ms. The midmyocardial model features
an unstable hypocycloidal trajectory with a dominant period of 430 ms. Frames
in all cases correspond to 5.45, 5.50, 5.55, and 5.60 s, and tissue sizes are 14.4 cm
× 14.4 cm except for the OVVR epicardial cell type, where the size is 18.0 cm ×
18.0 cm. Dominant periods were obtained using the full 10 s of simulation time.
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4.3.6 Spiral wave dynamics
The dynamics and stability of reentrant spiral waves in two-dimensional homo-
geneous and isotropic tissue also differ between the GPB and OVVR models, as
shown in Fig. 4.7. Spiral waves in the GPB model feature a precessing linear tip
trajectory about 4 cm long for both the epicardial and endocardial formulations
(see Fig. 4.7 A-B), with the epicardial spiral wave precessing more quickly. In the
OVVR model, predominantly linear trajectories are observed for the epicardial
and endocardial formulations with the maximum distances traversed about 10
and 4 cm, respectively, as shown in Fig. 4.7 C-D. However, in these cases, each
time the tip turns, it does so rapidly, causing it to encounter refractory tissue and
die out. A new tip then forms along the spiral arm where propagation remains
possible. The midmyocardial formulation shows different dynamics, with an un-
stable hypocycloidal trajectory featuring petals approximately 0.6 cm in length,
as shown in Fig. 4.7 E.
By recording the times between action potential upstrokes at all sites in the
tissue, histograms of periods were recorded and dominant APDs and periods cal-
culated for each case. The dominant periods for the GPB model were 308 ms and
321 ms for the epicardial and endocardial formulations, respectively. The dom-
inant periods for the OVVR model generally were longer, with the endocardial
and midmyocardial formulations showing periods of 405 ms and 430 ms, respec-
tively. For the OVVR epicardial cell types, two prominent dominant periods of
337 ms and 481 ms were observed, with the broad spectrum of periods reflecting
the especially highly meandering nature of the spiral wave for this case (note the
much longer lengths in the tip trajectory compared to the other formulations).
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Figure 4.8: Spiral waves for all six models using epicardial formulations. Tissue
sizes are 14.4 cm × 14.4 cm for the GPB model, 18.0 cm × 18.0 cm for the OVVR
model, and 23.0 cm × 23.0 cm for the PB, IMW, TP, and BCF models. The
spatial resolution is 0.015 cm in all cases and the time step is 0.02 ms except
for the IMW model, where it is 0.01 ms. The IMW model used initial values
corresponding to pacing a single cell at 3 Hz. Color bar is in mV.
Figure 4.8 shows snapshots of spiral waves for all six models. Note that the
other models exhibit a variety of dynamics, including quasi-breakup (PB model),
sustained breakup (IMW model), and stable spiral waves (TP and BCF models).
For the PB, TP, and BCF models, the dominant periods were 318, 233, and 286
ms, respectively. The IMW model displayed three dominant periods of 121, 178,
and 283 ms and a much broader spectrum of periods overall, between about 120
and 300 ms, due to its high degree of meandering and sustained breakup.
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4.4 Discussion
4.4.1 Action potential rate adaptation and APD restitu-
tion
It is important to compare the model properties with available observations, al-
though experimental data on rate adaptation and restitution of APD in normal
human tissue are somewhat limited due to the difficulty in obtaining nondiseased
human cardiac tissue. Therefore, most studies are performed during other cardiac
surgical procedures. Koller et al. [124] reported maximum APD restitution curve
slopes of 0.97±0.16 (steady-state protocol) and 0.83±0.15 (S1-S2 protocol, S1 =
500 ms) for right ventricular endocardium. Similarly, Nash et al. [171] found a
median value of 0.91 for the maximum S1-S2 restitution curve slope in human
epicardium; only 27% of all electrode sites recorded slopes less than 0.5. Pak et
al. [183] found even higher maximum slopes using an S1-S2 protocol in normal
human tissue: 1.9±0.8 at the right ventricular outflow tract and 1.7±1.1 at the
right ventricular apex, with similar values obtained for a steady-state protocol.
In contrast, the maximum restitution curve slopes in the models in tissue as
measured by the steady-state protocol were considerably lower: the GPB model
achieved a maximum slope of 0.3 for both cells types, whereas with the OVVR
model maximum slopes were 0.1 for the epicardial cell type and 0.2 for both the
endocardial and midmyocardial cell types. Thus, neither model achieves a max-
imum restitution curve slope in tissue comparable to experimentally measured
values.
Bueno-Orovio et al. [19] observed APDs varying between about 165 and 205
ms for endocardial cells using the S1-S2 protocol (S1 = 500 ms). In comparison,
Franz et al. [63] found a larger variation in APD, between about 190-200 ms and
245-270 ms, and they also observed biphasic S1-S2 restitution curves. In terms
of the models, the GPB model has nearly flat S1-S2 APD restitution curves for
nearly all S1 cycle lengths. However, the OVVR model more closely matches the
experimental values, with APD varying between 197 and 215 ms. Changes to the
INa formulation, as discussed below, may reduce the OVVR model minimum APD
further in this case and thus achieve better agreement with the data of Bueno-
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Orovio et al. The OVVR model showed no indication of biphasic restitution
curves (see Fig. 4.4 E), whereas the GPB model showed an increase in APD at
shorter DIs for longer S1 cycle lengths (see Fig. 4.4 B). However, the biphasic
restitution curves observed by Franz et al. showed an increase in APD at short,
but not the shortest, DIs, and a significant decrease in APDs for the smallest
DIs, in contrast with findings for the GPB model.
Figure 4.9: Action potentials for the OVVR model using the TP formulation of
INa. Traces show action potentials for (A) epicardial, (B) endocardial, and (C)
midmyocardial cell types of the OVVR model using the TP model formulation
of INa (green solid) compared to the original OVVR model (blue dashed). Insets
show upstrokes, where the action potential shapes change most.
4.4.2 Transmural heterogeneity
The GPB model includes epicardial and endocardial formulations, and the OVVR
includes both of these as well as a midmyocardial formulation. The different cell
types of the models in tissue exhibit some action potential properties similar
to experimental observations, but there are also a number of differences. The
amplitudes of epicardial action potentials (100.4 and 107.8 mV for the GPB and
OVVR models, respectively) are smaller than experimental observations of 123
mV [165] and 131 mV [131]; most likely this results from the decreased upstroke
amplitude of the model APs in tissue compared to single cells (see Fig. 4.3).
The values of dV/dtmax for the epicardial formulations of the GPB and OVVR
models are 302.9 and 81.6 V/s, which are significantly different from observations
of 228±11 V/s [49] and 196±20 V/s [185]. The human epicardial APD at a CL of
67
1000 ms has been measured at 271±13 ms [131], which is nearly the same as for
the GPB epicardial model (275.0 ms), but longer than that of the OVVR model
(229.7 ms).
Human endocardial AP amplitudes have been measured at 119 mV [165] and
123 mV [131]; in tissue, the GPB model is still below these values with an AP
amplitude of 100.7 ms, but the OVVR model amplitude of 114.4 ms is close to
the experimental values. As for the epicardial models, the maximum upstroke
velocities of the endocardial models are still larger (GPB model, 303.3 V/s) and
smaller (OVVR model, 83.9 V/s) compared to experimental values (234±28 V/s
[49] and 231±30 V/s [185]). However, the endocardial APDs for both models
(288.0 ms for the GPB model and 258.6 ms for the OVVR model) are within
the range of what some experimental studies have found for endocardial APD
values (263±33 ms [131] and 270±7 ms [124]), although longer than reported in
other studies (196.7±20.1 ms and 207.8±21.5 ms for right and left ventricular
endocardium, respectively [19]).
Perhaps because of continued controversy surrounding the existence and func-
tion of midmyocardial cells [102; 173; 265], only the OVVR model includes a mid-
myocardial formulation. The model AP amplitude of 105.2 ms is lower than the
experimentally observed value of 128 mV [131], and its upstroke velocity remains
quite low at 81.9 V/s compared to the experimentally observed value of 326±16
V/s [49].
Overall, both the GPB and OVVR models in tissue exhibit action potential
amplitudes smaller than experimental observations. Also, the GPB model over-
estimates and the OVVR model underestimates the maximum upstroke velocity.
In addition, the APDs in the GPB model are close to experimental values for
both epicardial and endocardial cells, whereas the in OVVR model, endocardial
but not epicardial, APDs are close to experimental measurements.
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Figure 4.10: Rate adaptation and spiral wave properties for the OVVR model
with the TP INa formulation. (A-B) Steady-state APD restitution curves in
isolated cells (A) and a one-dimensional cable (right) for epicardial (green), en-
docardial (red), and midmyocardial (blue) cells. Original model restitution curves
are shown as dots (A) or dashed lines (B). The different INa formulation decreases
the minimum DI that can be reached in tissue. (C) Steady-state CV restitution
curves for the epicardial (green), midmyocardial (blue) and endocardial (black)
cells in a one-dimensional cable. Original model CV restitution curves are shown
as dashed lines. The modification increases the maximum CV by almost a fac-
tor of two. (D-F) Spiral wave snapshots, tip trajectories, and dominant periods
for the epicardial, endocardial, and midmyocardial formulations of the modified
model. Frames in all cases correspond to 1.85, 1.90, 1.95, and 2.00 s, and tissue




Maximum conduction velocity values for the GPB model as well as for the earlier
models are between 60 and 75 cm/s. This range agrees well with the range of
65-87 cm/s obtained in human heart studies [167; 230]. The minimum conduction
velocity obtained has been found experimentally using an S1-S2 protocol to be
25% lower than the maximum [271], which is comparable to the OVVR model,
which has a decrease of 24.1%. The GPB, however, shows a larger decrease of
39.1% using the S1-S2 protocol with an S1 CL of 1000 ms. Thus, the GPB model
may show extra rate adaptation.
However, the main discrepancy where CV is concerned is in the maximum CV
of the OVVR model, which, at about 38 cm/s, is about half of what has been
observed experimentally. The low velocity is related to the sodium channel formu-
lation of the OVVR model. This could include temperature-related adjustments
to the data from Sakakibara et al. [211] which is used as the basis for many INa
formulations along with the novel incorporation of Ca2+/calmodulin-dependent
protein kinase II effects. One simple remedy is to substitute the INa formulation
of the TP model, which nearly doubles the maximum CV. Figure 4.9 shows the ef-
fect of this substitution on the epicardial, endocardial, and midmyocardial action
potential shapes. In all cases, the revised sodium current increases action poten-
tial amplitude in isolated cells by 10-15 mV, but otherwise there is little effect
on action potential shape; APD is decreased slightly by 2.2, 6.6, and 1.4 mV for
epicardial, endocardial, and midmyocardial cells. Figure 4.10 demonstrates the
rate adaptation and spiral wave properties of the modified model. The primary
effects in tissue of the INa substitution are an increase in maximum conduction
velocity to nearly twice its original value, a decrease in minimum CL by 65-115
ms (and thus the minimum APD by 20-30 ms), a decrease in dominant APD and
spiral wave period, and changes to spiral wave dynamics. Spiral wave stability is
not affected. Thus, the INa substitution provides a realistic CV for the OVVR
model while leaving many other model properties unchanged.
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4.4.4 Alternans
Although alternans is known to occur in normal human hearts from both clinical
[124] and ECG studies [204], the GPB model does not exhibit alternans at any
CL. Alternans occurs in the OVVR model in tissue for a CL of 320 ms in epicardial
cells a CL of 310 ms in endocardial cells; the magnitudes of alternans for those cell
types were 25.2 and 70.8 ms, respectively. Koller et al. [124] found the alternans
of onset occurred at a much lower CL of 267 ms, with a maximum alternans
magnitude of 11 ms. Thus, although alternans occurs for the OVVR model but
not the GPB model, alternans in the OVVR model is present earlier and achieves
a significantly greater magnitude than what has been observed clinically.
4.4.5 Reentrant wave dynamics
All of the GPB and OVVR model variations exhibit stable or quasi-stable dy-
namics, with no sustained breakup of spiral waves occurring. Well-defined pe-
riods occur in all cases except for the OVVR epicardial formulation, which has
two peaks associated with the spiral wave rotation and the broadly meandering
trajectory of the spiral wave. Converting these dominant periods to dominant
frequencies facilitates comparison with experiments. The dominant frequencies
of the GPB model, which are 3.25 and 3.12 Hz for epicardial and endocardial
cells types, respectively, both lie within the range of clinically observed dominant
frequencies of VT, 2.9-4.2 Hz [124] (VF frequencies are higher, up to about 7.5 Hz
[34; 167; 168]). For the OVVR model, the dominant frequencies measured of 2.08,
2.47, and 2.33 Hz for epicardial, endocardial, and midmyocardial preparations,
respectively, are lower than those observed clinically for VT, except for the second
epicardial frequency, which at 2.97 Hz is just inside the clinical range. Thus, the
GPB model corresponds well to VT, whereas the OVVR model frequencies are
somewhat lower than the values typically observed for VT clinically. However,
the substitution of the TP model formulation of INa changes the observed domi-
nant frequencies of the OVVR model to 4.74, 4.35, and 2.94 Hz for the epicardial,
endocardial, and midmyocardial formulations. The modification thus brings the
dominant frequency for midmyocardial cells within the clinical range, with the
frequencies for epicardial and endocardial cells just above that range.
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Although induced reentrant waves do not produce breakup in two dimensions,
it is possible that additional breakup mechanisms specific to three-dimensional
tissue [58] could produce fibrillatory-like states. Further study is needed to de-
termine how tissue thickness and anatomy affect the stability of reentry for these
models.
4.5 Conclusions
We have analyzed quantitatively the dynamics of two recently published models
of human ventricular cells, the GPB model and the OVVR model, in isolated
cells and in one- and two-dimensional tissue constructs and have compared the
observed properties with those of other ventricular models and with available ex-
perimental and clinical data. We have shown that each model has strengths and
limitations that suggest how it can be best utilized for cardiac tissue studies. The
GPB model produces APDs and a maximum CV value closer to experimentally
observed values along with clinically relevant dominant frequencies correspond-
ing to VT. The OVVR model shows greater fidelity of APD variation with S1-S2
restitution curves and produces alternans, although with a magnitude greater
than observed experimentally. Using the TP model formulation for INa restores
the maximum CV of the OVVR model, decreases minimum DI, and increases
dominant spiral wave periods. Both models exhibit action potential amplitudes
and maximum restitution curve slope values below what has been reported ex-
perimentally, do not agree well with observations of maximum upstroke velocity
in tissue, and show APD restitution curve maximum slopes below typical exper-
imental values.
Although the models studied in many cases generate different predictions,
we emphasize that model disagreement may arise for many possible reasons. The
models may exhibit normally observed biological variability or may reflect spatial
heterogeneity other than transmural heterogeneity, such as apico-basal [171] , left-
right [19; 171], or other regional [171; 183] gradients. Differences also may arise
from study subject differences such as age and gender. In addition, it is important
to note although models generally are designed to reproduce normal cells, it is
difficult to access healthy human tissue experimentally. The other models used
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for comparison also have limitations, although, like the GPB and OVVR models,
many of them match experimental data for some properties well [18]. Thus,



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The purpose of this chapter is to present the electrophysiological activity of a
transmural single myocyte, which was simulated using well-justified modifications
of a recent mathematical model of the human ventricular AP [181] to replicate
the experimentally reported human HF phenotypes. In addition, systematic and
quantitative variability in ionic currents and exchangers was introduced utiliz-
ing experimental observations published in the literature. In order to reproduce
action potential properties under heart failure electrophysiological conditions, as
observed by experimentalists, it is essential to investigate all currents, pumps,
concentrations, and exchangers activity, which impact the dynamics of an AP. In
this chapter, we start by itemizing the identified hallmarks that were observed
in a single HF myocyte. These hallmarks include: reduction of AP amplitude
and upstroke velocity, diminishing the notch of an AP, prolongation of an APD,
increasing the accumulated [Na+]i concentration, and altering the [Ca
2+]i dy-
namics. Then, we explain in detail how each current/exchanger was remodeled
based on experimental observations. This is one of the aims of this thesis: to
simulate remodeling currents/pumps that have physiological meaning and in a
comprehensive manner. We explain how each remodeled current/exchanger con-
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tributes to AP properties and to which phase. After that, we present the analysis
results of our HF model with fixed set of parameters. This developed HF model
used to simulate electrical properties in a 0D single cell considering remodeling
variations for each ion channel expression. Then, we simulate 1D cable and 2D
tissue aiming to investigate the effects of remodeling currents and exchangers in
a single myocyte on the properties of arrhythmias on tissue. Finally, we discuss
the results and relate it with experimental observations.
5.1 Introduction
There are vast numbers of cellular cardiac electrophysiological models that have
been created, which represent either normal or diseased cases. The objective of
these models is to explain how the biological system works, replicate the experi-
mental observations, predict quantitatively and simultaneously all properties that
are complex to be measured experimentally, and suggest the direction of future
experiments and drugs for certain diseases.
In many cases, animal models are used to investigate cardiac electrophysiolog-
ical properties for both control and HF cases. However, mathematical models and
computer simulations also are important tools for studying arrhythmias. To study
the mechanisms of VA in humans arising from HF, the mathematical model should
be based on recent human data and reproduce important arrhythmogenic phe-
nomena, such as the AP, [Ca2+]i, and alternans. Therefore, we developed a human
ventricular cell model under HF conditions that is based on a recently published
undiseased human ventricular cell model, namely Thomas O’Hara, László Virág,
András Varró, and Yoram Rudy (OVVR) model [181]. This physiologically-based
mathematical model of a normal human ventricular cell was chosen because it is
formulated to reproduce the normal human ventricular AP with a broad range
of essential physiological properties. This original undiseased OVVR model was
evaluated through the steady-state (S-S) rate-dependence and restitution curves
of an action potential in a single myocyte based on data from more than one
hundred normal human hearts. Furthermore, the model can reproduce alternans.
In addition, it presents new formulations for unavailable measurements of ICaL,
potassium currents, and INaCa. However, the model was not formulated to in-
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vestigate disease-specific situations such as HF, which is our aim in the present
thesis. In addition, the OVVR model was designed to simulate heterogeneous
transmural cell types, i.e. epicardial, midmyocardial, and endocardial cell types.
Unlike comparable models that represent either two cell types, epicardial and en-
docardial, such as the Grandi, Pasqualini, and Bers (GPB) model [73], or other
models which simulate one cell type, i.e. epicardial, such as Iyer, Mazhari, and
Winslow (IMW) model [99].
5.2 Remodeling of heterogeneous transmural AP
HF conditions
This section will explain in detail the quantitative changes of ion channels, trans-
porters, and pump activities with respect to the original OVVR model to rep-
resent the HF model in a single myocyte. The refined parameters are chosen
based on the published observations from the previous experimental studies on
transmural cell types in failing hearts considering the interval of remodeling for
each current/exchanger. We will start by enumerating the characteristics that
the HF cell type possesses, which are different from a normal cell type. These
identified hallmarks of a single myocyte can be summarized as follows:
• Prolongation of an APD in failing myocytes compared to control myocytes.
• Slight nonsignificant increase in the RMP in failing myocytes.
• Heightened plateau phase of an AP in failing myocytes.
• Decrease in the AP amplitude in failing myocytes.
• Decrease in the maximum upstroke velocity of an AP in failing myocytes.
• Diminishment in the notch during phase 1 of early repolarization of an AP
in failing myocytes.
• Increased minimum cycle length in failing myocytes.
• Increased minimum diastolic interval (refractory period) in failing myocytes.
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• Decline of the [Ca2+]i decay time in failing myocytes.
• Reduction in the [Ca2+]i systolic amplitude in failing myocytes.
• Shortening in the [Ca2+]i time to peak in failing myocytes.
• Increase in the [Ca2+]i diastolic steady-state in failing myocytes.
• Increase in the accumulated [Na+]i concentration in failing myocytes.
• Raise in the alternans cycle length onset in failing myocytes.
• Expansion in the range of alternans in failing myocytes.
• Steep steady-state APD restitution curve in failing myocytes.
• Dispersion of repolarization in the failing myocytes.
To accomplish the desired remodeling of an AP, [Ca2+]i, [Na
+]i, and all other
related properties that should match observed AP properties of ventricular hu-
man cell type under HF conditions, we modulate the maximum conductances
and permeabilities of the undiseased human ventricular cell model, the OVVR
model. This modulation is based mainly on the experimental measurements of
human HF cells. In addition, to make our developed HF model more realistic
in simulating ventricular myocytes under HF conditions, we simulate all three
ventricular cell types, i.e. epicardial, midmyocardial, and endocardial cells, with
different parameter settings.
We simulated our developed heart failure OVVR model under two different
sets of parameters:
• Fixed set of parameters: In this type of simulation, we setup each remodeled
current conductance under heart failure conditions with a single value which
represents the percentage of each remodeled current. Table 5.1 summarizes
the remodeled current conductances with fixed set of parameters.
• Variable set of parameters: To make the HF model more robust and be able
to cover all variabilities encountered during HF, we represent the remodeled
data currents and exchangers as mean ± standard deviation (µ±SD), as




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In this work, the Iion of the aforementioned equation 3.1 can be represented
by the following equation:
Iion = INa + INaL + ICaL + ICaK + IK1 + IKr + IKs+
Ito + INaCa + INaK + INab + ICab + IKb + IpCa (5.1)
For the main ionic currents and pumps, we will explain each one of them and
its function separately. In addition, we will highlight the degree and phase that
each current/pump participates in reproducing HF AP properties. The remodeled
currents are presented first followed by remodeled exchangers and pumps:-
• Fast Sodium Current (INa): This current is activated during the de-
polarization phase of an AP, which is responsible for upstrokes during the
normal impulses in a single myocyte. Most experimental studies on HF-
affected myocytes show that the peak INa is decreased in a range from
↓39.3±6.5% to ↓91.1±9.3% [65; 220; 246], except for one study [211], which
indicates that the peak INa is unchanged from normal levels. We calcu-
lated the mean (µ) and standard deviation (SD) of observed remodeling
of INa in cardiomyocytes isolated with these recent experimental studies
[65; 220; 246]. In our simulations, we use (µ±2SD) to express the range of
variations. Fig. 5.3 (A) shows the simulated reduction of the INa. Figure
5.1 shows the simulated reduction of INa current (upper panel) along with
the observed experimental results (lower panel). Figure 5.2 exhibits the
effect of reducing INa current on the amplitude of the simulated AP during
the depolarization phase.
• Late Sodium Current (INaL): The participation of this current is during
the plateau and repolarization phases, not during the depolarization phase
of an AP due to its slow dynamics. Most experiments on HF human my-
ocytes [151; 152; 244; 246] show that the INaL density is increased within
a range from ↑30.0±0% to ↑238.5±1.3%. However, one study [150] showed
similar INaL densities in failing and normal hearts, although the small sam-
ple size did not allow a statistically significant comparison. Therefore, we
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Figure 5.1: (A) Simulation results of the peak INa current under normal con-
ditions. (B) Simulation results of the peak INa current under HF conditions
expressed within a range of mean+2SD and mean-2SD at CL=1000 ms. (C)
Peak INa current recorded from myocytes of normal human hearts that have
been recorded in control solution. (D) Peak INa current recorded from myocytes























































































































































































































































































































































































Figure 5.3: Simulated (A) INa, (B) IKr, and (C) INaCa under normal condi-
tions OVVR (black lines) and heart failure conditions HF-OVVR expressed as
mean±2SD of the endocardial cell type at CL=1000 ms.
computed the average of these experimental observations in human HF my-
ocytes from [151; 152; 244; 246] considering the variation between these
studies. Figure 5.4 shows the simulated increase of INaL current (upper
panel) at CL=1000 ms along with the observed experimental data (lower
panel). Figure 5.5 exhibits the effects of increasing INaL current on the
plateau and repolarization phases of the simulated AP.
• L-type Calcium Current (ICaL): This current plays an essential role in
shaping the AP morphology, especially in the long plateau phase. Also, it
initiates the excitation-contraction coupling. The majority of previous HF
observations report that there is no significant difference between ICaL in
failing and non-failing myocytes [9; 12; 14; 26; 114; 133; 158; 198; 213; 215;
235]. However, one study [231] observed a decrease in the dihydropyridine
(DHP) binding sites within a range from ↓35% to 48% and mRNA by
↓47%. We decided to use the same ICaL density as in non-failing myocytes
as reported by most of these experiments for all cell types. Figure 5.6
shows the simulated ICaL current (upper panel) along with the observed
ICaL current (lower panel) under normal and HF conditions.
• Transient Outward Current (Ito): This current impacts the notch por-
tion during the rapid phase 1 repolarization of an AP. It is agreed across
most experimental observations on human ventricular species that Ito is de-
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Figure 5.4: (A) Simulation results of the OVVR model peak INaL current under
normal conditions. (B) Simulation results of the OVVR model peak INaL current
under HF conditions expressed within a range mean+2SD and mean-2SD at CL
1000 ms. (C) A representative traces from normal and failing myocytes obtained









































































































































































































































































































































Figure 5.6: (A) Simulation results of the OVVR model peak ICaL current under
normal (green) conditions. (B) Simulation results of the OVVR model peak ICaL
current under HF (red) conditions. (C) Original recordings of the ICaL myocytes,
that are expressed as current densities (pA/pF), which isolated from non-failing
and (D) failing ventricular hearts. Reproduced from [158]
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creased with a range from ↓26.4±1.3% to ↓73.2±5.8% under HF conditions
[13; 91; 114; 133; 164; 165; 235; 261; 274]. However, these studies claim that
there is no significant change in the kinetics of Ito in failing myocytes when
compared with non-failing myocytes. Therefore, we chose to incorporate
a downregulation of Ito under HF conditions heterogeneously. This means
that different outward potassium conductance settings (Gto values) are used
to model the transmural heterogeneity of cardiac ventricular cells based on
the previous experimental observations [91; 133; 165; 274] for epicardial
cells, [13; 91; 114; 164; 235] for midmyocardial cells, and [91; 165; 261; 274]
for endocardial cells. As a consequence, Ito is reduced by ↓40.4±8.7%,
↓37.6±3.3%, and ↓50.8±2.0% for epicardial, midmyocardial, and endocar-
dial cell types, respectively. Figure 5.7 shows the simulated decrease of
the Ito current (upper panel) along with compared experimental observa-
tions (lower panel), for the midmyocardial cell type. Figure 5.8 exhibits
the effects of decreasing the Ito current on the notch as well as the plateau
amplitude of the simulated AP at CL=1000 ms.
• Inward Rectifier Current (IK1): IK1 plays a significant role in stabiliz-
ing the resting membrane potential (RMP) and in shaping the last portion
of the repolarization phase of an AP [280]. Observations from numerous
studies have shown that IK1 is significantly downregulated within a range
from ↓40±0% to ↓64±0% [2; 13; 101; 114; 125; 133; 231; 235]. Hence, we
adopted a reduction of the peak IK1 by reducing its conductance (GK1)
heterogeneously, after calculating the mean and standard deviation, by
↓55.3±13.9%, ↓52.7±14.8%, and ↓55.0±16.1% for epicardial, midmyocar-
dial, and endocardial cell types, respectively. The transmural remodeling is
based mainly on the experimental observations from [125; 133; 231; 235] for
epicardial, [13; 125; 231; 235] for midmyocardial, and [125; 231; 235] for en-
docardial cells. Figure 5.9 shows the simulated decrease of the IK1 current
(upper panel) along with the observed experimental data (lower panel), for
the epicardial cell type. Figure 5.10 exhibits the effects of decreasing the
IK1 current on the terminal repolarization phase of the simulated HF AP.
89












































































Figure 5.7: (A) Simulation results of the OVVR model peak Ito current under
normal conditions of the epicardial cell type. (B) Simulation results of the OVVR
model peak Ito current under HF conditions of the epicardial cell type that are
expressed within a range mean+2SD and mean-2SD at CL=1000 ms. (C) The
Ito current recorded from human ventricular myocytes isolated from the mid-
myocardial wall of the left ventricle. (D) The Ito current recorded from human





































































































































































































































































































































Figure 5.9: (A) Simulation results of the OVVR model peak IK1 current under
normal conditions of the epicardial cell type. (B) Simulation results of the OVVR
model peak IK1 current under HF conditions of the epicardial cell type that are
expressed within a range mean+2SD and mean-2SD at CL=1000 ms. (C) The
IK1 current recorded at 0.5Hz from human ventricular myocytes isolated from
the epicardial surface tissue, which isolated from relatively normal histology cells.
(D) The IK1 current recorded at 0.5Hz from human ventricular myocytes isolated






























































































































































































































































• Rapid Delayed Rectifier Potassium Current (IKr): IKr plays an im-
portant role in the repolarization phase of an AP (see Fig. 5.12). This cur-
rent has been studied extensively with controversial observations. Many ex-
periments observed a reduction within a range from ↓27.3±1.7% to ↓51±0%
[2; 91; 203; 238], but some studies [114; 115; 133] indicated that IKr is un-
changed. This controversial observation is due in part to the cell type inves-
tigated. We speculate that the IKr current has a prominent effect on char-
acterizing an AP and contributing to induced-HF including the increased
susceptibility of alternans onset and initiating an EADs phenomenon based
on the great effect of this current that has been reported in the original
OVVR model [181]. Therefore, we decided to incorporate remodeling of
this current based on the cell type, due to the differences in the shape and
duration of APs between these cells, by ↓45.9±9.5% for epicardial cells [91],
unchanged for midmyocardial cells [114; 115; 133], and ↓27.3±1.7% for en-
docardial cells [91]. The simulated IKr current traces are shown in Fig.
5.3 (B). Figure 5.11 shows the simulated decrease of the IKr current under
normal and HF conditions (upper panel), along with the observed experi-
mental current (middle panel), for the epicardial cell type. The unchanged
observations of the midmyocardial cell type between normal and HF con-
ditions is shown in the lower panel. Figure 5.12 exhibits the great effects
of decreasing IKr current on both the plateau and repolarization phases of
the simulated HF AP.
• Slow Delayed Rectifier Potassium Current (IKs): IKs is a slow acti-
vating current that affects the last portion of repolarization of an AP. Most
of the former studies show an agreement on the downregulation of IKs within
a range from ↓49.5±1.6% to ↓61.7±1.4% [2; 132; 133]. Only one study [258]
exhibits that the KCNE1 mRNA increases by ↑25%. Another noticeable
result from experiments, shows that the reduction of the IKs current density
in all three layers becomes more homogeneous during HF, as opposite to
non-failing myocytes in these layers. We decided to follow the majority of
the previous experimental observations through reducing the peak current
density of IKs heterogeneously by ↓59.4±2.1% [132; 133], ↓49.5±1.6% [132],
94
































































































Figure 5.11: (A) Simulation results of the OVVR model peak IKr current under
normal conditions of the epicardial cell type. (B) Simulation results of the OVVR
model peak IKr current under HF conditions of the epicardial cell type that are
represented within a range mean+2SD and mean-2SD at CL=1000 ms (upper
panel). (C-D) Representative tracings of the IKr current recorded from rabbit
ventricular myocytes, which isolated from control and failing cells [238] (middle
panel). (E-F) The IKr current recorded at 0.1Hz from rabbit LV midway free





























































































































































































































































and ↓57.7±2.2% [132] for epicardial, midmyocardial, and endocardial cell
types, respectively. Figure 5.13 shows the simulated decrease of the IKs
current (upper panel), along with the compared experimental observations
(lower panel), for the epicardial cell type. Figure 5.14 exhibits the effects
of decreasing IKs current on the second half of the repolarization phase of
the simulated AP.
• Sodium-Calcium Exchanger Current (INaCa): INaCa supports regu-
lating the intracellular calcium concentration. Many experimental observa-
tions on the myocardium of HF patients found that the measured activity
of the Na+/Ca2+ exchanger is modified in a wide range from ↑80.0±0%
to ↑200.0±0% compared to non-failing myocytes [61; 81; 199; 228; 229].
Therefore, a homogeneous upregulation of INaCa by ↑131.4±62.8% for all
different cell types is incorporated into the undiseased OVVR model, which
includes both the membrane INaCai and subspace INaCass . Fig. 5.3 (C)
exhibits the simulation results of the modified INaCa. Figure 5.15 shows
the simulated regulation of the INaCa current for an epicardial cell type.
Figure 5.16 exhibits the effects of regulating INaCa current on almost all
phases of the simulated AP starting from the spike and dome, the plateau
amplitude, and the repolarization phase where it effects the APD. This is
because the INaCa current involves both the Na
+ and Ca2+ concentrations
that contributes to all stages of an AP.
• Sodium-Potassium Exchanger Current (INaK): INaK maintains the
resting membrane potential (RMP) and ionic homeostasis inside the cell.
The majority of experimental studies report that Na+/K+ pump activity
is downregulated within a range from ↓36±0% to ↓56±0% [113; 121; 145;
216; 219]. One study [106], observed a non-significant decrease of ↓10%.
We decreased the peak of INaK homogeneously by ↓40.2±15.5% in our HF-
OVVR cellular model. Figure 5.17 shows the simulated reduction of the
INaK current for an epicardial single myocyte. Figure 5.18 exhibits the
small effects of reducing INaK current on the repolarization phase of the
simulated HF AP.
97
















































































Figure 5.13: (A) Simulation results of the OVVR model peak IKs current under
normal conditions of the epicardial cell type. (B) Simulation results of the OVVR
model peak IKs current under HF conditions of the epicardial cell type that are
represented within a range mean+2SD and mean-2SD at CL=1000 ms. (C)
The voltage dependent IKs recordings at 0.1Hz in relatively normal histology
cells isolated from the epicardial surface tissue. (D) The voltage dependent IKs













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































• Sarcoplasmic Reticulum Ca2+ (SERCA) pump: This pump trans-
ports calcium ions from the cytosol into the SR. Most of the experimental
observations claim that an alteration of [Ca2+]i in failing human and an-
imal myocytes is based on the dynamics of the SR Ca2+ pump, which is
decreased in a range from ↓15.4±0% to ↓50.0±0% [7; 46; 78; 80; 81; 107;
144; 157; 187; 192; 268]. [Ca2+]i under HF conditions is characterized by a
reduction of calcium levels during the systolic phase, an elevation of calcium
levels during the diastolic phase, and prolongation of calcium levels during
the relaxation phase. We decided to incorporate a remodeling of SERCA
in our HF-OVVR model through decreasing the SERCA activity hetero-
geneously by ↓41.3±12.5% [78; 80; 81; 144; 157; 192; 268], ↓42.3±11.3%
[78; 80; 81; 157; 187; 192; 268], and ↓41.1±10.1% [78; 80; 81; 107; 144; 157;
192; 268] for epicardial, midmyocardial, and endocardial cell types, respec-
tively. Figure 5.19 shows the simulated normal [Ca2+]i dynamics (upper
panel), along with validated experimental observation for the epicardial cell
type (lower panel). Figure 5.20 depicts the simulated HF [Ca2+]i dynamics
(upper panel), along with validated experimental observation for the epi-
cardial cell type (lower panel). Figure 5.21 shows the simulation results of
the OVVR model peak ICaL current after remodeling SERCA under HF
conditions. Figure 5.22 exhibits the small effects of reducing SERCA dy-
namics on the plateau and early repolarization phases of the simulated HF
AP.
5.3 Single cell results with the general set of
HF-OVVR model parameters
5.3.1 Heart failure simulation of an action potential
in a single cell
Both action potentials of control and failing myocytes were simulated and
compared for all kinds of cells. Figure 5.23, shows the simulated normal
and HF APs (upper panel), along with experimental observations (lower
104




































Figure 5.19: (A) Simulation results of the OVVR model [Ca2+]i dynamics under
normal conditions of the epicardial cell type at CL=1000 ms. (B) Cytosolic Ca2+
transients in a myocyte from a control heart in physiologic solution, Reproduced
from [12].
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Figure 5.20: (A) Simulation results of the OVVR model [Ca2+]i dynamics under
HF conditions of the epicardial cell type that are represented within a range
mean+2SD and mean-2SD at CL=1000 ms. (B) Cytosolic Ca2+ transients in a














































































































































































































































































































































































































































































































































































panel) that are reproduced from [133] for epicardial cell types. Figure 5.24,
exhibits the simulated normal and HF APs (upper panel), along with ex-
perimental observations (lower panel) for midmyocardial cell types. Fig-
ure 5.25, depicts the simulated normal and HF APs (upper panel), along
with experimental observations (lower panel) for endocardial cell types. To
obtain a steady-state for all of the following: AP, currents, as well as in-
tracellular [Ca+2]i concentration, for both undiseased and HF models; the
simulation was run for 60 s, and the last AP was elicited with its currents
and concentrations at a pacing frequency of 1Hz (CL=1000 ms). Table 5.3
, depicts the quantitative biomarkers difference between normal and HF
properties of the OVVR model in a single myocyte, along with Table 5.4
that shows quantitative comparison of these biomarkers with experimental
observations under HF conditions. The values of HF are represented as a
range to cover many variations of observed action potentials as can be seen
in Figures 5.26 and 5.27. 5.6, 5.7.
As you can see from Figures 5.23, 5.24, and 5.25 for epicardial, midmyocar-
dial, and endocardial cell type, respectively, the AP at 90% repolarization
of failing myocytes is prolonged within a range 339.1 - 606.9, 441.7 - 869.7,
and 404.5 - 609.3, respectively, over non-failing myocytes due to sustained
plateau (like epi-), or much slower repolarization (like mid- and endo-) dy-
namics of an AP. These results are in agreement with experimental obser-
vations from [12; 133; 193]. The same pattern is observed for APD50. The
AP amplitude is decreased for all three cell types. The upstroke velocity is
significantly reduced within a range 113.8 - 114.6, 114.6 - 116.2, and 115.2
- 117.8 in failing epi-, mid-, and endo- myocytes, respectively, compared
with corresponding non-failing myocytes. These observations matched the
previous findings where previous studies report that the upstroke velocity
reduces to its half value under HF conditions compared to control condi-
tions. Additionally, the resting membrane potentials are barely increased
in all cell types in the developed HF model, which are in agreement with
experimental observations of HF cells [126; 132; 159; 238; 248].
The prolongation of an APD induces the ICaL peak current to increase and
109










































Figure 5.23: (A) Simulation results of an AP dynamics OVVR model of the
epicardial cell type at CL=1000 ms under normal and HF conditions. (B) Exper-
imental observations of an AP dynamics in an epicardial myocyte extracted from































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.26: Experimental observation of an AP in a single myocyte that was
extracted from patients with HF [12].
contributes to the INaCa to remove Ca
+2 during the repolarization phase.
The cause of this alteration is that the rate of the SR buffer is decreased,
which causes the intracellular [Ca+2]i concentration to slowly decay and
at the same time it reduces the Ca+2 stored in the SR buffer. This leads
to reduced Ca+2 release from the SR buffer, which induces more influx
of Ca+2 during the plateau phase that causes increasing the height of the
plateau phase. Two factors contributed to this additional Ca+2 influx, the
increased of ICaL peak current and the slow decay of intracellular [Ca
+2]i
concentration. This means that the sodium-calcium exchanger increased its
contribution for Ca+2 removal.
For Ca2+ dynamics, the [Ca]i systolic amplitude in the developed HF model
matches the experimental observations [12; 44; 47; 85; 189; 190; 270], where
it decreases to almost half values compared to non-failing myocytes. One
of the prominent proarrhythmia biomarkers is the repolarization time from
APD50 to APD90, which is known as triangulation, because as the time
difference between APD50 and APD90 prolongs, the action potential takes
a more triangular shape. It is an important proarrhythmia biomarker be-
cause it measures the slow rate of repolarization of an AP, which is one



















































main factors that induces proarrhythmia whether the APD is lengthened
(PVT) or shortened (MVT) [92]. Also, it has been shown that triangula-
tion increases the incidence of EADs [142; 260]. As observed in our modi-
fied HF OVVR model that the range of triangulation values are increased
in all kinds of cells, but with different values, by 69.8 - 128.0 ms, 89.8 -
120.6 ms, and 86.1 - 132.7 ms for epi-, mid-, and endocardium, respectively,
when compared with the original undiseased OVVR model. The increased
triangulation is in agreement with experimental observations of HF cells
[12; 193].
Even with our consideration of the variability that was observed during HF,
there are some experiments that observed an increase APD that was less
than our results, where the measured difference of APD at 80% of repolar-
ization at, 94 ms, 40 ms, and 12 ms, for subepicardial, midmyocardial, and
subendocardial, respectively. These measurements were taken from non-
failing and failing human ventricle myocytes with stimulation duration of
2000 ms. However, [12] observed an increase in APD, measured at 90%
of repolarization, by 389 ms in myocytes isolated from hearts with end
stage heart failure caused by dilated cardiomyopathy (DCM) or ischemic
cardiomyopathy (ICM). This is in agreement with our results.
5.3.2 Rate dependence of APD and major currents
We compared the action potentials, main transmembrane currents (ICaL,
INaCa, IK1, IKr, IKs, and Ito), and calcium and sodium transients in single
cells of the normal and HF OVVR models for a range of different CLs
for the epicardial formulations. As shown in Figure 5.28 A-B, the action
potentials of the two models have different shapes where the HF APs do not
have spikes during early repolarization phase, due to the reduction of INa
current. Also, the repolarization dynamics more slowly on HF cells where
the shape of an action potential appears like a triangle. Although action
potentials obtained using the normal OVVR model have higher amplitude

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































plateaus, longer durations and exhibits more rate dependence than those of
the normal OVVR model.
The main transmembrane currents of the two models generally show differ-
ences in magnitude and in the degree of rate dependence. Neither model
displays much rate dependence of ICaL current (see Figure 5.28 C-D), but
the peak current at all cycle lengths is more than twice as large for the HF
OVVR model (-4.9 pA/pF) as for the normal OVVR model (-2.0 pA/pF)
at CL=1000 ms. INaCa exhibits stronger rate dependence for both models
with a larger degree for the HF OVVR model, as shown in Figure 5.28 E-F.
The peak inward current is twice as large for the HF OVVR model as for
the normal OVVR model for all ranges of CLs.
IK1 has similar patterns in the two models, however, the peak current is
about 100% larger for the normal model than for the HF OVVR model,
as shown in Figure 5.28 G-H. In addition, IK1 in the HF OVVR model
displays almost no rate dependence, whereas for the normal OVVR model
the peak value decreases slightly with decreasing CL. As shown in Figure
5.28 I-J, IKr exhibits very slight rate dependence in both models, but its
peak value for the normal OVVR model is two times larger than for the
HF OVVR model, indicating that it plays a more significant role during
repolarization for the normal OVVR model. IKs is also a little bit larger
for the normal OVVR model than for the HF OVVR model (see Figure 5.28
K-L). The HF OVVR model shows almost no rate dependence of IKs with
slight decreasing amplitude, but in the opposite way: as CL decreases, the
peak value of IKs increases for the normal OVVR model. For the Ito current,
both models show limited rate dependence, as shown in Figure 5.28 M-N.
The peak current is five times larger for the normal OVVR model than for
the HF OVVR model at slow pacing rates, and increases at fast rates six
times.
Figure 5.28 O-P, shows the calcium transients (intracellular calcium concen-
tration [Ca2+]i) for both models. The peak value is about twice as large for
the normal OVVR model as for the HF OVVR model during slow and fast
rates. In both models, the [Ca2+]i peak value increases as the CL decreases
118
Metric Cell Type
Cell Status Repo. epicardium midmyocardium endocardium
Normal
50% 65.8 ms (35.1%) 84.8 ms (30.1%) 71.3 ms (34.3%)
90% 65.5 ms (28.6%) 79.3 ms (23.0%) 74.1 ms (28.3%)
HF
50% 126.3 ms (36.1%) 117.6 ms (32.0%) 118.3 ms (31.7%)
90% 127.4 ms (28.8%) 97.4 ms (19.8%) 112.5 ms (22.7%)
Table 5.5: Summary of the steady state APD50 and APD90 rate dependency
observed in normal and HF single cell; Repo.: Repolarization threshold.
from 1000 ms to 300 ms, so that the [Ca2+]i peak-frequency relationship
is always positive. In addition, the calcium transient rises and falls more
slowly for the HF OVVR model than for the normal OVVR model.
5.3.3 Restitution curves and short-term memory
Action potentials for both the original and HF OVVR models exhibit signif-
icant rate adaptation, as shown in Figure 5.30 for single cells. The steady-
state restitution curves reflect this adaptation to rate, with the APD in a
single myocyte varying by about 65.5 ms and 127.3 ms for the normal and
HF OVVR models, respectively, over CLs below 1000 ms, as shown in Fig-
ure 5.31 A and D (solid lines). For all cell types detail, see Table 5.5. The
slopes of the steady-state restitution curves in single cells for both models
are <1 over all DIs, with a maximum slope of 0.54 for the endocardial cell
type of the normal OVVR model and 0.62 for the midmyocardial cell type
of the HF OVVR model. Also, as it expects that all APDs measured either
at 90% or 50% are longer for the HF OVVR model than the normal OVVR
model as depicted in Figure 5.31.
Figure 5.31 shows steady-state APD restitution curves at 90% and 50% of
repolarization from both normal and HF OVVR models. All curves decrease
monotonically with different degrees. For CLs below 1000 ms, APDs vary
the most for the epicardial cell types of the HF OVVR model (with a
126.3 ms or 36.1% decrease) at 50% of repolarization and the least for the







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































decrease) at 90% of repolarization. It is obvious that the APD range of HF
cells is wider than the normal OVVR model which reflects the phenomenon
known as dispersion of repolarization. The normal OVVR APD range is in
between for all cell types, as shown in Figure 5.30 and Figure 5.31.
Short-term memory, which reflects the influence of pacing history, is an im-
portant property demonstrated by both the normal and HF OVVR models,
but with different degrees. The effects of short-term memory can be ob-
served through differences in the S1-S2 APD restitution curve as the S1 CL
is varied. Figure 5.30 (dashed lines) shows S1-S2 APD restitution curves
for a range of S1 CLs superimposed with the steady-state restitution curve
for the normal OVVR model (upper panel), but not for the HF OVVR
model (lower panel). Both models show memory; we quantify the memory
using the memory amplitude, which is defined as the difference between
the maximum and minimum APDs over the range of S1 CLs at the longest
DI of 1000 ms [29]. The memory amplitude for the epicardial cell type is
considerably lower for the normal OVVR model (18.1 ms) than for the HF
OVVR model (35.1 ms) in a 0D single cell, as well as for other cell types
(see Figure 5.30). In terms of restitution curve shapes and slopes, S1-S2
curves for both the normal and HF OVVR models decreases monotonically
and with more steep decreasing at shorter DIs (≤ 200 ms).
To examine the changes in APD after a sudden sustained change in CL,
the cell was first paced at a constant CL=1000 ms until the APD reaches a
steady-state, for 8 min. Then, the CL was abruptly decreased to CL=600
ms and maintained for 8 min with this new CL until the APD reaches a
steady-state. Finally, the CL was restored to the original CL=1000 ms and
held for this CL until the APD reached a steady-state, for 8 min.
Figure 5.33 exhibits the time course (24 min.) of APD adaptation for an
abrupt decreasing and increasing CL for both the normal and HF OVVR
models. For abruptly decreasing CL, three cell types, namely normal en-
docardial, and HF epicardial and midmyocardial, possess two phases of
adaptations; the first phase is fast and has blunted decrease and increase
of an APD, where the second phase is characterized by slow decay until
124













































































































































Figure 5.32: Steady-state and S1-S2 APD 90% restitution curves for the OVVR
model in a single: (A) normal epicardial cell. (B) normal endocardial cell. (C)
normal midmyocardial cell. (D) HF epicardial cell. (E) HF endocardial cell.
(F) HF midyocardial cell. Curves were obtained after pacing for 60 s and show
significant differences among the status condition of cell type.
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it reaches a steady state APD. The APD adaptation for the other three
types of cells, namely normal epicardial and midmyocardial and HF endo-
cardial, are decreasing monotonically with greater degree after an abrupt
CL change. For abruptly increasing CL, all of the cell types exhibit spike
and dome, but with different degrees, resembling the shape of an action po-
tential, except the normal endocardial cell type which shows monotonically
increasing APD until it reaches a steady state.
5.3.4 Alternans
Alternans occurs for a small number of CLs in 0D for the normal OVVR
model in both the epicardial and endocardial cell types, but not in midmy-
ocardial cells. For the HF OVVR model alternans appears only in epicardial
cell types. Figure 5.34 A-B, shows that in a non-failing single epicardial cell,
alternans occurs only for a CL of 165 ms, with a magnitude (difference in
the APDs of two consecutive beats) of 1.48 ms, as depicted in Figure 5.35 A.
In a failing single epicardial cell, an alternans occurs at higher CLs accom-
panied by an extended alternans range, which develops to between 320 and
460 ms, as shown in Figure 5.34 C-D, and increased alternans magnitude
to become 8.0 ms, as depicted in Figure 5.35 A. Alternans for a non-failing
single endocardial cell occurs for CLs between 200 and 280 ms, as shown in
Figure 5.34 E-F, with a maximum magnitude of 11.76 ms, as depicted in
Figure 5.35 B. However, for HF an alternans does not occur.
5.4 Single cell results with more human-specific
set of HF-OVVR model parameters
5.4.1 HF Simulation of an AP in transmural cells:
Figure 5.36 depicts the transmural simulated APs of the normal OVVR
model (dotted green lines) and HF-OVVR model (solid black lines) for epi-





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.35: (A) Alternans magnitude of the non-failing (green bar) and failing
(red bars) epicardial cell type. (B) Alternans magnitude of the non-failing (green
bars) endocardial cell type.
ms. As shown in the left panel of Fig. 5.36, the HF settings of the OVVR
model diminish the spike-and-dome morphology of an epicardial AP and
the plateau is increased. In addition, APD90 is increased due to the slow
repolarization dynamics. Similar behavior is observed in the failing midmy-
ocardial cell type (see Fig. 5.36 middle panel), where APD90 is increased.
Some HF population cases exhibit a two-phase repolarization, which also
has been observed experimentally [12]. For the failing endocardial cell type,
Fig. 5.36 left panel, the maximum amplitude is unchanged, but the AP gets
delayed due to the reduction of INa for all of the HF population. Table 5.8
summarizes all the extracted biomarkers of the OVVR model under undis-
eased and HF conditions for heterogeneous cell types.
5.4.2 Rate dependence of APD and major currents:
An important role in excitation is the adaptation of an AP to changes in
pacing cycle length. As illustrated in Fig. 5.37 A-B, the APs of the HF-
132











































































Figure 5.36: Representative variation of the simulated OVVR action potentials
under normal (dotted green) and different HF (solid black) conditions for (A)
epicardial, (B) midmyocardial, and (C) endocardial cell types. (*) The four black
solid lines represent different variations in parameter values of µ-2SD, µ-SD, µ,
and µ+SD for all ionic currents at a CL of 1000 ms.
OVVR model exhibit stronger rate dependence than APs of the OVVR
model. For ICaL, the HF-OVVR also exhibits stronger rate dependence
than the OVVR model. However, the maximum amplitude in the HF-
OVVR is two times larger than in the OVVR model for all CLs (see Fig.
5.37 C-D). Due to the reduction of SERCA, the systolic calcium amplitude
is reduced and contributes to the slow diastolic decay of calcium, which
induces more calcium influx during the AP plateau phase. Similar rate
adaptation is observed for INaCa, where the HF-OVVR model possesses
stronger rate adaptation than the OVVR model, as shown in Fig. 5.37 E-
F. Regarding IK1, both models exhibit limited rate dependence, as depicted
in Fig. 5.37 G-H, but the OVVR model possesses maximum values larger
than the HF-OVVR model by ∼100%. For IKr, both models show limited
rate dependence, with the HF-OVVR model peak current values smaller
than the OVVR model by ∼50% for all CLs (see Fig. 5.37 I-J). For IKs,
the OVVR model exhibits larger rate dependence than the HF- OVVR
model. As shown in Fig. 5.37 K-L, the maximum value is increased as the
CL is decreased for the OVVR model, but it is slightly decreased for the
HF-OVVR model before it is increased at shorter CLs. In contrast, the
HF-OVVR model has stronger rate dependence for INaL than the OVVR
133
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Figure 5.37: Rate dependence of action potentials, primary transmembrane cur-
rents, and intracellular calcium concentration in a single myocyte for the normal
OVVR (columns 1 and 3) and HF-OVVR (columns 2 and 4) models for cycle
lengths of 1000 ms (solid black), 800 ms (dashed green), 600 ms (dashed red),
400 ms (dashed blue), and 350 ms (dashed purple). The HF-OVVR model gen-
erally shows more rate dependence; however, the normal OVVR model shows
greater rate dependence for IKs and [Ca
2+]i. The inset bar diagrams indicates
the peak values for each specific curve.
model at shorter CLs (see Fig. 5.37 M-N). Both models exhibit large rate
dependence of the calcium transient for all CLs, as shown in Fig. 5.37 O-P.
However, the OVVR model has a peak calcium value four times larger than
that of the HF-OVVR model.
5.4.3 Restitution curves and short-term memory (STM):
Figure 5.38 (dashed lines) shows S1-S2 APD restitution curves for a range
of S1 CLs for the HF-OVVR model. These S1-S2 curves are superimposed
with S-S APD restitution curves. All HF-OVVR restitution curves decrease
134




















































































Figure 5.38: Steady-state (black lines) and S1-S2 (dotted lines) APD restitution
curves for the HF-OVVR model in a single myocyte: (A) epicardial. (B) midmy-
ocardial. (C) endocardial. Curves were obtained after pacing for 60 s and show
significant differences among the cell type.
monotonically with CL. Also, all transmural cell types exhibit short-term
memory with the midmyocardial cell possessing the largest STM=23.6 ms,
and the epicardial cell having the shortest, STM=14.7 ms. The endocardial
cell falls in between with STM=20.9 ms. Fig. 5.39 exhibits the time course
(24 min) of APD adaptation to an abrupt decrease and increase of CL for
both the normal OVVR and HF-OVVR models. When accommodating to
a decrease in CL, the HF-OVVR model for the epicardial cell type has two
phases of accommodation. In the first phase the APD has a rapid decrease
and increase in the AP duration followed by slow decay until it reaches a
steady state. However, for the normal epicardial cell type of the OVVR
model, the APD is consistently decreasing. Similar behavior was observed
for accommodation to an increase in CL (see Fig. 5.39).
5.4.4 Alternans (ALTs):
Alternans occurs for all three types of cells of the HF-OVVR model, but
with a different alternans window and magnitude. For epicardial cells, Fig.
5.40 A-B, the alternans onset occurs at a CL of 400 ms and lasts to a CL
of 350 ms with a maximum alternans amplitude of ∼30.0 ms. As shown
in Fig. 5.40 C-D, which represents the midmyocardial cell, the alternans
135





































Figure 5.39: Time course of APD accommodation after an abrupt change in cycle
length for the (A) normal OVVR and (B) HF-OVVR model. The epicardial cell
type was used.
window is 420 - 600 ms with ∼36.0 ms maximum APD90 difference. The
endocardial cell type, as depicted in Fig. 5.40 E-F, has the lowest alternans
amplitude (∼22.0 ms) along with the lowest alternans onset CL of 380 ms.
The alternans window falls between 270 and 380 ms.
5.4.5 Early afterdepolarizations (EADs):
Usually, ventricular arrhythmias (VA) and sudden cardiac death (SCD) are
associated with HF [108], and EADs are thought to play a major role in the
initiation of arrhythmias. As depicted in Fig. 5.41, the HF-OVVR model
favors the occurrence of EADs because of the prolongation of APD90, shown
here for a cycle length of 1000 ms. This APD90 prolongation is caused by
both ICaL and INaL, which lengthen the plateau phase and allow the late
calcium current to reactivate. When preventing ICaL recovery or blocking
INaL in the HF-OVVR model, EADs were suppressed.
5.4.6 Comparison with previous HF models:
In this subsection, we compare HF biomarkers of the HF-OVVR model with


















































































































Figure 5.40: Alternans in a single epicardial (first row), midmyocardial (second




































































































Figure 5.41: Mechanisms for early afterdepolarizations (EADs) of the HF-OVVR
model for the epicardial cell type. (A) AP traces. (B) ICaL. (C) INaL. (D) INaCa
under normal (solid green lines), HF (solid red lines), and blocked INaL (dotted
blue lines) with CL=1000 ms.
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– AP duration at 90%: APD90 in [193], 548.8 ms, increased by 46.7%;
in [273], 273.0 ms, increased by 22.9%, 369.0 ms, increased by 44.1%,
and 338.0 ms, increased by 50.2% for epicardial, midmyocardial, and
endocardial cell types, respectively; in [237], ∼470.0 ms, increased by
24.0%; in [266], 500.0 ms, increased by 66.7%; in [272], 600.0 ms, in-
creased by 106.9%; in [222], increased by ∼30.0%; in [160], increased
by 562.5 ms; in [143], increased by ∼45.0%; in [72], increased by ∼
400.0 ms for epicardial and endocardial cell types in one of their HF
model; and in [161], 350.0 ms, increased by ∼18.0%. Two studies
[195; 254] measured different repolarization thresholds; [254] calcu-
lated APD80 and had a population median increased by 19.6%, while
[195] computed APD75 and found 215.0 ms increased by ∼30.0%. In
our HF-OVVR model, the variability of parameters covers these APD
prolongations, where APD90 increased within a range from 306.9 to
590.7 ms (33.6% - 157.2%), 392.8 to 628.8 ms (13.9% - 82.3%), and
352.2 to 512.2 ms (34.3% - 95.3%) for epicardial, midmyocardial, and
endocardial cell types, respectively.
– AP duration at 50%: Two studies [193; 237] quantified APD50, where
in [193] quantified APD50 with a measured value 374.5 ms, increased
by 20.7%; in [237] increased by 18.0% from normal level. For the HF-
OVVR model, the APD50 ranges were increased by 249.0 - 436.9 ms
(32.7% - 132.9%), 318.3 - 466.4 ms (13.2% - 65.8%), and 277.7 - 373.1
ms (33.8% - 79.7%), for epicardial, midmyocardial, and endocardial
cell types, respectively.
– AP triangulation: For triangulation, a sole study [237] quantified it
and found an increase of 43.0%. In our HF-OVVR model, the ranges
are increased by 57.9 - 153.8 ms (37.5% - 265.3%), 74.5 - 162.4 ms
(16.9% - 154.9%), and 74.5 - 139.1 ms (19.8% - 154.3%), for epicardial,
midmyocardial, and endocardial cell types, respectively. In addition,
[254] measured the median population and found an increase ranging
between 7.0 and 10.0%.
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– Calcium transient dynamics: The peak value of [Ca2+]i was 334.0
nmol/L as reported by [193] with a reduction of 45.6% from the normal
level. A study [272] found that the amplitude was 580.0 µM with a de-
crease of 22.7% from the normal peak. Another study [237] measured
that the amplitude was reduced by 41.0% from the normal model. An-
other study [222] found a reduction in the calcium peak levels under
HF without quantifying it. Yet another study [195] found a decrease
less than 40.0%. In our HF-OVVR model, the peak value of [Ca2+]i
falls within a range increased by 193.3 - 627.8 µM, 255.7 - 793.6 µM,
and 267.5 - 352.3 µM, for epicardial, midmyocardial, and endocardial
cell types, respectively. One study [272] measured the time to peak
[Ca2+]i as 420.0 ms, increased by 460.0%, while our ranges increased
by 44.7 - 175.5 ms, 47.6 - 181.7 ms, and 64.9 - 168.5 ms, for epicardial,
midmyocardial, and endocardial cell types, respectively. The diastolic
steady-state was reported by [193] with a value of 136.0 nmol/L in-
creased by 13.3%; our HF-OVVR model obtains values of 82.1 - 89.3
µM, 94.1 - 96.8 µM, and 94.8 - 99.1µM, for epicardial, midmyocardial,
and endocardial cell types, respectively. The time to reach steady-state
for [Ca2+]i is 630.0 ms, increased by 39.7%, as reported by [237]. One
study [254] measured the median calcium transient peak value, dura-
tion, and triangulation for the whole population and found a reduction
of 44.4%, increase of 51.7%, and reduction of 11.6%, respectively. An-
other study [143] found that [Ca2+]SR under HF conditions is reduced
by 15.0% in store because the restoring rate is slower.
– Sodium dynamics: For [Na+]i accumulation, [237] observed an in-
crease in levels compared with a normal model. Also, [161] found
that the intracellular sodium concentration level was 11.45 mM, in-
creased by ∼28.7%. In our HF-OVVR model, the peak [Na+]i values
are increased by 2.6-15.6%, 6.1-15.9%, and 5.3-18.7% for epicardial,
midmyocardial, and endocardial cells, respectively.
– Induction of EADs: For EADs, only one HF simulation study [237]
reported that EADs can be induced. As shown in Fig. 5.41, our HF-
140



























































































































Figure 5.42: Rate dependence in a 1D cable for the undiseased OVVR model. (A)
Action potentials at cycle lengths of 1000, 600, 500, 400, and 300 ms. Compared
to isolated cell APs, the upstroke amplitude is decreased because of electrotonic
effects. (B) Steady-state and S1-S2 APD restitution curves. Steady-state restitu-
tion curves (solid lines) were obtained after pacing for 30 s and S1-S2 restitution
curves (dashed lines) were obtained after 30 s of pacing for five different S1 cycle
lengths. OVVR model shows memory in APD. (C) Steady-state and S1-S2 CV
restitution curves. The OVVR shows limited CV memory.
OVVR can induce EADs. Table 5.8 indicates the EADs CLs range
and APD90 in the EADs regime for all cell types.
5.5 1-Dimensional cable results
While we worked on the OVVR model under both normal and HF condi-
tions, we discovered that the CV of the original undiseased model was too
low and worse when we implement our HF settings. As you can see from
Fig. 5.42, the conduction velocity is nonphysiologically slow. The effect
of this slow CV makes the OVVR original model reach 2:1 faster than it
should, see Fig. 5.43.
After investigation, we found that the problem was caused by the formula-
tion of a fast sodium current INa. We solved this dilemma by replacing the
original INa with a more accurate INa current from the Ten, Noble, Noble,
141









































































































































Figure 5.43: Steady-state and S1-S2 APD 90% restitution curves for OVVR
model in a 1D strand for: (A) normal epicardial cell. (B) normal endocardial
cell. (C) normal midmyocardial cell. (D) HF epicardial cell. (E) HF endocardial
cell. (F) HF midmyocardial cell. Curves were obtained after pacing for 60 s and
show significant differences among the status condition of cell type.
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and Panfilov (TNNP) model. The effect of this adaptation can be seen in
Fig. 5.44.
5.5.1 Heart failure simulation of an AP in a 1D cable
of OVVR-TP
We analyzed the properties of action potentials of the OVVR-TP in a 1D
strand under normal and HF conditions. In 1D tissue, the action potential
upstrokes are decreased by electrotonic effects in both cases. For epicardial
cell types, Fig. 5.45 shows the simulation results of action potential dynam-
ics of the updated model under HF conditions at CL=1000 ms (left panel)
and comparable experimental observations (right panel). For midmyocar-
dial cell types, Fig. 5.46 shows the simulation results of action potential
dynamics of the updated model under HF conditions at CL=1000 ms (left
panel) and comparable experimental observations (right panel).
Fig. 5.47 shows the simulation results of endocardial action potential dy-
namics of the updated model under HF (upper panel) and normal (lower
panel) conditions at CL=1000 ms. Fig. 5.48 exhibits comparable experi-
mental observations of failing (upper panel) and non-failing myocytes (lower
panel).
One of our aims was to introduce uncertainties to the model through adapt-
ing variations to the currents and exchangers parameters to reproduce the
maximum variations of an AP that were observed in experiments, see Fig.
5.49.
5.5.2 Rate dependence of APD and Major Currents:
We compared the action potentials, main transmembrane currents (INaL,
INaCa, IK1, IKr, IKs, and ICaL), and calcium transients in a 1D strand of
the normal and HF OVVR-TP models for a range of different CLs for the
epicardial formulations. As shown in Figure 5.50 A-B, the action potentials

























































































































































































































































Figure 5.45: (A) Simulation results of an AP dynamics OVVR model of the
epicardial cell type at 1000 ms under HF conditions. (B) representative optical
recordings of AP and CaT from location within subepicardium. Reproduced from
[139]
spikes during the early repolarization phase. Also, the repolarization dy-
namics are slower on HF tissue. The HF OVVR-TP model possesses higher
plateaus, longer durations and exhibits significantly more rate dependence
than those of the normal OVVR-TP model.
The main transmembrane currents of the two models generally show dif-
ferences in magnitude and in the degree of rate dependence. Both models
display rate dependence of INaL current (see Figure 5.50 C-D). However, the
peak current at larger cycle lengths is more than three times as large for the
HF OVVR-TP model (-0.49 pA/pF) as for the normal OVVR-TP model
(-0.13 pA/pF) at CL=1000 ms. INaCa exhibits stronger rate dependence
for both models with a larger degree for the normal OVVR-TP model, as
shown in Figure 5.50 E-F. The peak inward current is twice as large for the
HF OVVR-TP model as for the normal OVVR-TP model for all CLs range.
IK1 has similar patterns in the two models, however, the peak current is
about 100% larger for the normal model than for the HF OVVR-TP model,
as shown in Figure 5.50 G-H. In addition, IK1 in the HF OVVR model
displays almost no rate dependence, whereas for the normal OVVR model
the peak value decreases slightly with decreasing CL. As shown in Figure
145









































Figure 5.46: (A) Simulation results of an AP dynamics OVVR model of the mid-
myocardial cell type at 1000 ms under HF conditions. (B) representative optical
recordings of AP and CaT from location within midmyocardium. Reproduced
from [139]
5.50 I-J, IKr exhibits very slight rate dependence in both models, but its
peak value for the normal OVVR-TP model is more than two times larger
than for the HF OVVR-TP model, indicating that it plays a more significant
role during repolarization for the normal OVVR-TP model. IKs is a little
bit larger for the normal OVVR-TP model than for the HF OVVR-TP
model (see Figure 5.50 K-L). HF OVVR-TP model shows rate dependence
of IKs with slight decreasing amplitude, but in the opposite way: as CL
decreases, the peak value of IKs increases for the normal OVVR-TP model.
For the ICaL current, both models show limited rate dependence, as shown
in Figure 5.50 M-N. The peak current is about 50% larger for the HF
OVVR-TP model than for the normal OVVR-TP model at slow pacing
rates.
Figure 5.50 O-P, shows the calcium transients (intracellular calcium con-
centration [Ca2+]i) for both models. The peak value is more than twice
as large for the normal OVVR-TP model as for the HF OVVR-TP model
during slow rates, and increases to more than five times as large at fast
rates. In both models, the [Ca2+]i peak value increases as the CL decreases
from 1000 ms to 200 ms, so that the [Ca2+]i peak-frequency relationship
146






























Figure 5.47: Simulation results of an
AP dynamics OVVR model of the
endocardial cell type at 1000 ms un-
der HF and normal conditions
Figure 5.48: Simultaneous record-
ings of AP and CaT at one site at
subendocardium from a failing hu-
man heart (F, top) and a nonfailing
human heart (NF, bottom). Repro-
duced from [138]
is always positive. In addition, the calcium transient rises and falls more
slowly for the HF OVVR-TP model than for the normal OVVR-TP model.
5.6 2-Dimensional sheet results
Fig. 5.55 illustrate the procedure of inducing spiral wave. We begin with
generating a wave by stimulating one side of the tissue known as S1 stim-
ulation. This wave propagates from the stimulated side of the tissue to
the other side. The, we stimulate another part of the tissue known as S2





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































because the cells of the tissue are still in the refractory period. This causes
the wave to curl and propagate in the other direction and constitute a spiral
wave. As shown in Figs. 5.56 and 5.57 that there are differences regarding
the tip trajectory, dominant APD, and dominant period. For the epicardial
cell type, the tip trajectory has a cycloidal shape for failing cells while it
does not has a clear shape for normal myocytes. The dominant APD for
failing myocytes are 488.0ms, while it is 178.0ms for normal myocytes. The
dominant period peaks for failing myocytes are 537.0ms and 574.0ms, while
for normal myocytes are 211.0ms.
For the midmyocardial cell type, the tip trajectory has a cycloidal shape
with increasing the diameter each period for failing cells while it has stable
cycloidal shape for normal myocytes. The dominant APD peaks for failing
myocytes are 344.0ms, 355.0ms, and 376.0ms while it is 295.0ms for normal
myocytes. The dominant period peaks for failing myocytes are 375.0ms,
401.0ms, and 438.0ms while for normal myocytes are 340.0ms
For the endocardial cell type, the tip trajectory has a stable cycloidal shape
for failing cells while it does not has a clear shape for normal myocytes.
The dominant APD peaks for failing myocytes are 307.0ms, 320.0ms, and
338.0ms while it is 205.0ms for normal myocytes. The dominant period
peaks for failing myocytes are 352.0ms, 364.0ms, and 397.0ms while for
normal myocytes are 230.0ms
5.7 Discussion
In this chapter, we present a human heart failure model (HF-OVVR) de-
rived from experimental observations on remodeling of ion channels mainly
from human data and for comparison use the undiseased ventricular cell
model (OVVR) [181]. Our new HF-OVVR model can reproduce many of
the AP properties of failing human myocytes. We have compared the prop-
erties of the HF-OVVR model with available experimental observations and
found good agreement. We have found that APD90 is prolonged by 77.2 -
361.0 ms, 47.8 - 283.8 ms, and 89.9 - 249.9 ms for epicardial, midmyocardial,
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and endocardial cells in our model, which agrees with experimental obser-
vations of ∼181±28 ms prolongation for the HF case [133]. In addition, we
found that APD50 is prolonged by 61.4 - 249.3 ms, 37.0 - 185.1 ms, and
70.1 - 165.5 ms during HF for epicardial, midmyocardial, and endocardial
cells, which are close to experimental findings of ∼156±22 ms at a CL of
2000 ms [133].
We defined AP triangulation as the difference between APD90 and APD50
and found that our simulated AP triangulation was comparable with experi-
mental studies [12; 12]. Also, experiments showed a non-significant increase
in the resting membrane potential ranging between 0.2 and 1.0 ms [126],
which is in agreement with the 0.0 - 1.3 ms, 0.1 - 1.8 ms, and 0.1 - 1.4 ms
increases in resting membrane potential for epicardial, midmyocardial, and
endocardial cells in our HF-OVVR model.
In addition, the dynamics of simulated [Ca2+]i match experimental find-
ings, including decreased systolic amplitude (SA) range 10.0 - 72.3%, 23.0 -
75.2%, and 12.3 - 33.4% for epicardial, midmyocardial, and endocardial cells
in our HF-OVVR model compared to a reduction of 41% in experiments
[12], [259]. Also, previous experiments observed a slight increase in dias-
tolic [Ca2+]i [12], which matches our simulation results, which increased by
6.5 - 15.8%, 1.4 - 4.3%, and 8.5 - 13.4% for epicardial, midmyocardial, and
endocardial cells. The difference between the systolic amplitude of [Ca2+]i
in HF and normal cells has been observed to be 379±140 nM [193], which
is in the range of the difference observed for our HF-OVVR model of 69.6
- 504.1 nM and 237.4 - 775.3 nM for epicardial and midmyocardial cells.
The difference of the upstroke time or time to peak (TT) for the Ca2+
transient is 20±11 ms for a CL of 3000 ms [77], whereas in our HF-OVVR
model it is 3.2 - 134.0 ms, 15.3 - 149.4 ms, and 9.5 - 113.1 ms for epicardial,
midmyocardial, and endocardial cells, respectively. [Na+]i is increased in
HF-OVVR cells for all stimulation rates when compared with the normal
cell, which matches previous findings [41].
Our approach includes some limitations. Recent work on mRNA [254] has
shown that alternans in human HF cells begins at a CL of 350 ms, whereas
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alternans in our case is higher by 50 ms, 250 ms, and 30 ms for epicardial,
midmyocardial, and endocardial cells, respectively. However, alternans on-
set CLs are in the range of the observed values reported in other studies
[264] of ≤500 ms for epicardial and endocardial cells, respectively. In ad-
dition, in our simulation results, we observed that the maximum range of
APD S-S restitution curve slopes are 0.26 - 0.60, 0.23 - 0.70, and 0.28 - 0.86
for epicardial, midmyocardial, and endocardial cells. For epicardial and
midmyocardial cells, the maximum range of APD S1-S2 restitution curve
slopes are less than the slope value of 0.86±0.12 measured in the LV free
wall of the failing human heart [70] for epicardial and midmyocardial cells,
but it matches the measured endocardial cells.
In addition, to build the HF-OVVR model that was used in this thesis,
the experimental data came from various sources of previously published
studies. The data for each study has various HF causes, and we do not
have access to the raw data of these studies. Therefore, in our HF-OVVR
simulations, we calculated the mean of the means of these studies and the
standard deviation as the square root of the squared sum of the variances of
these studies. This would not represent uncertainty arising from different
HF causes; instead, it is averaging the variability within each of these studies
across different HF causes.
In comparing our model with previous HF simulation models [193; 272], we
found that many of those models did not reproduce as many of the proper-
ties of HF that are observed in a single human HF-remodeled myocyte, such
as increased accumulated [Na+]i, alternans, and EADs. These models were
designed to reproduce the two prominent properties: prolonged APD90 and
altered [Ca2+]i dynamics. Also, these studies used more limited data and
did not show most of the HF-remodeled properties in a quantitative man-
ner. Most of the previous models [193; 272], did not consider remodeling
INa in reproducing the reduction in the upstroke velocity of HF cells. Also,
these models either did not remodel the INaL [193] or increased it more than
has been observed [272]. Moreover, previous simulation studies did not in-
corporate remodeling of Ito and IKr. Previous simulation studies [193; 272]
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did not change these currents. Regarding APD rate dependence, only one
study [273] compared with control at a fast rate.
The aim of 2D simulations is to explore the behavior of spiral wave dynamics
on the developed HF cellular model in a 2D sheet and how the spiral wave
dynamics differ from the undiseased cellular model. It is already known
that reentrant waves underlie life threatening arrhythmias, but the detailed
mechanisms are still unclear. Therefore, understanding the response of the
2D cardiac sheet to an electrical stimulation is important for appropriate
treatment and alleviation of cardiac arrhythmias. We quantify the domi-
nant APD and rotation period for all cells that constitute the tissue sheet.
Also, we extract the tip trajectory of each cell type under both conditions.
This extraction will help disclose the area that the core reentrant waves







for the HF OVVR Model
The purpose of this chapter is to present an arrhythmia application of the
developed human heart failure model (HF-OVVR), which is an early after-
depolarization (EAD). The organization of the chapter will be as follows:
it begins with a brief introduction, which includes cellular level remod-
eled ionic currents and reviews some experimental studies. Then, it dis-
cusses the general heart failure model that was used to induce an EAD for
each cell type and is explained. After that, it discusses how we measured
the formation of EAD in the human-specific heart failure myocytes across
population-level variability in ion channel expression. Then, a comparison
between simulated and experimentally observed EADs is discussed along




Ventricular arrhythmias and sudden cardiac death (SCD) are often associ-
ated with cardiac hypertrophy and failure [15; 108], which can take many
forms. In the clinic, some of these observations under certain conditions are
long-QT syndrome [118; 137; 162; 269], cardiotoxicity [116; 134], Torsade de
Pointes (TdP) [178; 252; 260], and many other forms [224; 250]. All of these
syndromes associated with prolongation of an action potential and increased
regional dispersion of repolarization [235], share the same underlying char-
acteristic, known as early afterdepolarizations (EADs) [39; 197; 201], which
are action potentials that get excited during the plateau, or repolarization
phase.
From the cellular level point of view, to induce EADs, there are many mech-
anisms which incorporate several currents for each mechanism. It is difficult
to know what is the percentage of each involved current is in inducing EADs
for each mechanism.
Previous experimental studies prolong an action potential duration using
pharmacological agents in many ways including, reducing the IKr current [6;
23; 129], slowing down an inactivation of the INa current [16; 98; 112; 223],
or slowing down an inactivation of the ICaL current [103; 104], with much
attention to reactivating both the INa and ICaL currents [105; 163; 175]. A
recent study [197], shows that the L-type calcium, sodium, and potassium
channels as well as the sodium-calcium exchanger and intracellular Ca2+
cycling are associated with inducing EADs.
6.2 Inducing EAD through APD prolonga-
tion
One important afterdepolarization proarrhythmia that may cause heart fail-
ure is early afterdepolarization (EAD). To reiterate, we developed two heart





INa ↓(57.1%) ↓(57.1%) ↓(57.1%)
INaL ↑(238.5%) ↑(238.5%) ↑(238.5%)
ICaL unchanged unchanged unchanged
Ito ↓(32.1%) ↓(36.3%) unchanged
IK1 ↓(56.3%) ↓(43.4%) ↓(41.1%)
IKr ↓(75.0%) ↓(25.0%) ↓(70.0%)
IKs ↓(61.7%) ↓(49.5%) ↓(57.7%)
INaCa ↑(200.0%) ↑(200.0%) ↑(200.0%)
INaK ↓(42.0%) ↓(42.0%) ↓(42.0%)
SERCA ↓(15.0%) ↓(43.6%) ↓(40.0%)
Table 6.1: Summary of the remodeled currents to induce early afterdepolariza-
tions (EADs) relative to the undiseased OVVR model. ↑: increase; ↓: decrease.
HF remodeling is either general without considering species type, or more
human-specific where it is mainly based on humans, except when there is a
scarcity of data on humans, we used available animal species data. There-
fore, this section is focusing on these two developed models. The first one is
examining how the general heart failure set of remodeled ionic parameters
can induce EAD. The second one discusses the inducibility of EAD with
varying each remodeled ionic current under heart failure conditions for the
more human-specific HF model.
6.2.1 General heart failure set of remodeled ionic con-
ductances
Since EADs are often associated with arrhythmias such as heart failure
[132; 179], long-QT, and TdP, it is important to reproduce EADs in a
single myocyte from our developed HF OVVR model. Developing a fixed
set of remodeled ionic conductances, which contribute to inducing an EAD
for each cell type, will help in studying the dynamics of the EAD in tissue
and predicting the consequences of inducing an EAD when the tissue cells
are under heart failure conditions.
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As a preliminary investigation, we started with the remodeled ionic cur-
rents of our developed general heart failure model. As we explained in
previous chapters, our developed HF OVVR model is heuristically based
on observations from former experimental studies. We based on that and
further refined the ionic conductances for each cell type to investigate its
influence on action potential prolongation for setting the stage to induce an
EAD until one or more spikes are experienced at CL=4000 ms (see Table
6.1). For the epicardial cell type, we decreased IKr to 70% when it exhibits
an alternans EAD, which means that one AP exhibits an EAD while the
other does not. For the midmyocardial cell type, decreasing IKr by only
20% causes EADs to formulate. For the endocardial cell type, its behavior
is closer to the epicardial cell, where 65% reduction of IKr induces EADs.
Figure 6.1 shows induced EADs for all cell types with one spike.
6.2.2 Towards more human-specific set of remodeled
ionic conductances
Although animal HF models mimic human HF models in some aspects,
models that were built based on remodeled animal species differ from hu-
man models. There are big differences between remodeled failing human
myocytes and animal species myocytes. For example, the remodeled fast
sodium current density under heart failure conditions in canines is ↓(39.3%±6.5),
while in humans it is ↓(57.1%±1.6) [246]. For the late sodium current,
the percentage of change under HF conditions in canines and humans are
↑(113.6%±10.0) and ↑(238.5%±1.3), respectively [246]. Also, the changes in
the calcium independent transient outward potassium current under heart
failure conditions differ between canines ↓(73.2%±5.8) [274] and humans
↓(32.1%±6.4) [133] and ↓(26.4%±1.3) [165] for epicardial cell type, for ex-
ample. The inward potassium current in human heart failure for the epicar-
dial cell type is ↓(56.3%±2.2) [133] which is larger than the observed remod-
eled current in canine species (↓(40.9%±0.8) [132] and ↓(50%±0) [2]). For
the midmyocardial cell type, the inverse behavior was observed compared

















































































































































































































for canine is ↓(64.0%±0) [2] and overlaps in another study ↓(40.7%±0.6)
[132]. For IKs current, the observed remodeled tail current density under
HF conditions for the epicardial cell type in humans (↓(61.7%±1.4) [133])
is higher than the canine species (↓(57.1%±1.6) [132]). In addition, the
remodeled Na+/Ca2+ exchanger for rat species (↓50% [229]) is less than
the observed in humans (↓80% and ↓90% [229]). Moreover, the remodeled
Na+/K+ pump differs between human (36%) and animal species (ham-
ster 33% and rat 20%) for endocardial cell type [121]. Also, the remodeled
SERCA2a in endocardial cells are different where for canine it is ↓(65%±7)
and for human it is ↓(30%±5) [107].
Here, we focus on measuring the formation of EAD in heart failure myocytes
across population-level variability in ion channel expression. For each cell
type, we vary each ionic current conductance within a range between µ −
3SD and µ+ 3SD with down sweep protocol starting with CL=10,000 ms.
Tables 6.2, 6.3, and 6.4 depict the settings of ionic conductance variations
for epicardial, midmyocardial, and endocardial cell types, respectively, for
all considered remodeling ionic parameters.
We considered remodeling ten ionic conductances for each cell type, namely
GNa, GNaL, Gto, GK1, GKr, GKs, GNaCa, PCa, PNaK , and SERCA pump
activity. From these ten parameters, we found only three parameters (GNaL,
GKr, and GNaCa) have substantial effect on the action potential duration,
which is the essential factor for inducing early afterdepolarization arrhyth-
mia.
Fig. 6.2 A, shows the steady-state curves for varying the late sodium current
of the epicardial cell type. The range of APD90 is between 611.9 ms and
624.6 ms. For the midmyocardial cell type, the variation of INaL current
causes APD90 to increase within a range of 671.7 ms - 688.7 ms (see Fig.
6.2 B). As shown in Fig. 6.2 C, the range of APD90 is between 628.4 ms
and 649.9 ms which is caused by the variation of the slow sodium current
for the endocardial cell type.
For the rapid delayed rectifier potassium current variation, the epicardial
cell type exhibits the greatest APD90 variation with a range of 454.8 ms
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and 1,873.0 ms as shown in Fig. 6.3 A. Also, it is the only varied current
that can induce EAD. For the midmyocardial cell type, we did not vary its
IKr conductance because most of the previous experimental studies did not
observe remodeling of this current. Fig. 6.3 B exhibits the range of varying
the GKr parameter, which falls within a range of 607.9 ms - 675.1 ms.
For the sodium-calcium exchanger variation, as shown in Fig. 6.4 A, the
range of APD90 is 454.5 ms - 734.6 ms for the epicardial cell type. For
the midmyocardial cell type, varying the INaCa current causes the APD90
to range between 471.9 ms and 772.9 ms (see Fig. 6.4 B). Fig. 6.4 C
depicts that the range of APD90 falls between 458.0 ms and 734.2 ms,
when changing the GNaCa parameter.
For the fast sodium current variation, the ranges for APD90 of the epicar-
dial, midmyocardial, and endocardial cell types are 617.1 ms - 619.8 ms,
677.9 ms - 682.4 ms, and 636.1 ms - 641.1 ms, respectively (see Fig. 6.5).
As shown in Fig. 6.6, the variation of the inward rectifier potassium cur-
rent has a large effect on the duration of an action potential which ranges
between 598.3 ms - 698.1 ms, 660.6 ms - 761.8 ms, and 619.0 ms - 672.1 ms
for epicardial, midmyocardial, and endocardial cell types, respectively.
For the slow delayed rectifier potassium current variation, the epicardial cell
type exhibits the greatest APD90 variation with a range between 609.9 ms
and 627.3 ms as shown in Fig. 6.7 A. Fig. 6.7 B exhibits a small range of
variation, which falls between 674.5 ms - 686.2 ms. For the endocardial cell
type, the duration of an action potential ranges between 632.5 ms - 643.9
ms, when varying the GKs parameter (see Fig. 6.7 C).
Fig. 6.8 depicts that the variation of the outward potassium current has
a very small effect on the APD90. This effect ranges between 615.9 ms
- 620.8 ms, 678.7 ms - 681.8 ms, and 639.0 ms - 639.4 ms for epicardial,
midmyocardial, and endocardial cell types, respectively.
The sodium-potassium pump has a large effect on changing the action po-
tential duration where it changes between 575.9 ms - 653.1 ms for the epi-
cardial cell type (see Fig. 6.9 A). As shown in Fig. 6.9 B, the midmyocardial
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cell type has a larger APD90 variation (622.0 ms - 736.3 ms). For the en-
docardial cell type, the action potential duration ranges between 593.2 ms
- 673.2 ms (see Fig. 6.9 C).
Also, SERCA variation has greater effect on the APD90, where the ranges
fall between 537.0 ms - 742.0 ms, 594.1 ms - 748.3 ms, 560.6 ms - 687.2 ms
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6.11: (A) Simulated EADs of the modified-OVVR HF model for epicardial
cell type with CL=4000 ms. (B) Action potentials recorded in a left ventricular
myocytes from failing human heart at CL=4000 ms [76].
6.3 Discussion
The simulation results of our general heart failure model of an APD90
are not as good compared with failing human experimental observations
[76; 133]. However, our results are in good agreement with failing dog
myocytes [132; 151; 243]. For example, our APD90 simulation results are
1247.0 ms and 1248.0 ms for epicardial and endocardial cell types, respec-
tively, while APD90 experimental observations in failing human myocytes is
∼800 ms [76]. But, our action potential durations match the APD90 in car-
diomyocytes from dogs with heart failure ∼1100.0+300.0 ms (mean+SD)
[243].
As shown in Fig. 6.11 with one initiation of EAD for the epicardial cell type
the APD90 is not in good agreement with the recorded action potentials in
a left ventricular myocyte from failing human heart at cycle length 4,000 ms
[76]. However, Fig. 6.12 exhibits that our action potential duration matched
the APD90 which was recorded from failed cardiomyocytes of 13 dogs [243].
In addition, our developed heart failure model can induce multiple EADs
as depicted in Fig. 6.13 (A) and matches the experimental observations
qualitatively, see Fig. 6.13 (B) [133].
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Figure 6.12: (A) Simulated EADs of the modified-OVVR HF model for epicardial
cell type with CL=4000 ms. (B) Action potentials recorded in cardiomyocytes
from dogs with heart failure at CL=4000 ms [243].
For our second developed heart failure model towards more human-specific
species, we varied the remodeled ionic conductances. The only remodeled
current that causes EAD formulation is the IKr current for the epicardial
cell type. Remodeling the IKr for midmyocardial and endocardial cell types
can not induce EADs. Based on human experimental observations, the
IKr current does not remodel in our HF model. For the endocardial cell
type, the range of variation is small, which does not allow the EAD to be
induced. Remodeling IKr for the epicardial cell type induces EADs with a
different number of spikes under different cycle lengths. Because inducing
EAD necessitates a slow pacing rate, we began our pacing with cycle length
10,000 ms. At this cycle length, a stable EAD was observed with APD90
equalling 1,873.0 ms. An EAD formulation was continuously observed as
we decreased the cycle length until the CL=4,500 ms.
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Figure 6.13: (A) Simulation results of the HF OVVR model in epicardial cell type
with decreasing IKr 74%, 75%, 75.8%, and 76% at CL=4000 ms. (B) Experiments
in isolated nonfailing human epicardial myocytes from Li et. al. [133] showed
EADs with slow pacing (CL=4000 ms) in the presence of IKr block.
When the cycle length reached 4,250 ms, 2:1 EAD alternate spikes were
observed. This alternans EAD lasted for a single cycle length. When
CL=4,000 ms, a new stable EAD was formulated, but with a single spike.
This stable EAD formulation was observed until the CL=2,500 ms. Then,
a 1:0 alternation of EAD was observed at cycle length 2,250 ms. This
EAD alternation was observed continuously until an EAD formulation was
diminished at CL=1,800 ms (see Fig. 6.14).
In terms of how the variation of each ionic current affects the APD90, we
found that the IKr current variation has the most effect for epicardial cell
types with a range of 1,418.2 ms. However, it has less effect for endocardial
cell types with a range of 67.2 ms. This difference in response of inducing
EAD is related to the variation range of remodeling IKr for each cell type.
As indicated in Table 6.2, the range of variation of the IKr for the epicar-
dial cell type is 17.4%-70.4%. However, for the endocardial cell type the
remodeled IKr variation range is 22.2%-32.4% (see Table 6.4).
The second greatest effect on APD90 comes from the INaCa current varia-
tion. The range of the action potential duration is 280.1 ms, 301.0 ms, and
276.2 ms for epicardial, midmyocardial, and endocardial cell types respec-
tively.
For SERCA variation, the APD90 has a wide range, where it is 205.0 ms
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for the epicardial, 154.2 ms for the midmyocardial, and 126.6 ms for the
endocardial cell type. In addition, varying the INaK current has a large
effect on the APD90 with the midmyocardial cell possessing the largest
range (114.3 ms); the epicardial cell has the smallest range (77.2 ms), and
the endocardial cell has an in-between with a range of 80.0 ms. The same
behavior is observed where the range of APD90 depends on the cell type
when varying the IK1 current. Both epicardial and midmyocardial cells have
wider ranges (99.8 ms and 101.2 ms respectively) than the endocardial cell
(53.1 ms).
Regarding the variation of the IKs current, all three cell types have min-
imum effect with ranges of 17.4 ms, 11.7 ms, and 11.4 ms for epicardial,
midmyocardial, and endocardial cell types, respectively. Also, the variation
of the INaL current has a similar effect with APD90 ranges of 12.7 ms, 17.0
ms, and 21.5 ms for epicardial, midmyocardial, and endocardial cell types,
respectively.
Both the INa and Ito currents have the least effect on the APD90. The
variation of the INa current causes change of an APD90 with ranges of 2.7
ms, 4.5 ms, and 5.0 ms for epicardial, midmyocardial, and endocardial cell
types, respectively. Also, the variation of the Ito has the same minimum
effect on APD90 with ranges of 4.9 ms, 3.1 ms, and 0.4 ms for epicardial,
midmyocardial, and endocardial cell types, respectively.
For further investigation, we varied all ionic current conductances and in-
vestigated if we could observe EAD for each cell type under normal and
heart failure conditions. Among ten ionic conductances, three of them,
namely the INaL, IKr, and INaCa, show the ability to induce EAD, but with
a different degree of remodeling. Table 6.5 summarizes the variations of
ionic current conductances with observed EAD that has one spike. Table
6.6 shows the exact conductance values used in our simulations for each cell
type under both conditions, i.e., normal and heart failure, for the onset of
EADs.
As depicted in Fig. 6.15, the HF OVVR model favors the occurrence of
EADs because of the prolongation of APD90, shown here for a cycle length
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of 1000 ms. This APD90 prolongation is caused by both ICaL and INaL,
which lengthen the plateau phase and allow the late calcium current to re-
activate. When preventing ICaL recovery or blocking INaL in the HF OVVR
model, EADs were suppressed. These simulation results are in agreement
with experimental observations of Undrovinas and his group when they
showed that tetrodotoxin blocks late sodium current and causes shortened
APs in isolated failing human ventricular myocytes and eliminates EADs
[244].
6.4 Conclusion
We presented an arrhythmia application for our developed heart failure
models, which is an early afterdepolarization (EAD). since EAD is an im-
portant cause of ventricular arrhythmias in heart failure. Also, one of the
hallmarks of failed myocytes is the prolongation of AP, which sets the stage
to induce an EAD. Therefore, we measured the formulation of EAD for
all cell types under heart failure conditions when varying the remodeled
ionic currents, as observed experimentally. We found that the epicardial
failing myocyte can induce EADs, when varying the rapid delayed rectifier
potassium current between mean±3 standard deviations. In addition, we
compared the initiation of EADs between the normal and failing myocytes.
Based on our developed models we found that heart failure myocytes are













































































































































































































































































































































































































































































































































































































































Normal HF Normal HF Normal HF
Epicardial - 0.75 0.00276 0.0207 0.068 0.0048
Midmyocardial 0.75 0.1875 0.0161 0.0345 0.008 0.0024
Endocardial - 0.9375 0.0046 0.0184 0.048 0.0056
Table 6.6: Summary of the parameter values that represent the variations of ionic



































































































Figure 6.15: Mechanisms for early afterdepolarizations (EADs) of the HF-OVVR
model for the epicardial cell type. (A) AP traces. (B) ICaL. (C) INaL. (D) INaCa
under normal (solid green lines), HF (solid red lines), and blocked INaL (dotted
blue lines) with CL=1000 ms.
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Chapter 7
Conclusions and Future Work
7.1 Conclusions
Developing a robust cellular electrophysiological model under heart failure
conditions involves incorporating remodeled ionic currents as observed in
experiments, considering the uncertainty of the remodeled ionic currents,
validating the developed model at the tissue level, and further applying
this model into a specific application. In this thesis, the contributions are
fourfold:
First due to a large number of ventricular cell models available, it becomes
a challenge to select an appropriate mathematical model. Therefore,
we analyzed quantitatively the dynamics of recently published models
of human ventricular cells under normal condition in isolated cells to
ease selecting an appropriate model. In addition, this analysis encom-
passed the tissue level by constructing a one-dimensional cable and a
two-dimensional sheet because at higher spatial dimensions the pas-
sive current between cells can cause new properties to emerge and their
characteristics differ from the characteristics of isolated cells [28; 33].
The extracted physiological properties from the simulation results were
compared with those of previously developed ventricular models and
with available experimental and clinical data. We had shown that
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each model has strengths and limitations that suggest how it can be
best utilized for cardiac tissue studies. For example, the GPB model
produces APDs and a maximum CV value closer to experimentally
observed values [167; 230] along with clinically relevant dominant fre-
quencies corresponding to VT [124]. In addition, the OVVR model
shows greater reliability of APD variation with S1-S2 restitution curves
and produces alternans, although with a magnitude greater than ob-
served experimentally. In order to avoid the unphysiological conduc-
tion velocity of the OVVR model, and to match the experimentally
measured data, we used the TP model formulation for INa current
to restore the maximum CV of the OVVR model to a physiologically
normal value. This decreases the minimum DI and increases the dom-
inant spiral wave periods. However, there are 3 issues that the results
from both models did not match experimental observations. These
issues are: 1) Both models exhibited action potential amplitudes and
maximum restitution curve slope values below what has been reported
experimentally. 2) The maximum upstroke velocity in tissue did not
agree well with experimental observations. 3) The APD restitution
curve maximum slopes are below typical experimental values.
Although the models studied in many cases generate different pre-
dictions, we emphasize that model disagreement may arise for many
possible reasons. The models may exhibit normally observed biological
variability or may reflect spatial heterogeneity other than transmural
heterogeneity, such as apico-basal [171], left-right [19; 171], or other
regional [171; 183] gradients. Differences also may arise from study
subject differences such as age and gender. In addition, it is important
to note that although models generally are designed to reproduce nor-
mal cells, it is difficult to access healthy human tissue experimentally.
The other models used for comparison also have limitations, although,
like the GPB and OVVR models, many of them match experimental
data for some properties well [18]. Thus, reproducing observed dynam-
ical properties of the human ventricles remains a significant modeling
challenge.
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Second in many cases, animal cell models are used to investigate car-
diac electrophysiological properties for heart failure cases. However,
to study the mechanisms of ventricular arrhythmia in humans arising
from HF, the mathematical model should be based on recent human
data and reproduce important arrhythmogenic phenomena. There-
fore, we developed a general heart failure model that was biologically
inspired from experimental observations and based on the mathemati-
cal OVVR human ventricular cell model. Although, the original model
used is based on human data, the remodeled ionic currents utilized in
developing this general heart failure model relied upon human and
animal species experimental observations without any differentiation
between them. So, we analyzed the dynamics of the developed HF-
induced model quantitatively in isolated cells, a one-dimensional ca-
ble and a two-dimensional sheet. We find that APD90 is prolonged
by 211.8 ms in our developed general HF model, which agrees with
human-specific experimental observations of ∼181±28 ms prolonga-
tion for the HF case [133]. In addition, we find that APD50 is pro-
longed by 155.5 ms during HF, similar to human-specific experimental
findings of ∼156±22 ms at a CL of 2000 ms [133]. AP triangulation is
the difference between APD90 and APD50. Our simulation results for
AP triangulation were 56.3 ms, which falls within the range of exper-
imental values ∼25±35.6 ms [133] . Experiments also showed a slight
increase in resting membrane potential (RMP) ranging from 0.2 to 1.0
ms [126], which is in agreement with the 0.38 ms in our general HF
model. Regarding the calcium dynamics, we found that our simulated
Ca2+ transient match experimental findings, including decreased sys-
tolic amplitude (↓46% in our general HF model compared to ↓41% in
experiments [12; 259]) and a slight increase in diastolic [Ca2+]i [12].
Also, the difference between the systolic amplitude of [Ca2+]i in HF
and normal cells has been observed to be 379±140 nM [12], which is
in the range of the difference observed for our developed general HF
model of 296 nM. Moreover, the difference of the upstroke time or time
to peak for the Ca2+ transient is 20±11 ms for a CL of 3000 ms [77],
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whereas in our general HF model it is 18.8 ms. We found that our
results are in good accordance with experimental findings reported in
the literature and might motivate further research on remodeling and
simulation of heart failure at the whole organ level. The developed gen-
eral HF-OVVR model established in this part of the thesis was mainly
used to investigate the transmural electrophysiological heterogeneities
of different ventricular cell types in failing hearts.
Third due to difference of remodeled ionic currents under heart failure
conditions between human and animal species, we moved forward to-
wards constructing a more specific human HF model based mainly on
remodeled human heart failure experimental data. As a consequence,
the baseline of the remodeled ionic currents differs between the general
heart failure model and this new human-specific heart failure model. In
addition, we enriched this new model with a new feature that was ab-
sent in the general heart failure model, which is the uncertainty of these
remodeled ionic currents. The incorporated variability is also based
mainly on the uncertainty observed in human remodeled ionic cur-
rents under heart failure conditions. To do so, we split the framework
into two main components: First, the electrophysiological activity of
a transmural single myocyte was simulated using well-justified modifi-
cations of a recent mathematical model of the human ventricular AP,
the OVVR model, to replicate the experimentally reported human HF
phenotypes. Second, systematic and quantitative variability in ionic
currents and exchangers was introduced utilizing experimental obser-
vations published in the literature mostly from the human species. In
this project, the contributions can be summarized as follows: 1- A sim-
ulation study of an AP waveform of different ventricular cell types was
presented based on recent experimental studies of transmural electro-
physiological heterogeneities in the HF-OVVR model and compared
with the normal OVVR model. 2- We evaluated how major cellular
ionic currents influence the AP repolarization phase and how the APD
rate dependence changed in transmural cells. 3- We found that these
results are in good accordance with experimental findings reported in
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the literature and might motivate further research on remodeling and
simulation of heart failure at both tissue and the whole organ levels.
Fourth we presented an arrhythmia application of our developed heart
failure models, and this arrhythmia application is an Early afterdepo-
larization (EAD). The aim of this project begins with measuring the
formation of an EAD in the general heart failure model for each cell
type. Then, we assess the inducibility of an EAD across population-
level variability in ion channel expression for epicardial, midmyocar-
dial, and endocardial cell types for human-specific heart failure model.
We performed simulations in a single cell on both HF-OVVR models.
For the human-specific HF model, the simulations involved varying all
ten remodeled ionic current parameters one at a time with fixing all
other nine parameters. The assessment of inducing EADs based on
three different quantitative measurements: 1- The onset of EAD cycle
length (CL). 2- The range of CLs for which EADs can be induced. 3-
The number of additional peaks (upstrokes) during the EAD phase
in each cycle length. We found that the epicardial failing myocytes
can induce EADs, when varying the rapid delayed rectifier potassium
current between mean±3 standard deviations. In addition, we found
that the heart failure myocytes are more susceptible to inducing EADs
across population-level variability in ion channel expression than the
normal myocytes.
7.2 Limitations
Our work has many limitations that should be considered:
First Associated tissue limitations
– Isotropic tissue assumption In our work, we assumed that the
electrical conductivity is isotropic in all directions. For example,
we constructed 2D sheets with equal tissue conductivities in the x-
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and y-directions. Inclusion of anisotropy might alter the conduc-
tion pathway, conduction velocity, and upstroke velocity [36; 225].
This could be in the form of fiber directions, which has different
representation at different dimensions. For instance, we could as-
sume that the fiber direction aligned with the x-direction to repre-
sent fast electrical propagation and the y-direction represents the
fiber transverse direction which has slower electrical propagation.
As reported by [245] that anisotropy has been increasingly recog-
nized as a potential substrate for abnormal rhythms and reentry,
both in normal as well as pathological conditions. This means that
inclusion of anisotropy into our HF model will enhance the discon-
tinuous propagation and increase the probability of unidirectional
block which can lead to reentry.
– Homogeneous tissue assumption In this thesis, we constructed
1D and 2D tissues with homogeneous cell models. However, it is
important to construct a transmural heterogeneous tissue and in-
vestigate how the heterogeneous APD can affect the related elec-
trophysiological properties. For example, in a 2D sheet, it is be-
lieved that spiral waves are strongly associated with ventricular
arrhythmias, such as tachycardia and fibrillation, and it is impor-
tant to investigate their dynamics, such as their initiation, stabi-
lization, maintenance, and diminishment. Inclusion of transmural
heterogeneity could be a source of arrhythmogenic substrate and
it could be applied for tissues under normal as well as heart fail-
ure conditions [2; 70; 140]. Even though electrotonic effects may
smooth the transmural differences under normal conditions, it can
be exposed under pathological conditions such as heart failure. In
addition, from our simulation results, we experienced that our
initiated spiral waves, in spite of their stability, have one rotor.
This kind of observation is associated with tachycardia. However,
tachycardia could be degenerated into fibrillation where it is as-
sociated with breakup spiral waves, which inclusion of transmural
heterogeneous cells could setup a stage for it because wavebreak
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occurs when wavefronts encounter patches of myocardium with
heterogeneous excitability or refractoriness [84]. This could in-
crease the dominant frequencies from our simulations to lie with
the ventricular fibrillation frequencies.
– Regular tissue discretization and resolution assumptions
In this work, we used uniform squared tissue with regular spatial
discretization. However, the ventricular anatomy is usually irregu-
lar in shape. We strongly simplified the geometrical tissue shapes
at the time where real anatomical geometries obtained always re-
quire irregular discretization to handle these arbitrary geometries.
In addition, the spatial resolution itself can alter the dynamics
of the cellular electrophysiological model in different ways. For
instance, coarser spatial resolution can develop corners caused by
curved wave fronts [33] and breakup spiral waves [58]. On the
contrary, stable spiral waves with coarse spatial resolution can
breakup using finer spatial resolution [18].
– Tissue propagation model used In this thesis, we used a mon-
odomain approach to simulate the propagation of excited action
potential in the tissue. This approach assumes that the extracel-
lular domain is isopotential and only considers the intracellular
domain. However, it is more accurate and physiologically realistic
to consider the extracellular domain using a bidomain approach
[205]. For example, this approach allows using more complicated
boundary conditions setup [83].
Second Associated data sources limitations
– Experimental disagreement As we explained in the previous
conclusion section, we found places where our work matched ex-
perimental observations. There are other places where our simu-
lation results differ from experimental observations. For example,
for the normal OVVR model, the dominant frequencies measured
of 2.08, 2.47, and 2.33 Hz for epicardial, endocardial, and midmy-
ocardial preparations, respectively, are lower than those observed
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clinically for ventricular tachycardia, except for the second epicar-
dial frequency, which at 2.97 Hz is just inside the clinical range.
The simulation results of 2.08, 2.47, and 2.33 Hz do not match
the ventricular fibrillation frequencies experimental observations
of 7.5 Hz [58; 167; 168].
Recent work on mRNA [254] has shown that alternans in human
HF cells begins at a CL of 350 ms, whereas alternans in our case
is higher by 50 ms, 250 ms, and 30 ms for epicardial, midmyocar-
dial, and endocardial cells. However, alternans onset CLs are in
the range of the observed values reported in other studies [264] of
≤ 500 ms for epicardial and endocardial cells. In addition, in our
simulation results, we observed that the maximum range of APD
S-S restitution curve slopes is 0.26-0.60, 0.23-0.70, and 0.28-0.86
for epicardial, midmyocardial, and endocardial cells. For epicar-
dial and midmyocardial, the maximum range of APD S-S restitu-
tion curve slopes is less than the slope value of 0.86±0.12 measured
in the LV free wall of the failing human heart [70] for epicardial
and midmyocardial cells, but it matches the measured endocardial
cell.
– Variability representation In our work, we introduced the vari-
ability of the functional remodeled transmural cells under heart
failure conditions. The experimental studies documented in the
literature measured heart failure under different stages. However,
in this thesis, we considered the remodeled ionic currents as mean
and standard deviation. The calculated mean and standard devia-
tion are based on various experimental studies without considering
the stages of heart failure. In addition, we did not consider the
heart failure etiology, species, and the sample size of every exper-
iment when representing the variability of our developed model.
Moreover, we did not take into account the variability of the orig-
inal model. It is vital to study the variability of the undiseased
model to get deep insights into the border zone, or overlap be-
tween both sets of parameters. This will help constraining each
197
parameter under every condition.
7.3 Future Work
In addition to the aforementioned contributions to the field of cellular mod-
els, this thesis opens new avenues for possible future directions of this field,
as follows:
– Enhancement of cellular heart failure model In our developed
HF model, we remodeled ionic currents and exchangers through chang-
ing their conductance explicitly. However,in reality each of these ionic
currents represents the sum of currents of functional channels and their
properties, which include the current amplitude, open probability, and
availability. Any alteration of these properties will affect whole cell
ionic currents. Therefore, it is important to consider the potential
consequences of these properties under heart failure conditions. Es-
pecially, previous experimental studies observed agreement and alter-
ation of these properties depending on the current type. One study,
[213], shows that the single channel activity of L-type Ca+2 channels is
increased in failing myocardium compared to nonfailing myocardium.
In addition, [244] studied single channel properties of the INaL current
in humans and compared its gating property in normal and failing
hearts and found similar properties under both conditions.
– Improvement of heart failure model in 1D cable It is known
that the remodeling development during heart failure creates many
changes including molecular, cellular, structural, or functional alter-
ations. During this development process many elements are involved
such as fibroblasts. Our 1D simulation could be improved in two ways:
1) By including transmural cell types for building ventricular strands,
instead of homogeneous cells. Including this factor will help elucidate
how transmural cells affect the remodeled electrophysiological proper-
ties such as dispersion of repolarization, which is an important factor
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to arrhythmia [1; 139] and has controversial experimental observations
[70; 140]. 2) By including structural remodeling such as cellular un-
coupling or proliferation of fibroblasts [100; 123; 279] because it is
another contributor to arrhythmia [69; 91]. For this purpose, we could
integrate a fibroblast model such as [147; 208] with our developed HF
model.
– Electrophysiological and structural remodeling during heart
failure in setting the stage for arrhythmias In this thesis, we
focused on the electrophysiological side of remodeled ventricular my-
ocytes. However, to have a more robust result and make better pre-
dictions, the structure of ventricular myocytes should be incorporated.
If we integrate both the remodeled electrophysiology and structure of
ventricular myocytes under heart failure conditions, we will get more
realistic results when compared with experimental observations. For
example, considering the remodeled fiber structure allows one to as-
sess the relative effect of fibers on electrical propagation. The frame-
work can be built upon the original ventricular cellular model and our
developed heart failure model and incorporated with existing three-
dimensional anatomical structures from normal and HF human hearts.
Then, arrhythmia properties can be quantified with four possible com-
binations: 1) normal anatomy and normal electrophysiology, 2) HF
anatomy and normal electrophysiology, 3) normal anatomy and HF
electrophysiology, and 4) HF anatomy and HF electrophysiology.
– Electromechanical properties under heart failure conditions
in human ventricular cells Since the heart is an electromechanical
organ, it is important to incorporate mechanical properties such as
kinematics, forces, and material properties of the heart in the anal-
ysis of remodeled ventricular myocytes. Therefore, integrating the
cardiac electrophysiology and mechanical cellular models will provide
clearer insights to diagnose failing myocytes. Also, performing this in-
tegration will be more realistic, but complicated cardiac functions can
be simulated, which will help in predicting unseen properties under
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pathological conditions, such as heart failure.
– A drug application for the human heart failure model Another
new avenue could be using the developed heart failure model towards
drug applications. For example, the inclusion of CaMK in the model
will facilitate investigating how drug-induced alterations in ionic cur-
rent and exchanger properties may modulate the electrophysiological
properties in heart failure.
– Artificial Neural Networks for parameter sensitivity analy-
sis: applications to the understanding of heart failure mech-
anisms During HF, electrophysiological properties in a single cell are
altered. These alterations as observed by experimentalists include for
example, ion channel remodeling, altered calcium homeostasis, and in-
creased accumulated sodium concentration. Mathematical modeling
of disease-specific electrical activity of human ventricular cell types is
a powerful tool to complement experimental observations. However,
given a ventricular cellular model with typically a large number of
ionic parameters, it remains a great challenge to properly constrain
the value of these parameters to simulate pathological conditions of
interest, especially because distinctive sets of ionic parameters may
reproduce similar action potential characteristics.
In this new avenue, artificial neural networks (ANNs) can be used in
assessing the relative importance of various ionic parameters in their
contribution to the alterations that occur in the action potential or cal-
cium concentration during heart failure. The presented investigation
could be done using our developed HF-OVVR model. By training an
ANN on a large dataset of healthy versus HF electrophysiological con-
ditions simulated by the OVVR model, one will learn the relationship
between ionic parameters and action potential / calcium concentra-
tion characteristics. Using the learned ANN model, one can identify
parameter sets that are most associated with electrophysiological re-
modeling in HF. In addition, this can provide quantitative predictions
of these parameter values that correspond to experimentally observed
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cellular alterations. Performing this study can provide new insights
into the underlying mechanisms of HF, and potentially provide guid-
ance in application areas such as pharmaceutical intervention.
– Assessment of scroll wave dynamics To this point, our developed
heart failure model is not validated on three dimensional tissue. Even
though we applied our HF model on 2D tissue and initiated spiral
waves, it created stable and quasi-stable spiral waves. It could be the
case in 3D where the scroll wave breaks up into multiple scroll waves,









Valdivia et al. [246] ↓(39.3%±6.5) &
↓(57.1%±1.6)
canine & human -
Shang et al. [221] ↓(63%) human protein levels
Gao et al. [65] ↓(91.1%±9.3) human -
Sakakibara et al. [211] unchanged human -








Undrovinas et al. [244] ↑(-%) human Midmyocardium.
















Maltsev et al. [150] unchanged human -
Table A.2: Summary of changes in the late sodium (Na+) current density in







Rasmussen et al. [198] - human unchanged DHP B sites
& ↓(50%) β-receptors
Beuckelmann et al. [14] unchanged human
Beuckelmann et al. [47] unchanged human
Beuckelmann et al. [12] unchanged human in both DCM & ICM
Mewes et al. [158] unchanged human
Tomaselli et al. [235] unchanged human
Ouadid et al. [9] unchanged human
Schröder et al. [213] unchanged human ↑ SCA activity,
↑(189.4%) peak av-
erage current in a single
channel.
Kääb et al. [114] - human unchanged mRNA
Schwinger et al. [215] - human unchanged mRNA, P &
DHP
Chen et al. [26] unchanged human
Li et al. [133] unchanged human epicardium.
Takahashi et al. [231] ↓(35%-
48%) &
↓(47%)
human in DHP B sites & mRNA
Piot et al. [188] ↑ human with rapid stimulation
Table A.3: Summary of changes in the L-type Ca2+ current density in human
HF. ↓: decrease; DCM: dilated cardiomyopathy; ICM: ischemic cardiomyopathy;
SCA: single channel activity; B, binding; P: protein; epi: epicardium; endo:
endocardium; mid: mid-myocardial; DHP: dihydropyridine; CA: channel activity;


















Wettwer et al. [261] unchanged &
↓(47%)





human subepi- & subendo-
Kääb et al. [114] ↓(48%) human ↓(30%) in Kv4.3 mRNA.
Midmyocardium.
Li et al. [133] ↓(32.1%±6.4%) human epi- cell.
Zicha et al. [274] ↓(73.2%±5.8) &
↓(54.6%±2.0)
canine epi- & endo-. ↓(36%) &
(56%) Kv4.3 protein expres-
sion epi- & endo- human
↓(14%) & (50%) in KChIP2
expression epi- & endo- hu-
man
Holzem et al. [91] ↓(30%) human in Kv4.3 mRNA
Wettwer et al. [262] unchanged human -
Table A.4: Summary of changes in the Ca2+-independent transient outward
potassium (K+) current density in models of heart failure. ↓: decrease; P, pro-
tein; epi: epicardium; endo: endocardium; mid: mid-myocardial; IK,Slow: the
















Koumi et al. [125] ↓ human SCA in (56%) &
(77%) of patches are
active in DCM &
ICM.
Kääb et al. [114] ↓ human unchanged Kir2.1
mRNA. Midmy-
ocardium.
Li et al. [132] ↓(40.9%±0.8),
↓(40.7%±0.6),
↓(41.1%±2.9)
canine epi-, mid-, and endo-
cardial cell type.
Li et al. [133] ↓(56.3%±2.2) human epi- cell.
Akar et al. [2] ↓(50%), ↓(47%)
& ↓(64%)
canine epi-, endo-, & mid-
& unchanged mRNA
and P
Wang et al. [257] - human unchanged IRK
mRNA levels.
Table A.5: Summary of changes in the inward potassium (K+) current density
in human HF. ↓: decrease; DCM: dilated cardiomyopathy; ICM: ischemic car-
diomyopathy; SCA: single channel activity; P, protein; epi: epicardium; endo:







Kääb et al. [115] unchanged canine barley measure IK midmy-
ocardium.
Kääb et al. [114] - human unchanged HERG gene
Li et al. [133] unchanged human epicardium
Watanabe et al. [258] - human endo- RV. Unchanged
KCNH2 & KCNQ1
Verkerk et al. [248] unchanged rabbit in both DCM & ICM
Akar et al. [2] ↓ canine epi-, endo-, & mid- &
unchanged mRNA and
↓(39%), ↓(46%), & ↓(51%)
cERG P in epi-, endo, &
mid-




hERG1b in epi- & endo-
Beuckelmann et al.
[13]
- human could not observe IK in nor-
mal hearts
Table A.6: Summary of changes in the rapid delayed rectifier potassium (K+) cur-
rent density in human HF. ↓: decrease; DCM: dilated cardiomyopathy; ICM: is-
chemic cardiomyopathy; SCA: single channel activity; P, protein; epi: epicardium;







Li et al. [132] ↓(57.1%±1.6),
↓(57.7%±2.2),
& ↓(49.5%±1.6)
canine tail IKs epi-, endo-, & mid-
Li et al. [133] ↓(61.7%±1.4) human tail current density, epi- cell
Akar et al. [2] ↓ human &
canine
epi-, endo-, & mid- & un-
changed mRNA and P
Watanabe et al.
[258]
- human ↑(25%) KCNE1 mRNA
Beuckelmann et
al. [13]
- human could not observe IK in nor-
mal hearts
Table A.7: Summary of changes in the outward slow delayed rectifier potassium
(K+) current density in human HF. ↓: decrease; P, protein; epi: epicardium;







Studer et al. [228] ↑2.0-fold human ↑55% in mRNA and ↑41%
in CAD protein levels.
Reinecke et al.
[199]
↑(86.9%±0.12) human ↑(160%) immunoreactive
Na+/Ca2+ P
Flesch et al. [61] ↑Trend human ↑(79%) & ↑(58%) in DCM
& ICM mRNA and ↑(36%)
& ↑(20%) in DCM & ICM
P







↑(36%) & ↑(50%) in CAD &
DCM mRNA and ↑(170%)
& ↑(130%) in CAD & DCM
P & ↑(250%) in rat P
Hasenfuss et al.
[81]
↑2.0-fold human protein levels. ↑(80%) G1,







unchanged human protein levels.
Diedrichs et al. [45] unchanged human in DCM
Table A.8: Summary of changes in the sodium/calcium (Na+/Ca2+) exchanger
in human HF. ↓: decrease; DCM: dilated cardiomyopathy; ICM: ischemic car-
diomyopathy; CAD: coronary artery disease; NF: non-infarct; MI: myocardial in-
farction; P, protein; epi: epicardium; endo: endocardium; mid: mid-myocardial;






















- human ↓(38%) OUA
Shamraj et al.
[219]
↓(42%) human ↓(26%-56%) range of
decrease.
Zahler et al. [253] ↓ canine, rat &
human




↓(42%) human ↓(39%) in both β1 &
OBS
Allen et al. [106] tendency to de-
crease
human non-significantly
↓(10%) in DCM &
ICM
Table A.9: Summary of changes in the sodium/potassium (Na+/K+) exchanger
in human HF. ↓: decrease; DCM: dilated cardiomyopathy; ICM: ischemic car-
diomyopathy; CAD: coronary artery disease; NF: non-infarct; MI: myocardial in-
farction; P, protein; epi: epicardium; endo: endocardium; mid: mid-myocardial;









↓(48%) human mRNA levels.
Hasenfuss et al.
[79]
↓(50%) human Ca2+ uptake function.
Arai et al. [7] ↓ human SR gene expression.
Hasenfuss et al.
[81]
↓(41%), ↓(33%) human SERCA2a & phospho-
lamban protein levels.




↓(48%) human SR Ca2+-ATPase pro-
tein levels.





human SERCA2a protein &
mRNA levels in the
endo-, endo-, mid-, &
endo- relative to pro-
tein levels in epi-.
Yamamoto et al.
[268]
↓(55%) human The amount of Ca2+
uptake.








↓(43.6%±2.7) human rate of SR in midmy-
ocardium.
Lou et al. [139] ↓(15.4%), &
↓(40%)




Table A.10: Summary of changes in the sarcoplasmic reticulum Ca2+-ATPase
(SERCA) under HF conditions. ↓: decrease; DCM: dilated cardiomyopathy;
ICM: ischemic cardiomyopathy; CAD: coronary artery disease; NF: non-infarct;
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[185] Yann Péréon, Sophie Demolombe, Isabelle Baró, Emmanuel Drouin,
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[195] José L. Puglisi and Donald M. Bers. Labheart: an interactive
computer model of rabbit ventricular myocyte ion channels and
ca transport. American Journal of Physiology - Cell Physiology,
281(6):C2049–C2060, 2001. 27, 28, 29, 30, 139, 140
[196] H. Qin, M. W. Kay, N. Chattipakorn, D. T. Redden, R. E. Ideker,
and J. M. Rogers. Effects of heart isolation, voltage sensitive dye, and
electromechanical uncoupling agents on ventricular fibrillation. Am.
J. Physiol. Heart Circ. Physiol., 284(5):H1818–1826, 2003. 18
[197] Zhilin Qu, Lai-Hua Xie, Riccardo Olcese, Hrayr S. Karagueuzian,
Peng-Sheng Chen, Alan Garfinkel, and James N. Weiss. Early after-
depolarizations in cardiac myocytes: beyond reduced repolarization
reserve. Cardiovascular Research, 99(1):6–15, 2013. 162
[198] Randy P. Rasmussen, Wayne Minobe, and Michael R. Bristow. Cal-
cium antagonist binding sites in failing and nonfailing human ventric-
ular myocardium. Biochemical Pharmacology, 39(4):691 – 696, 1990.
21, 81, 85, 204
[199] Hans Reinecke, Roland Studer, Roland Vetter, Jrgen Holtz, and Hel-
mut Drexler. Cardiac na+/ca2+ exchange activity in patients with
end-stage heart failure. Cardiovascular Research, 31(1):48–54, 1996.
25, 81, 97, 209
[200] Dan M. Roden, Jeffrey R. Balser, Alfred L. George Jr, and Mark E.
Anderson. Cardiac ion channels. Annual Review of Physiology,
64(1):431–475, 2002. PMID: 11826275. 10
[201] Dan M. Roden and Prakash C. Viswanathan. Genetics of acquired
long qt syndrome. The Journal of Clinical Investigation, 115(8):2025–
2032, 8 2005. 162
238
BIBLIOGRAPHY
[202] Wayne Rosamond, Katherine Flegal, Gary Friday, Karen Furie, Alan
Go, Kurt Greenlund, Nancy Haase, Michael Ho, Virginia Howard,
Bret Kissela, Steven Kittner, Donald Lloyd-Jones, Mary McDermott,
James Meigs, Claudia Moy, Graham Nichol, Christopher J. ODon-
nell, Veronique Roger, John Rumsfeld, Paul Sorlie, Julia Steinberger,
Thomas Thom, Sylvia Wasserthiel-Smoller, Yuling Hong, for the
American Heart Association Statistics Committee, and Stroke Statis-
tics Subcommittee. Heart disease and stroke statistics2007 update.
Circulation, 115(5):e69–e171, 2007. 14
[203] Jochen Rose, Antonis A. Armoundas, Yanli Tian, Deborah DiS-
ilvestre, Miroslava Burysek, Victoria Halperin, Brian O’Rourke,
David A. Kass, Eduardo Marbn, and Gordon F. Tomaselli. Molecular
correlates of altered expression of potassium currents in failing rabbit
myocardium. American Journal of Physiology - Heart and Circulatory
Physiology, 288(5):H2077–H2087, 2005. 22, 46, 81, 94, 117, 130
[204] David S. Rosenbaum, Lance E. Jackson, Joseph M. Smith, Hasan
Garan, Jeremy N. Ruskin, and Richard J. Cohen. Electrical alternans
and vulnerability to ventricular arrhythmias. New England Journal
of Medicine, 330(4):235–241, 1994. PMID: 8272084. 71
[205] Bradley J. Roth and John P. Wikswo. A bidomain model for the
extracellular potential and magnetic field of cardiac tissue. Biomedical
Engineering, IEEE Transactions on, BME-33(4):467–469, April 1986.
196
[206] John A. Rumberger, Thomas Behrenbeck, Jerome R. Breen, Judd E.
Reed, and Bernard J. Gersh. Nonparallel changes in global left ven-
tricular chamber volume and muscle mass during the first year after
transmural myocardial infarction in humans. Journal of the American
College of Cardiology, 21(3):673 – 682, 1993. 8
[207] Stanley Rush and Hugh Larsen. A practical algorithm for solving
dynamic membrane equations. Biomedical Engineering, IEEE Trans-
actions on, (4):389–392, 1978. 41
239
BIBLIOGRAPHY
[208] Frank B. Sachse, Alonso P. Moreno, and J. A. Abildskov. Electrophys-
iological modeling of fibroblasts and their interaction with myocytes.
Annals of Biomedical Engineering, 36(1):41–56, 2008. 199
[209] Rajan Sah, Rafael J Ramirez, Roger Kaprielian, and Peter H
Backx. Alterations in action potential profile enhance excitation-
contraction coupling in rat cardiac myocytes. The Journal of Physi-
ology, 533(1):201–214, 2001. 22
[210] D A Saint, Y K Ju, and P W Gage. A persistent sodium current
in rat ventricular myocytes. The Journal of Physiology, 453:219–231,
1992. 19
[211] Y. Sakakibara, T. Furukawa, D. H. Singer, H. Jia, C. L. Backer, C. E.
Arentzen, and J. A. Wasserstrom. Sodium current in isolated human
ventricular myocytes. American Journal of Physiology - Heart and
Circulatory Physiology, 265(4):H1301–H1309, 1993. 20, 70, 82, 202
[212] Wolfgang Schillinger, Jan W Fiolet, Klaus Schlotthauer, and Gerd
Hasenfuss. Relevance of na+ca2+ exchange in heart failure. Cardio-
vascular Research, 57(4):921–933, 2003. 25
[213] Frank Schrader, Renate Handrock, Dirk J. Beuckelmann, Stephan
Hirt, Roger Hullin, Leo Priebe, Robert H. G. Schwinger, Joachim
Weil, and Stefan Herzig. Increased availability and open probability
of single l-type calcium channels from failing compared with nonfailing
human ventricle. Circulation, 98(10):969–976, 1998. 21, 81, 85, 198,
204
[214] Gernot Schram, Marc Pourrier, Peter Melnyk, and Stanley Nattel.
Differential distribution of cardiac ion channel expression as a basis
for regional specialization in electrical function. Circulation Research,
90(9):939–950, 2002. 19, 21
[215] R.H.G. Schwinger, S. Hoischen, H. Reuter, and R. Hullin. Regional
expression and functional characterization of the l-type ca2+-channel
240
BIBLIOGRAPHY
in myocardium from patients with end-stage heart failure and in non-
failing human hearts. Journal of Molecular and Cellular Cardiology,
31(1):283 – 296, 1999. 21, 25, 81, 85, 204, 209
[216] Robert H. G. Schwinger, Jiangnan Wang, Konrad Frank, Jochen
Mller-Ehmsen, Klara Brixius, Alicia A. McDonough, and Erland Erd-
mann. Reduced sodium pump 1, 3, and 1-isoform protein levels and
na+,k+-atpase activity but unchanged na+-ca2+ exchanger protein
levels in human heart failure. Circulation, 99(16):2105–2112, 1999.
25, 26, 81, 97, 210
[217] Gerdes A.M. Kellerman S.E. and Schocken D.D. Implications of car-
diomyocyte remodeling in heart dysfunction. Raven Press Publishers,
New York, NY, 1995. 8, 9
[218] Maxime Sermesant, Herv Delingette, Yves Coudire, Phani Chincha-
patnam, Kawals. Rhode, Reza Razavi, and Nicholas Ayache. N.: An
anisotropic multi-front fast marching method for real-time simulation
of cardiac electrophysiology. In In: FIMH07. Volume 4466 of LNCS,
pages 7–9, 2007. 17
[219] Olga I Shamraj, Ingrid L Grupp, Gunther Grupp, David Melvin,
Nathalie Gradoux, Walter Kremers, Jerry B Lingrel, and Alain De
Pover. Characterisation of na/k-atpase, its isoforms, and the inotropic
response to ouabain in isolated failing human hearts. Cardiovascular
Research, 27(12):2229–2237, 1993. 26, 81, 97, 210
[220] Lijuan L. Shang and et al. Human heart failure is associated with
abnormal c-terminal splicing variants in the cardiac sodium channel.
Circulation Research, 101(11):1146–1154, 2007. 81, 82
[221] L.L. Shang, A.E. Pfahnl, S. Sanyal, Z. Jiao, J. Allen, K. Ba-
nach, J. Fahrenbach, D. Weiss, W.R. Taylor, A.M. Zafari, and S.C.
Dudley Jr. Human heart failure is associated with abnormal c-
terminal splicing variants in the cardiac sodium channel. Circ Res,
101(11):1146–54, 2007. 20, 202
241
BIBLIOGRAPHY
[222] Thomas R. Shannon and et al. Regulation of cardiac sarcoplasmic
reticulum ca release by luminal [ca] and altered gating assessed with
a mathematical model. Biophysical Journal, 89(6):4096 – 4110, 2005.
27, 28, 29, 30, 139, 140
[223] Wataru Shimizu and Charles Antzelevitch. Sodium channel block
with mexiletine is effective in reducing dispersion of repolarization
and preventing torsade de pointes in lqt2 and lqt3 models of the long-
qt syndrome. Circulation, 96(6):2038–2047, 1997. 162
[224] Karin R Sipido, V. Bito, G. Antoons, Paul G Volders, and Marc A
Vos. Na/ca exchange and cardiac ventricular arrhythmias. Ann N Y
Acad Sci, 1099:339–348, March 2007. 25, 162
[225] M S Spach, W T Miller, D B Geselowitz, R C Barr, J M Kootsey,
and E A Johnson. The discontinuous nature of propagation in nor-
mal canine cardiac muscle. evidence for recurrent discontinuities of
intracellular resistance that affect the membrane currents. Circula-
tion Research, 48(1):39–54, 1981. 195
[226] J F Spear and E N Moore. Mechanisms of cardiac arrhythmias. An-
nual Review of Physiology, 44(1):485–497, 1982. PMID: 7041803. 14
[227] Francis G. Spinale, Christine Clayton, Ryuhei Tanaka, B.Martin Ful-
bright, Rupak Mukherjee, Bradley A. Schulte, Fred A. Crawford,
and Michael R. Zile. Myocardial na+,k+-atpase in tachycardia in-
duced cardiomyopathy. Journal of Molecular and Cellular Cardiology,
24(3):277 – 294, 1992. 26
[228] R Studer, H Reinecke, J Bilger, T Eschenhagen, M Bhm, G Hasen-
fuss, H Just, J Holtz, and H Drexler. Gene expression of the cardiac
na(+)-ca2+ exchanger in end-stage human heart failure. Circulation
Research, 75(3):443–53, 1994. 25, 81, 97, 209
[229] R. Studer, H. Reinecke, R. Vetter, J. Holtz, and H. Drexler. Expres-
sion and function of the cardiac na+/ca2+ exchanger in postnatal
242
BIBLIOGRAPHY
development of the rat, in experimentaliduced cardiac hypertrophy
and in the failing human heart. Basic Research in Cardiology, 92:53–
58, 1997. 25, 97, 166, 209
[230] Peter Taggart, Peter MI Sutton, Tobias Opthof, Ruben Coronel,
Richard Trimlett, Wilfred Pugsley, and Panny Kallis. Inhomogeneous
transmural conduction during early ischaemia in patients with coro-
nary artery disease. Journal of Molecular and Cellular Cardiology,
32(4):621 – 630, 2000. 60, 70, 191
[231] T Takahashi, P D Allen, R V Lacro, A R Marks, A R Dennis, F J
Schoen, W Grossman, J D Marsh, and S Izumo. Expression of di-
hydropyridine receptor (ca2+ channel) and calsequestrin genes in the
myocardium of patients with end-stage heart failure. The Journal of
Clinical Investigation, 90(3):927–935, 9 1992. 21, 22, 81, 85, 89, 204,
206
[232] KHWJ Ten Tusscher, D Noble, PJ Noble, and AV Panfilov. A model
for human ventricular tissue. American Journal of Physiology-Heart
and Circulatory Physiology, 286(4):H1573–H1589, 2004. 17, 42, 47,
49
[233] Kirsten HWJ ten Tusscher and Alexander V Panfilov. Alternans and
spiral breakup in a human ventricular tissue model. American Jour-
nal of Physiology-Heart and Circulatory Physiology, 291(3):H1088–
H1100, 2006. 42, 47, 49, 51
[234] Henk E. D. J. ter Keurs and Penelope A. Boyden. Calcium and
arrhythmogenesis. Physiological Reviews, 87(2):457–506, 2007. 31
[235] G F Tomaselli, D J Beuckelmann, H G Calkins, R D Berger, P D
Kessler, J H Lawrence, D Kass, A M Feldman, and E Marban. Sudden
cardiac death in heart failure. the role of abnormal repolarization.
Circulation, 90(5):2534–9, 1994. xvi, 21, 22, 25, 81, 85, 89, 90, 162,
204, 205, 206, 209
243
BIBLIOGRAPHY
[236] Gordon F. Tomaselli and Eduardo Marbn. Electrophysiological re-
modeling in hypertrophy and heart failure. Cardiovascular Research,
42(2):270–283, 1999. xi, 11, 22
[237] Beatriz Trenor, Karen Cardona, Juan F. Gomez, Sridharan Raja-
mani, Jose M. Ferrero, Luiz Belardinelli, and Javier Saiz. Simulation
and mechanistic investigation of the arrhythmogenic role of the late
sodium current in human heart failure. PLoS ONE, 7(3), 2012. 27,
28, 29, 30, 139, 140
[238] Yukiomi Tsuji, Tobias Opthof, Kaichiro Kamiya, Kenji Yasui, Weiran
Liu, Zhibo Lu, and Itsuo Kodama. Pacing-induced heart failure causes
a reduction of delayed rectifier potassium currents along with de-
creases in calcium and transient outward currents in rabbit ventricle.
Cardiovascular Research, 48(2):300–309, 2000. xvii, 46, 81, 94, 95,
109, 117, 130
[239] Yukiomi Tsuji, Stephen Zicha, Xiao-Yan Qi, Itsuo Kodama, and Stan-
ley Nattel. Potassium channel subunit remodeling in rabbits exposed
to long-term bradycardia or tachycardia: Discrete arrhythmogenic
consequences related to differential delayed-rectifier changes. Circu-
lation, 113(3):345–355, 2006. xvii, 95
[240] K. Ten Tusscher. Spiral wave dynamics and ventricular arrhythmias.
PhD thesis, Utrecht University, Netherlands, 2004. 14
[241] Carmen A. Ufret-Vincenty, Deborah J. Baro, W. Jonathan Lederer,
Howard A. Rockman, Luis E. Quiones, and L. Fernando Santana. Role
of sodium channel deglycosylation in the genesis of cardiac arrhyth-
mias in heart failure. Journal of Biological Chemistry, 276(30):28197–
28203, 2001. 19, 117, 130
[242] A I Undrovinas, I A Fleidervish, and J C Makielski. Inward sodium
current at resting potentials in single cardiac myocytes induced by the




[243] A. I. Undrovinas, V. A. Maltsev, and H. N. Sabbah. Repolarization
abnormalities in cardiomyocytes of dogs with chronic heart failure:
role of sustained inward current. Cellular and Molecular Life Sciences
CMLS, 55:494–505, 1999. xxvi, 19, 21, 181, 182
[244] Albertas I. Undrovinas, Victor A. Maltsev, John W. Kyle, Norman
Silverman, and Hani N. Sabbah. Gating of the late na+ channel in
normal and failing human myocardium. Journal of Molecular and
Cellular Cardiology, 34(11):1477 – 1489, 2002. 20, 81, 82, 85, 185,
198, 203
[245] Miguel Valderrabano. Influence of anisotropic conduction properties
in the propagation of the cardiac action potential. Prog Biophys Mol
Biol., 94(1-2):144–168, March 2007. 195
[246] C. R. Valdivia, W. W. Chu, J. Pu, J. D. Foell, R. A. Haworth, M. R.
Wolff, T. J. Kamp, and J. C. Makielski. Increased late sodium current
in myocytes from a canine heart failure model and from failing human
heart. Journal of Molecular and Cellular Cardiology, 38(3):475 – 483,
2005. xv, xvi, 20, 81, 82, 83, 85, 86, 164, 202, 203
[247] Andrs Varr, Beta Balti, Norbert Iost, Jnos Takcs, Lszl Virg, David A
Lathrop, Lengyel Csaba, Lszl Tlosi, and Julius Gy Papp. The role
of the delayed rectifier component iks in dog ventricular muscle and
purkinje fibre repolarization. The Journal of Physiology, 523(1):67–
81, 2000. 24
[248] Arie O. Verkerk, Antonius Baartscheer, Joris R. de Groot, Ronald
Wilders, and Ruben Coronel. Etiology-dependency of ionic remodel-
ing in cardiomyopathic rabbits. International Journal of Cardiology,
148(2):154 – 160, 2011. 23, 109, 117, 130, 207
[249] Jessica T Vermeulen, Mark A Mcguire, Tobias Opthof, Ruben Coro-
nel, Jacques M T De Bakker, Corinne Klpping, and Michiel J Janse.
Triggered activity and automaticity in ventricular trabeculae of failing
245
BIBLIOGRAPHY
human and rabbit hearts. Cardiovascular Research, 28(10):1547–1554,
1994. 20
[250] Paul G.A. Volders, Marc A. Vos, Bela Szabo, Karin R. Sipido,
S.H.Marieke de Groot, Anton P.M. Gorgels, Hein J.J. Wellens, and
Ralph Lazzara. Progress in the understanding of cardiac early afterde-
polarizations and torsades de pointes: time to revise current concepts.
Cardiovascular Research, 46(3):376–392, 2000. 162
[251] Tilmann Volk, Thi Hong-Diep Nguyen, Jobst-Hendrik Schultz, and
Heimo Ehmke. Relationship between transient outward k+ current
and ca2+ influx in rat cardiac myocytes of endo- and epicardial origin.
The Journal of Physiology, 519(3):841–850, 1999. 22
[252] M A Vos. Literature-based evaluation of four hard endpoint models for
assessing drug-induced torsades de pointes liability. British Journal
of Pharmacology, 154(7):1523–1527, 2008. 162
[253] Zahler R. Gilmore-Hebert M. Sun W. and Benz EJ. Na, k-atpase
isoform gene expression in normal and hypertrophied dog heart. Basic
Res Cardiol., 91(3):256–66, 1996. 26, 210
[254] John Walmsley and et al. mrna expression levels in failing human
hearts predict cellular electrophysiological remodeling: A population-
based simulation study. PLoS ONE, 8(2):e56359, 02 2013. 27, 28, 29,
30, 139, 140, 158, 197
[255] Yanggan Wang and Joseph A. Hill. Electrophysiological remodeling in
heart failure. Journal of Molecular and Cellular Cardiology, 48(4):619
– 632, 2010. 21, 23, 24
[256] Yanggan Wang, Samvit Tandan, Jun Cheng, Chunmei Yang, Lan
Nguyen, Jessica Sugianto, Janet L. Johnstone, Yuyang Sun, and
Joseph A. Hill. Ca2+/calmodulin-dependent protein kinase ii-
dependent remodeling of ca2+ current in pressure overload heart fail-
ure. Journal of Biological Chemistry, 283(37):25524–25532, 2008. 19
246
BIBLIOGRAPHY
[257] Zhiguo Wang, Lixia Yue, Michel White, Guy Pelletier, and Stan-
ley Nattel. Differential distribution of inward rectifier potassium
channel transcripts in human atrium versus ventricle. Circulation,
98(22):2422–2428, 1998. 23, 206
[258] Eiichi Watanabe, Kenji Yasui, Kaichiro Kamiya, Takahiro Yam-
aguchi, Ichiro Sakuma, Haruo Honjo, Yukio Ozaki, Shinichiro Mo-
rimoto, Hitoshi Hishida, and Itsuo Kodama. Upregulation of kcne1
induces qt interval prolongation in patients with chronic heart failure.
Circulation Journal, 71(4):471–478, 2007. 23, 24, 94, 207, 208
[259] C. R. Weber, V. 3rd. Piacentino, S. R. Houser, and D. M. Bers.
Dynamic regulation of sodium/calcium exchange function in human
heart failure. Circulation, 108:2224–2229, 2003. xix, 106, 158, 192
[260] James N. Weiss, Alan Garfinkel, Hrayr S. Karagueuzian, Peng-Sheng
Chen, and Zhilin Qu. Early afterdepolarizations and cardiac arrhyth-
mias. Heart Rhythm, 7(12):1891 – 1899, 2010. 115, 162
[261] E Wettwer, G J Amos, H Posival, and U Ravens. Transient outward
current in human ventricular myocytes of subepicardial and subendo-
cardial origin. Circulation Research, 75(3):473–82, 1994. 21, 22, 81,
89, 205
[262] Erich Wettwer, Gregory Amos, Jennifer Gath, Hans-Reinhard
Zerkowski, Jrgen-Christoph Reidemeister, and Ursula Ravens. Tran-
sient outward current in human and rat ventricular myocytes. Car-
diovascular Research, 27(9):1662–1669, 1993. 21, 205
[263] Ronald Wilders. Computer modelling of the sinoatrial node. Medical
and biological engineering and computing, 45(2):189–207, 2007. 49
[264] L. D. Wilson and et al. Heart failure enhances susceptibility to ar-




[265] Lance D. Wilson, Michelle M. Jennings, and David S. Rosenbaum.
Point: M cells are present in the ventricular myocardium. Heart
Rhythm, 8(6):930 – 933, 2011. 68
[266] Raimond L. Winslow, Jeremy Rice, Saleet Jafri, Eduardo Marbn, and
Brian ORourke. Mechanisms of altered excitation-contraction cou-
pling in canine tachycardia-induced heart failure, ii: Model studies.
Circulation Research, 84(5):571–586, 1999. 25, 27, 28, 29, 30, 139
[267] Jafri S. Winslow RL, Rice J. Modeling the cellular basis of altered
excitation-contraction coupling in heart failure. Prog Biophys Mol
Biol., 69(2-3):497 – 514, 1998. 27, 28, 29, 30
[268] T. Yamamoto, M. Yano, M. Kohno, T. Hisaoka, K. Ono, T. Tani-
gawa, Y. Saiki, Y. Hisamatsu, T. Ohkusa, and M. Matsuzaki. Abnor-
mal ca2+ release from cardiac sarcoplasmic reticulum in tachycardia-
induced heart failure. Cardiovasc Res., 44(1):146–55, Oct 1999. 26,
81, 104, 211
[269] Gan-Xin Yan, Ying Wu, Tengxian Liu, Jixin Wang, Roger A. Mar-
inchak, and Peter R. Kowey. Phase 2 early afterdepolarization as
a trigger of polymorphic ventricular tachycardia in acquired long-qt
syndrome: Direct evidence from intracellular recordings in the intact
left ventricular wall. Circulation, 103(23):2851–2856, 2001. 162
[270] Atsushi Yao, Zhi Su, Akihiko Nonaka, Iram Zubair, Kenneth W.
Spitzer, John H. B. Bridge, Gerhard Muelheims, John Ross, and
William H. Barry. Abnormal myocyte ca2+homeostasis in rabbits
with pacing-induced heart failure. American Journal of Physiology -
Heart and Circulatory Physiology, 275(4):H1441–H1448, 1998. 113,
117, 130
[271] Arthur M. Yue, Michael R. Franz, Paul R. Roberts, and John M.
Morgan. Global endocardial electrical restitution in human right and
left ventricles determined by noncontact mapping. Journal of the
American College of Cardiology, 46(6):1067 – 1075, 2005. 70
248
BIBLIOGRAPHY
[272] Yunliang Zang and Ling Xia. Electrical remolding and mechanical
changes in heart failure: A model study. In Kang Li, Li Jia, Xin Sun,
Minrui Fei, and GeorgeW. Irwin, editors, Life System Modeling and
Intelligent Computing, volume 6330 of Lecture Notes in Computer
Science, pages 421–429. Springer Berlin Heidelberg, 2010. 27, 28, 29,
30, 139, 140, 159
[273] Yu Zhang, Guofa Shou, and Ling Xia. Simulation study of transmural
cellular electrical properties in failed human heart. In Engineering in
Medicine and Biology Society, 2005. IEEE-EMBS 2005. 27th Annual
International Conference of the, pages 337–340, 2005. 27, 28, 29, 30,
139, 160
[274] Stephen Zicha, Ling Xiao, Sara Stafford, Tae Joon Cha, Wei Han,
Andras Varro, and Stanley Nattel. Transmural expression of transient
outward potassium current subunits in normal and failing canine and
human hearts. The Journal of Physiology, 561(3):735–748, 2004. 21,
89, 164, 205
[275] Heinz-Gerd Zimmer, A.Martin Gerdes, Sylviane Lortet, and Gerhard
Mall. Changes in heart function and cardiac cell size in rats with
chronic myocardial infarction. Journal of Molecular and Cellular Car-
diology, 22(11):1231 – 1243, 1990. 8
[276] Douglas P. Zipes and Hein J. J. Wellens. Sudden cardiac death. Cir-
culation, 98(21):2334–2351, 1998. 14
[277] D.P. Zipes and J. Jalife. Cardiac Electrophysiology: from Cell to
Bedside. Saunders Elsevier, Philadelphia, 2009. 11, 12, 14
[278] Sharon Zlochiver. Subthreshold parameters of cardiac tissue in a bi-
layer computer model of heart failure. Cardiovascular Engineering,
10(4):190–200, 2010. 27, 28, 29, 30
[279] Sharon Zlochiver, Viviana Munoz, Karen L. Vikstrom, Steven M.
Taffet, Omer Berenfeld, and Jose Jalife. Electrotonic myofibroblast-
to-myocyte coupling increases propensity to reentrant arrhythmias in
249
BIBLIOGRAPHY
two-dimensional cardiac monolayers. Biophysical Journal, 95(9):4469
– 4480, 2008. 199
[280] Carsten Zobel and et al. Molecular dissection of the inward rectifier
potassium current (iK1) in rabbit cardiomyocytes: evidence for het-
eromeric co-assembly of kir2.1 and kir2.2. The Journal of Physiology,
550(2):365–372, 2003. 46, 89
[281] A. C. Zygmunt, D. C. Robitelle, and G. T. Eddlestone. Ito1 dic-
tates behavior of icl(ca) during early repolarization of canine ventricle.
American Journal of Physiology - Heart and Circulatory Physiology,
273(3):H1096–H1106, 1997. 22
250
